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Abstract
Type I diabetes is an autoimmune disease affecting millions of people in the world. It occurs when
the pancreas cannot produce insulin, resulting in episodes of hyperglycaemia that can lead to heart
attacks, renal failure, or death. The main cause is the auto destruction of beta cells that produce
insulin, located in the pancreatic islets (or islets of Langerhans). Current treatments include insulin
injections that decrease the blood glucose level. However, it can sometimes generate hypoglycaemia
or insulin resistance on the patients. Bioprinting allows controlled engineering of pancreatic islets
with hydrogel scaffolds and transplanting them into the patients. Nevertheless, immunotolerance of
the grafted constructs has yet to be achieved. Currently, the islets are implanted together with
immunosuppressors to avoid the rejection, but these affect the functionality of the beta cells. Cotransplanting regulatory T cells (Tregs) that regulate the autoimmune response could be the solution
to immune rejection. Thus, co-axial extrusion printing is a promising approach, as it allows printing
two types of bioinks. Pancreatic islets can be printed in the core of the structure and Tregs in the
shell, protecting the islets. This project was mainly focused on the development of the bioink for
the shell. The ink consists of a hydrogel that promotes cell growth and allows bioprinting (2%
alginate/7.5% gelatin methacrylolyl (GelMA)/3.5% gelatin), and growth factors for Treg
functionality (IL-2). The growth factors were encapsulated in GelMA microspheres for a sustained
release inside the ink. The release rate of IL-2 was studied, as well as the ink properties and
printability.
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Laymen’s Summary
Type I diabetes affects millions of people in the world. It is an autoimmune disease, where the
patient’s own immune system attacks the body. It occurs when the immune system destroys the beta
cells that are responsible for generating insulin, located in the pancreatic islets. Insulin regulates and
reduces the sugar level in the blood stream when it is too high. However, type 1 diabetic people
have a lack of this hormone, therefore, they present episodes of hyperglycaemia (high levels of sugar
in blood). This can lead to heart attacks, renal failure or death. Current treatments include insulin
injections that decrease the blood glucose level. However, its extensive use can sometimes generate
hypoglycaemia (low levels of sugar in blood) or insulin resistance on the patients.
Bioprinting is an emerging technology where 3D printing is applied to the biology, providing the
opportunity to assemble cells with or without biomaterials in a spatially controlled manner. It allows
engineering pancreatic islets in scaffolds and transplanting them into the patients. Nevertheless,
immunotolerance of the grafted constructs has yet to be achieved. The immune system could attack
the transplanted constructs because the cells and materials used are foreign and/or because in type
1 diabetes, the pancreatic islets are generally attacked. Currently, the islets are implanted together
with immunosuppressors to mitigate the rejection and provide some immunotolerance. However,
these suppressors affect the functionality of the beta cells. Co-transplanting regulatory T cells
(Tregs) that regulate the autoimmune response could be the solution to immune rejection. Thus, coaxial extrusion printing is a promising approach, as it allows printing two types of bioinks. Extrusion
printing works delivering the material through a needle (called nozzle) and depositing it into 3D
constructs with desired coordination. In the co-axial variety, the nozzle has two inputs (one for each
material). These two materials are extruded simultaneously, one inside the other one. In the
approach for bioprinting a solution for type 1 diabetes, pancreatic islets could be printed in the core
of the structure (inside) and Tregs in the shell (outside), protecting the islets.
This project was mainly focused on the development of the bioink (the supporting biomaterial for
the cells, responsible for providing mechanical structure and environment for the cells) for the shell.
The ink consisted of a hydrogel, a material rich in water that promotes cell growth and allows
bioprinting (2% alginate/7.5% gelatin methacrylolyl (GelMA)/3.5% gelatin). Furthermore, some
growth factors necessary for Treg functionality (interleukin-2 or IL-2) were needed. The growth
factors were encapsulated in GelMA microspheres for a sustained release inside the ink. The
microspheres are sub-micron to micron sized hollow spheres, often used for drug encapsulation. In
the project, the release rate of IL-2 from the microspheres was studied, as well as the ink properties
and printability.
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Chapter 1
1. Introduction
1.1 Diabetes
Diabetes mellitus is a metabolic illness affecting millions of people worldwide. The cases of
diagnosed diabetes in the world have increased drastically on the recent years, for instance, only in
the United States the number of patients with type 2 diabetes has increased from 1.5 million to 24
million from 1958 to 2015 (Figure 1). It occurs when the pancreas does not function correctly (more
information about the pancreas is shown in Box 1). The pancreas consists of different types of cells
(Figure 2), which produce different hormones (Table 1). These cells include beta cells that generate
insulin, a hormone that controls glucose levels in the blood stream. When patients generate
insufficient insulin, they present elevated blood sugar levels (hyperglycaemia). This leads to
complications such as risk of heart attack, kidney failure, cornea and nerve damage, etc (1–3). Its
prevalence has increased significantly over the past decades, especially in developed and developing
countries (4,5): 180 million were affected in 1980, rising to 422 million in 2014 (3,6). For instance,
in the United States, the percentage of the diagnosed disease has increased from less than 1% to
almost 8% in the past 60 years (7).

Figure 1. Evolution of diagnosed type II diabetes cases over the last 60 years in the United States (7).
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(8),
(8,9)

Box 1. Structure and function of
pancreas.

The pancreas is composed of two main
components. One of them is the exocrine
pancreas, which includes ductal and acinar cells.
These generate enzymes that are delivered to the
small intestine for the digestion. The other one is
the endocrine pancreas, which represents less
than 5% of the whole organ but is of vital
importance.
The endocrine pancreas consists of the pancreatic
islets or islets of Langerhans, formed by
thousands of endocrine cells and a strong
vasculature (1,8). There are 5 types of cells, each
of them synthesising a different hormone:
Table 1. Summary of the quantity and hormone
produced by each cell type in the islets (8,9).

Figure 2. Structure of the human macroscopic

Cells

% of cells in
islets

Hormone
produced

Beta

50-70%

Insulin

Alpha

20-40%

Glucagon

Delta

(A) and microscopic (B) pancreas (modified
from (8)). Figure 2B shows the cell

Somatostatin

PP

< 10%
together

Epsilon

< 1%

distribution in the islets of Langerhans, which
make up to 5% of the whole organ.

Pancreatic
polypeptide
Ghrelin

Insulin and glucagon are the two enzymes
regulating glucose levels in blood. While insulin
decreases the blood glucose level when it is high,
glucagon increases it when it is low.
There are two main types of diabetes: type 1, also called insulin-dependent or juvenile diabetes; and
type 2, also known as non-insulin-dependent or adult diabetes (3,10). Table 2 summarises the
features of each type.

15

Table 2. Characteristics and differences of type 1 and 2 diabetes.

People

Type 1 Diabetes

Type 2 Diabetes

- 5-10% of diabetics (40 million) (1–3)

- 90-95% of diabetics (380 - 400

affected

million) (11)
- Usually young population (>85%
under the age of 20) (5)

- Generally adult people (3,12)
- Recently in younger ages as well
(related to increase in sedentarism and
obesity) (5)

Mechanism

-

Beta

cell

destruction

(insulin

- Insulin resistance: even if insulin is

generating cells) by patient’s own

created, target organs are resistant,

immune system (1,13)

keeping blood glucose levels high
(10,14,15)

- No insulin secretion (or very low)
- Insufficient compensatory insulin
secretion (2)
Cause

- Autoimmune (10,16)

- Genetic, environmental and lifestyle
factors, obesity (18–21)

- Combination of genetic, immunologic
and environmental factors, although not
fully understood yet (17)
Consequences

-

Risk

of

cardiovascular disease,

- Increased risk of stroke and heart

neuropathy, retinopathy, nephropathy

attack (22,23), kidney failure (24),

(1,13)

blindness, nerve damage (9) and limb
amputations (25,26)

Treatment

- Daily insulin injections to decrease

-

Lifestyle

changes:

diet,

blood glucose levels (1,13)

exercise… in early stages (6)

more

- Insulin injections in advanced stages
(10)
As Table 2 shows, the two types are different. For better understanding, the difference in the
mechanism between them is shown schematically in Figure 3. Even if fewer people are affected by
it, T1D is more dangerous: it is a chronic autoimmune disease that destroys the insulin producing
beta cells. As a consequence, they need daily controls to measure their blood glucose level, and a
lifetime treatment to keep it in a normal range (1,27). Whereas Type 2 diabetes is mainly prevalent
in the adulthood, more children suffer from the Type 1. Meanwhile, early T2D occurs when the
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target tissues such as liver, fat or muscle are resistant to the insulin produced (10,28,29). This means
that the problem is not the lack of insulin in the body, even if they lose beta cells in the advanced
stages of the disease, producing less insulin than healthy individuals (10,30,31). Therefore, their
condition can be initially improved by changing their lifestyle and acquiring healthier habits, to the
point of not needing any treatment (or not as often as the T1D patients). For this reason, this work
was focused on Type 1 diabetes.

Figure 3. Schematic representation of the mechanism of type 1 and 2 diabetes (10). When the β-cells are
destroyed, the insulin is not produced and glucose cannot be carried inside the cells, accumulating in the blood
stream (T1D). However, type 2 diabetes starts when the β-cells produce insulin, but the target tissues are
resistant, accumulating the part of the glucose in the blood stream. In later stages, less insulin is produced and
T2D also becomes insulin dependent.

1.1.2 Current treatments for Type 1 diabetes
Type 1 diabetes occurs when the immune system of the patients attacks and destroys the insulinproducing beta cells (located in the Langerhans islets). People affected by it present various
symptoms such as polydipsia (extreme thirstiness), polyphagia (increased appetite) and polyuria
(large production of urine), as well as the already mentioned hyperglycaemia (27). The lack of
treatment would result in serious consequences, especially cardiovascular events (stroke,
myocardial infarction, etc), which might lead to limb amputations (27). Moreover, other dangerous
effects are retinopathy, nephropathy and neuropathy (1,3).
Regeneration of the exocrine pancreas can be achieved naturally; however, the islets and the beta
cells have a limited regenerative capacity (28). Therefore, T1D is a chronic disease: the symptoms
usually appear when 90-95% of the beta cells are destroyed (1,27) and these cells are incapable of
self-regeneration. For this reason, T1D must be tackled externally. The most widely spread method
to treat diabetes is the use of insulin injections. These consist of subcutaneous administration of
insulin to the patient in a controlled way. The insulin decreases the blood glucose level, taking it to
a normal range. However, the exact dose and administration time might not match the functional
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rhythms, and the intensive use can generate hypoglycaemia (3,32). Hypoglycaemia occurs when the
glucose in blood is below the normal range. It can be as dangerous as hyperglycaemia, and it can
occur if there is too much insulin in the blood stream (due to overusing the treatment). Hence, the
main goal of the insulin administration (keeping blood glucose in a normal range) could fail on some
occasions (33). Currently there are some measurements to improve this treatment, by using insulin
analogues, insulin pumps or continuous glucose monitors (27). Additionally, the need of a daily
insulin administration results in a high cost for the treatment (estimated 14.5-14.9 billion USD were
spent in the USA in 2007 in T1D (34)). This leads to the treatment not being accessible for people
in lower social-economical situations or regions.
Pancreas transplants have been considered as a solution to daily insulin injections and constant
glucose monitoring. However, donor shortage and the frequent post-operatory complications are the
main reasons limiting the wider application of this treatment option (35).
Another possible solution is the transplantation of the endocrine islets (36). This method has been
previously proven as an effective therapy, by using allogenic pancreatic islets from deceased donors
(37,38). Tissue engineering and biofabrication approaches can be used to engineer personalised islet
constructs suitable for each patient.

1.2 Biofabrication and bioprinting
Biofabrication is a fast-evolving research field used increasingly on tissue engineering and
regenerative medicine (TERM) (39). It is defined as the “automated generation of biologically
functional products with structural organization from living cells, bioactive molecules,
biomaterials, cell aggregates such as micro-tissues, or hybrid cell-material constructs, through
Bioprinting or Bioassembly and subsequent tissue maturation processes” (39). These materials
often include either biological components or living cells, or both. Bioprinting is under the umbrella
of biofabrication. It incorporates the use of 3D printing (also known as additive manufacturing), to
deposit living materials in a specific 2D or 3D pattern (40). Therefore, bioprinting allows for the
precise deposition of materials, biomaterials, cells and growth factors, in a layer-by-layer fashion,
generating complex structures for TERM. A schematic representation of biofabrication and TERM
is shown in Figure 4.
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Figure 4. Scheme explaining biofabrication and its implication in TERM (39). On the one hand, biofabrication
can occur naturally or technologically in many different disciplines (biotechnology, synthetic biology, etc). On
the other hand, there are many different techniques that can be applied in tissue engineering and regenerative
medicine: classical tissue engineering, where cells are seeded and matured in scaffolds or matrices for
implantation; in situ tissue engineering, where biomaterials or inductive constructs are implanted to induce
regeneration; and cell therapy, where cells are injected on the host to induce regeneration. However,
biofabrication can also be applied in TERM. The main difference between using biofabrication or conventional
TERM technologies is the ability to spatially arrange materials, which is a huge advantage for complex tissues.

The two main biofabrication techniques in TERM are bioprinting and bioassembly. The first one is
a top-down manufacturing method and the second one, a bottom-up method (41). Top-down
methods dispense small units of the biomaterial to build the structure, whereas bottom-up ones use
blocks of materials and cell droplets as a starting point (42,43). This project will be focused on
bioprinting for TERM only.
Figure 5 shows a schematic representation of bioprinting. The two most important parts for
bioprinting are bioink and printing technique, which are introduced in detail. Depending on the
organ or tissue, the bioink will be different. Besides, depending on the characteristics of the print (a
model, a functional tissue and the type or size of tissue, etc), the printing method used will also be
different.
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Figure 5. Graphical representation of the bioprinting process (modified from (44)). First, the bioink, a mixture
of cells, polymers and crosslinkers, is chosen (A). Then, the bioink is printed, and different printing techniques
can be used depending on the bioink used or the desired characteristics for the final result (B). While printing,
the ink is crosslinked, generating a solid or gel-like composite comprising the polymers, cells and crosslinkers
(C). Finally, these printed constructs can be used in many different areas, such as tissue engineering, drug
testing or disease modelling (D).

1.2.1 Bioink
The mixture of components used in bioprinting (Figure 5) is referred as bioink. The bioink is
generally composed of the polymers, cells and functional peptides such as growth factors other
biological cues. Polymers work as a scaffold for cells. They support the desired structure of the
printed construct and can be printed as porous materials, for nutrient and oxygen exchange between
cells and the environment (45). The structure and composition of polymers vary depending on the
type of tissue, the mechanical properties and degradability that need to provide, as well as the
method of printing used (46,47). They can be natural, synthetic or a mixture of both. The cells added
to the mixture can be fully differentiated or not. Also, several types of cells can be printed
simultaneously, as well as cell clusters (aggregates). Finally, bioactive molecules (functional
peptides), generally growth factors or signalling molecules are added to the bioink to regulate cell
behaviour, phenotype and functions.

1.2.2 Bioprinting techniques
Different types of 3D printing technologies can be used for bioprinting. The main methods are
mentioned in Figure 5B: inkjet printing, laser-assisted printing, extrusion printing and digital light
processing (48,49).
-

Inkjet printing. The mechanism came from the conventional 2D ink printers (50). Bioink
droplets are expelled from the cartridge with a thermal or piezoelectric actuator (46,51).

-

Laser-assisted printing. A laser pulse hits the donor layer (absorbing layer + bioink) in a
certain position. The absorbing layer absorbs the energy of the laser, generating heat,
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evaporating part of the bioink adhered to the absorbing layer and creating a high-pressure
bubble. Then, a bioink droplet is ejected to the building plate (51).
-

Digital light processing (DLP) printing. There are two types of stereolithography (SLA):
laser-direct writing and mask-image projection printing. The second one is known as DLP
printing. It uses a defined mask image, which is projected on the surface of the photocurable
bioink, crosslinking an entire layer at a time (52,53).

-

Extrusion printing. The bioink is continuously extruded, depositing cylindrical filaments with
precision (51). The ink can be extruded with 3 different mechanisms: pneumatic, piston or
screw-based (54).

Table 3 shows some features, advantages and disadvantages of different bioprinting techniques.
Table 3. Summary of advantages and disadvantages of the 4 main bioprinting techniques.

Printing modalities

Inkjet printing

Advantages

High resolution (< 50 µm)
(46,51).

Medium cell densities (<108
Laser-assisted printing

cells/ml), high bioink
viscosity (1-300 mPa∙s) (51).

High resolution (50 µm), fast,
DLP printing

easy fabrication of complex
geometries (51,53).

Extrusion printing

Disadvantages
Liquid or low viscosity bioinks only
(<0.01 Pa∙s), low cell density (< 107
cells/ml) (55)

High cost, limited ink availability
(51).

Use only for photocurable materials,
limited biocompatible resins,
cytotoxicity of photoinitiators
(51,52).

High cell densities (no

Relatively lower resolution (100-200

limitation) (46,56), wide range

µm), limited printing conditions due

of bioinks available (51).

to high shear stress (46,51).

In summary, 3D bioprinting presents a promising avenue to treatment of diabetes. Islets of
Langerhans or insulin-producing beta cells could be 3D printed in a biological scaffold for TERM
purposes. After maturation of the printed constructs, they could be transplanted in diabetic patients.
In this way, the issue of donor shortage would be overcome, and the patients would be able to reestablish the insulin-producing system in their body. They would be in no need of more daily insulin
injections. However, all the tissue-printing solutions, including islet printing, are still in research
phase.
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1.3 3D printing of bioink for pancreatic islet transplantation
1.3.1 Limitations for islet transplantation
Previous studies showed that infusions of islets via the patients’ portal vein were successful as a
treatment for diabetes (38,57). These islets were administered with immunosuppressors and most of
the patients were insulin-independent for at least 5 years after several islet injections (58). However,
one of the main issues of this technique is the immune reaction. The infusion of islets into the portal
vein activates an innate immune response (10,59). In some cases, the islets could get trapped into
blood clots, become hypoxic and generate a bigger immune reaction (59–61). This reaction, together
with the side effects of the immunosuppressive drugs in the islets (62), contributes to the poor
survival rate of the islets initially transplanted (therefore the need of several infusions to succeed)
(36,63,64). Subcutaneous and gastric submucosa have been studied as alternative islet
transplantation methods, with a higher success rate when compared to portal vein infusion (65,66).
However, the three methods share the need of immunosuppressors (62,65,66).
Furthermore, type 1 diabetes patients have the immune system activated against the β cells,
presenting immune reactions for even autologous islet transplants (67). Figure 6 explains the
immune mechanism of T1D. A genetic defect in the bone marrow or thymus can present selfantigens (such as the ones of β cells) as harmful, generate autoreactive lymphocytes or have defects
in lymphocyte precursors, which results in the immune system attacking β cells. Moreover, the
immune system can also present anomalies that result in the immune cells attacking the islets and β
cells: defective immune regulation, production of autoreactive antibodies, etc. Finally, β cells can
also be defective. They can produce cytokines and chemokines that activate immune response,
present high quantities of antigens or have a limited potential for replication, resulting in a low β
cell renewing. For all these reasons, achieving immune tolerance is an essential requirement for islet
transplantation in T1D.
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Figure 6. Molecular and metabolic processes that occur in type 1 diabetes (27). Insulin deficiency and T1D are
caused by genetic and metabolic defects in the bone marrow and thyme (A), in the immune system (B) and in
the β cells (C). Teff = effector T cell, Treg = regulatory T cell, APC = anaphase-promoting complex, MHC =
major histocompatibility complex.

1.3.2 Achieving immune compatibility
The method previously explained uses a deceased donor (with no diabetes), mechanically and
enzymatically digests the pancreas, and isolates the islets. These islets are then transplanted into the
patient. However, this method has shown limited therapeutic outcome due to compromised islet
functions as a result of the following two aspects:
-

The infusion activates the innate immune response, killing the islets and creating blood clots
and other complications.

-

The use of immunosuppressors reduces β cell functionality as well as having other detrimental
effects (risk of infection, organ toxicity, etc) (35,62).

Hence, a promising solution could be the transplantation of bioprinted constructs made of islets and
supporting material to avoid the adverse reactions as a result of direct contact with blood flow.
Besides, the immunosuppressors could be replaced with an alternative approach by means of
providing immune-tolerant islet constructs. Two strategies have shown promise in reducing immune
rejection. The first strategy involved coating islets with hydrogels, which create a barrier against the
immune system (36). For example, alginate is an indigestible hydrogel in the human body, which
has been proven to be non-immunogenic (68,69). It has been used to encapsulate islets (in microor macrocapsules), retaining islet functionality for over 10 months in human trials (36). However,
the thickness of the capsules could determine the viability of the transplanted islets. If the alginate
coating is too thin, the transplant could still trigger the immune rejection on the host. But if it is too
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thick, the diffusion of nutrients and oxygen into the islets could be compromised, resulting in a poor
cell viability (70,71). As a solution, various types of hydrogels, some of them are porous, could be
mixed to provide a scaffold to facilitate oxygen and nutrient exchange. Gelatin methacrylolyl
(GelMA), for instance, would provide tuneable mechanical properties, high degradability and RGD
sequences that alginate lacks (72). Alternatively, other types of cells that provide immune tolerance
could be co-transplanted together with the islets. Regulatory T cells (Tregs) are known to help
suppressing the autoimmune reaction (37).

1.3.2.1 Regulatory T cells (Tregs)
Regulatory T cells are a type of lymphocytes. Their function is to promote tolerance to antigens
(self or foreign) and maintain immune homeostasis (73), suppressing effector T cell responses up to
a point (13,74). There are various types of Tregs that participate in the immunoregulation (75). Type
1 diabetes and a poor Treg function have been correlated, either due to an imbalance between
effector T cells (Teffs) and Tregs (76), or because the Tregs are deficient or dysfunctional (77). The
imbalance between Teffs and Tregs occurs when Teffs become resistant to Treg-mediatedimmunosuppression over time (78). Therefore, the addition of Tregs at the site of the transplanted
islets has been proven to improve their performance and longevity in vivo. Treg migration to the
transplanted area resulted to be an issue (79). Hence, Tregs need to be localised at the site of the
implanted islets to achieve their immunosuppression. This has been already tested by infusing both
cell types (islets and Tregs) together or adding growth factors that attract Tregs migration to the
islets (80).
Tregs need growth factors to proliferate and maintain their function. Interleukin-2 (IL-2) is a growth
factor for Treg cells, taking part in their development, proliferation and immunosuppressive
function (81). It is essential for Treg lineage stability and their survival (82), as defects in IL-2
production result in a reduced number of Tregs in the islet area (83). Thus, the addition of IL-2 in
the bioink is crucial for Treg survival and islet function in the transplanted site.

1.3.3 Extrusion bioprinting
As briefly discussed in 1.2.2, extrusion 3D printing consists of extruding a continuous flow of ink
through a nozzle when applying pressure (which can be pneumatic, piston or screw (84,85)). The
ink is deposited in the pre-designed coordinates to obtain a 3D structure. Moreover, temperature,
printing speed and flow can be controlled (by varying the pressure applied to the bioink cartridge)
(86). Extrusion-based printers have been widely used for bioprinting, as its main advantages are the
scalability of the process, relatively low price, high variety of bioinks printable, ability to print with
high cell densities, high ink viscosities and larger constructs (46,54,87). For this reason, hydrogels,
which may be viscous, and high cell densities that contribute on the increasing of the viscosity, can
be used. Even if it the relatively low resolution is one of the main disadvantages of this technique,
it might not be essential in this case, as human islets are <100-700 µm in diameter (8), being the
printing resolution 100-200 µm (46).
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Pancreatic islets have been previously bioprinted using extrusion bioprinting (36,86). The viability
of the islets decreased when the printing conditions entailed more stress to the cells (more pressure,
higher shear stress when printing) (86). The bioprinted islets were capable of maintaining their
structure and functionality, by reacting to glucose stimulation and generating insulin (36).

1.3.3 Co-axial bioprinting
Co-axial bioprinting is a type of extrusion printing where 2 different bioinks are printed at the same
time. One ink, known as the core, is printed inside the second ink, known as the shell. Previous
studies demonstrated the possibility to print very soft hydrogels in the core of the ink (88). The coreshell like structure is crosslinked after printing. Figure 7 shows a schematic representation of the
co-axial printing nozzle, and the way the ink is deposited, with the core (blue in Figure 7D) inside
the shell (red in figure 7D).

Figure 7. Schematic mechanism the co-axial nozzle (89). It shows the schematic configuration of the nozzle
(A-C), as well as the distribution of the ink on it (D), being the blue ink in the core (inside) and the red one in
the shell (outside).

In summary, co-axial bioprinting is an interesting approach to print islets with their supporting cells.
The Langerhans islets could be printed in the core (inner side) together with endothelial cells to
achieve vascularisation, and Tregs in the shell (outer layer) to act as an immunological barrier for
the islets (Figure 8). Moreover, the growth factor for the Tregs (IL-2) could be encapsulated and
added to the shell.

Figure 8. Distribution of cells in the islet co-axial bioprinting approach. Endothelial progenitor cells (EPCs)
could also be incorporated in the core for vascularisation.
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1.3.3.1 Custom-made printer
The co-axial extrusion printer used in this study was developed in house by the Translational
Research Initiative for Cell Engineering and Printing group (TRICEP) at the University of
Wollongong. The software used was also developed there. The XYZ axes, printing speed, flow rate,
core:shell ratio and temperature could be controlled with the software. Furthermore, simple squared
scaffolds (lattices) could be printed by introducing the scaffold width, length and height, number of
layers and number of lines in the X and Y directions (Figure 9E). A G-code could also be introduced
to print more complex structures. This was the second generation of a printer developed after the
Biopen. It featured two different extruders controlled by motors, one for the core and one for the
shell, which applied pressure on the core and shell syringes. These syringes were connected to a
custom-made titanium nozzle fabricated using SLS (selective laser sintering). The co-axial nozzle
is highlighted in Figure 9C and 9D, where the two inks were extruded, resulting in the core ink
being encapsulated by the shell ink. The printer had temperature regulation units surrounding the
syringes, therefore the temperature of the inks could be controlled before extruding them. However,
the temperature could not be controlled neither in the nozzle nor in the printing base.

Figure 9. Co-axial printer from TRICEPTM. The printer (A) and a zoom in the core-shell system (B) can be
observed, being C for core (left) and S for shell (right) (pointed with arrows). The syringes with loaded bioink
are screwed in the nozzle, and the pistons press the ink through the nozzle. A close-up of the tip of the nozzle
is also shown (C-D), with the core-shell separation (scale-bars: 1 mm (C), 500 µm (D)). Finally, an example
of a scaffold printed with the pre-made scaffold coding of the software (E), with blue ink in the core and pink
ink in the shell.
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When the print started, the printing arm moved to the starting point (X, Y, Z coordinates). The
printing arm would then start pressing the core and shell syringes (seen in Figure 9B) to get the ink
extruded through the nozzle (the core in the inner part, the shell in the outer part as shown in Figure
9D). The pressure applied on each of the syringes would determine the printing flow and the
core:shell ratio, controlled by the software (more pressure, more flow; more pressure on the core
syringe and less on the shell syringe, more core-shell ratio and vice-versa). The higher the flow, the
more ink came out of the nozzle per second, and vice-versa. The printer would then start moving to
the coordinates written on the G-code of the software, while extruding the ink. The speed it moved
while printing was determined by the printing speed on the software. The faster it moved, the fewer
ink it deposited at the same point and vice-versa. The excess of speed, or too little flow could make
the prints too thin and brittle, whereas a low speed or too high flow could make the prints thick and
lose resolution. The correct print thickness (like the one shown in Figure 9E) could be achieved by
finding a balance between the printing flow and speed. Once a layer was finished, the printing arm
would go a few millimetres up to start printing the next layer.

1.3.4 Bioink for pancreatic islet printing purposes
A bioink is essential for bioprinting. It provides cells with a structure and gives them mechanical
strength. The materials used as a bioink can vary depending on the aim and function of the tissue.
Generally, hydrogels are used. They are hydrophilic polymers that resemble the extracellular matrix.
Most of the hydrogels present high cytocompatibility and biocompatibility (90). They have tuneable
chemical and physical properties, and they also absorb 90-99% of their dry weight in water
(important for the biocompatibility) (91). Generally, this gelation occurs with crosslinking, which
can be induced chemically, by temperature or light (at a specific wavelength). Among these gelation
techniques, photopolymerisation is an attractive crosslinking method as the polymerisation is shorttimed and controllable, and with no need for extreme pH or temperature that could harm cells
(92,93). Different hydrogels have been previously used for bioprinting purposes: alginate, gelatin,
collagen, fibrin/fibrinogen, gellan gum, hyaluronic acid (HA), agarose, chitosan, silk (94). These
are 3D bioprintable, and complex morphologies can be engineered with this technique (95,96). The
immediate crosslinking after bioprinting stabilises the printed structures, maintaining their shape.
The choice of biomaterials or hydrogels depends on the target tissue or the mechanical properties
aimed to achieve. GelMA, alginate and gelatin are the constituents of the bioink used in this study,
and they will be introduced in the following part.

1.3.4.1 GelMA, alginate and gelatin
Gelatin methacrylolyl (GelMA) is a chemically modified gelatin. Gelatin is an inexpensive material
that can be extracted from various animals (97). It derives from the hydrolysis of collagen, which is
one of the most abundant proteins in the body (98). It has lower immunogenicity than collagen
(99,100) and it contains RGD sequences (arginine-glycine-asparagine) that support cell attachment
to the material (99–101).
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The phase behaviour of the aqueous solution of gelatin can be thermoreversible, becoming a gel in
cooler temperatures and liquid in warmer temperatures. Unfortunately, it is liquid at physiological
temperature (37ºC), hence, not useful for cell culturing (99,102). On the other hand, GelMA, a
derivative of gelatin, retains the thermoresponsive phase behaviour, and can be chemically
crosslinked to improve the structural stability. This makes gelMA an ideal substitute for gelatin and
one of the most widely used hydrogels in TERM. It has been proven to be biocompatible and suitable
for long-term cell culture (41,103). One of the most frequently used methods for crosslinking
GelMA hydrogels is photocrosslinking. GelMA is photocured in the presence of light (visible or
UV) using molecules called photoinitiators. Upon photo-irradiation, the photoinitiator produces free
radicals, initiating the polymerisation (102,104). Currently Irgacure 2959 remains one of the most
frequently used photoinitiators in 3D printing. It works under a broad spectrum, for cell printing, a
wavelength of 365 nm or below is required (93). However, the use of UV light in long-term exposure
is detrimental to cells (105). Therefore, alternative initiators are preferable. Lithium phenyl-2,4,6trimethylbenzoylphosphinate (LAP) is another commonly used photoinitiator which absorbs
photons in the near-visible light (106). LAP is a water-soluble molecule with relatively high molar
extinction coefficient. Its maximum absorption is at 375 nm wavelength, however, it has been
proven to be a successful photoinitiator at 405 nm (106). Figure 10 shows the absorption peaks of
LAP at different wavelengths. Even if LAP is cytotoxic at high concentrations, it is efficient at low
concentrations where there is no cytotoxicity (0.05% or 0.067% are enough for crosslinking) (105).

Figure 10. Molar extinction coefficient of lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) at a
function of wavelengths (modified from (106)). Even if the peak is at 375 nm (meaning the LAP is most
efficient with that wavelength), its molar extinction coefficient of 405 nm is >50 M-1cm-1. Hence, this molecule
can be used to initiate polymerisation at near-UV visible lights.

Another commonly used hydrogel is alginate, due to its low toxicity, ease of crosslinking and
relatively low cost (107). This polysaccharide is extracted and purified from brown algae. It is an
anionic polymer which crosslinks by divalent cations such as Ca+2 (36,69,107). It has been
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previously used to encapsulate various cell types, including islets that remained functional for over
10 months in humans (36,108). Alginate is non-biodegradable in the human body, and nonimmunogenic when high purity alginates are employed (68,69). This polysaccharide is composed
of mannuronic and guluronic acid. It is immunoprotective when the guluronic acid is predominant,
as the mannuronic acid has some mitogenic properties (109). The 3D crosslinked structure and
charge distribution of alginate might be the reason why smaller molecules than the pore size of the
scaffold are unable to penetrate it (67). This property might be related to the immune protection that
alginate provides.
Finally, the hydrogel precursors must be 3D printable by extrusion printing. In extrusion printing,
the material needs to be in gel-state in order to retain its shape after printing (if it is too rainy, the
construct will merge into a drop before crosslinking it). This can be achieved by modifying the
printing temperature (the cooler, the more gel GelMA and alginate are). However, one of the aims
of this project is to print at room temperature. The gelation behaviour of the bioink can be modulated
by adding gelatin to the bioink formulation and varying its concentration. Gelatin has previously
been blended with other hydrogels to improve the printability of bioinks (110). Figure 11 explains
the gelation process of GelMA, gelatin and alginate.

Figure 11. Gelation process of GelMA, alginate and gelatin (modified from (105)). GelMA, which derives
from gelatin, crosslinks under light exposure with LAP (A). Alginate crosslinks with calcium ions (B). Gelatin
(C) and cells (D) are also added to generate a scaffold with entrapped cells (E).

Finally, biological cues can also be added to the biomaterials apart from cells. In this case, IL-2 can
be used to promote Treg function and recruitment. This growth factor can be entrapped inside
microspheres to obtain a sustained release over time and avoid constantly adding growth factors to
the medium.
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1.3.4.2 Microspheres
Microspheres or microparticles (MPs) are microsized structures often used in pharmaceutical
engineering, medical applications and TERM for the delivery and sustained release of bioactive
molecules (111,112). Apart from delivering drugs and growth factors, appropriately designed
structures can also provide binding sites for cell attachment (111). Diverse materials, such as
poly(lactic-co-glycolic acid) (PLGA), gelatin, GelMA, alginate or collagen, have been employed
for the generation of MPs (111,113–116). Gelatin microspheres using glutaraldehyde as a
crosslinker were widely used in the past (113), but cytotoxicity is a major limitation of this
crosslinker (114). Using GelMA as a source for crosslinking is less toxic and provides a broader
range of crosslinking densities, as well as a better controlled reaction (117). The capability of these
MPs to retain and release growth factors has also been proven (114).
GelMA microspheres can be generated in water-in-oil emulsion. They can be crosslinked in situ
(when the emulsification is occurring) or after they are formed (post-crosslinking). Finally, the
growth factors are added after the generation and crosslinking of the spheres. Therefore, the IL-2
could be encapsulated in the GelMA microspheres after the creation of the MPs, and then
incorporated to the bioink.
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Chapter 2
2. Preliminary work
This project was a continuation of previous projects in the field of bioprinting for pancreatic islets.
Previous students characterised the ink and did preliminary cell studies. Sarah worked on the ink
characterisation for encapsulating islets, concluding on the use of 2% alginate/7.5% GelMA as the
best formulation in terms of mechanical properties, gel degradability and cell viability. After her,
Max optimised the printing conditions and studied the effect of the printing on cell viability.
However, he used the first generation of the customised printer, so these tests should be repeated on
the new printer. The most critical difference between the first and the second-generation printers
was that the latter lacked a temperature control unit at the printing plate, meaning that once the ink
was extruded it would be at room temperature. Max used the same bioink as Sarah and printed at
15ºC. However, in this project the printing was done at room temperature, as the printer did not
allow for a complete temperature control from when the ink was in the printing cartridge to after
extruding the ink.
The University of Wollongong is closely working with the Royal Hospital of Adelaide (South
Australia) in the bioprinting for pancreatic islets. All the cell work and animal studies are performed
there, while the university of Wollongong is focused on the characterisation and optimisation of the
ink and the printing parameters.
The new steps to be taken building upon the previous students were:
-

Use of new co-axial printing (optimisation of printing parameters)

-

Optimise printability at room temperature

-

Optimisation of core and shell formulations to the targeted cell types respectively (Tregs in
shell, endothelial progenitor cells (EPCs) and islets in core)

-

Introduction of microspheres with growth factors for sustained release

Due to time constraints (10 months as part of the double degree at Utrecht University), the focus of
this project was placed on the optimisation of the shell ink. The ink was characterised with
encapsulation of microspheres pre-loaded with IL-2. Gelatin was added to the ink to make it
printable at room temperature. Optimisation of the core ink was undertaken by another
biofabrication Master student (Narangerel).
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Chapter 3
3. Aim
The aim of this project was to characterise and optimise a GelMA/alginate/gelatin ink for co-axial
extrusion printing, which served as the shell ink. This ink contained GelMA microspheres loaded
with IL-2, and the release of the IL-2 was studied. The main objectives were separated in 3 main
blocks:
-

Preparation and characterisation of GelMA microspheres. GelMA microspheres were generated
using a water-in-oil emulsion method and post-crosslinked with ammonium persulfate (APS)
and tetramethylethylenediamine (TEMED).

-

Characterisation and optimisation of the shell ink for extrusion printing. The gelatin
concentration was optimised, and rheological studies were performed to determine the ink
characteristics. Finally, the printing parameters were established.

-

Release study of IL-2 from the GelMA microspheres.

The outcome of these experiments could be further used through collaboration to co-print Tregs and
pancreatic islets and test the behaviour, insulin-producing capacity and immunosuppression abilities
of the constructs in animal models.
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Chapter 4
4. Materials and methods
4.1 GelMA microspheres
4.1.1 Generation of GelMA microspheres
4.1.1.1 Water-in-oil emulsion
GelMA microspheres were prepared using a water-in-oil emulsion method. A 15% w/v GelMA
solution (82% Degree of Functionalisation (DoF), TRICEPTM, Australia) in deionised water,
previously heated at 37°C, was added drop by drop in olive oil (1:8 v/v) and homogenised at 5000
rpm for 5 minutes. Afterwards, samples were cooled down to induce gelation with ice and they were
homogenised for other 10 minutes. After the homogenisation, the water-in-oil emulsion was
transferred to a magnetic stirrer, in an ice bath. The stirring was kept at 800 rpm for 40 minutes,
then, chilled acetone (half the volume of the oil employed) was added. The stirring continued for
another 30 minutes, and the microspheres were collected. The oil was removed from the mixture by
3 washes with acetone, centrifuging the samples at 500 rpm for 7 minutes. Afterwards, the
microspheres were vacuum dried overnight.
The dried particles were weighed (m1) and the yield of the process was calculated (Y1):
𝑌1 =

𝑚1
∙ 100
𝑚0

(1)

m0: initial GelMA weight

4.1.1.2 Crosslinking of GelMA microspheres
The GelMA microspheres were chemically crosslinked using ammonium persulfate (APS, 228.2
g/mol, Chem-Supply, Australia) and N,N,N’,N’-Tetramethylethylenediamine (TEMED, 99%
purity, Sigma-Aldrich, USA). APS and TEMED were dissolved in a water:acetone mixture (20:80
v/v) at a final concentration of 0.25% w/v and 0.5% v/v respectively, and added to the suspension
of GelMA microspheres (10% w/v). After adding the mixture to the microspheres, they were
crosslinked for 16 hours (overnight) on an orbital shaker.
The next day, the spheres were washed 3 times with water/acetone (20:80 v/v) and then acetone to
eliminate the APS and TEMED and stop the reaction. They were centrifuged at 500 rpm for 5
minutes. The samples were then vacuum dried for 2 hours and weighed (m2). Then, the yields of
this part of the process (Y2) and of the whole process until that point (Y3) were calculated:
𝑌2 =
𝑌3 =

𝑚2
𝑚0

𝑚2
∙ 100
𝑚1

∙ 100 or 𝑌3 = 𝑌1 ∙ 𝑌2 ÷ 100
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(2)
(3)

4.1.1.3 Crosslinking efficiency
Once the microspheres were crosslinked, they were washed with water. To do so, water was added
to the mixture, waited for 10 minutes, and centrifuged for 5 minutes at 500 rpm. Another wash was
made with water, and other 2 with acetone, to substitute the water for it. Finally, the samples were
again vacuum dried for 2 hours and weighed (m3). The crosslinking efficiency (Y4) and the yield of
the whole process (Y5) were calculated. The microspheres were stored at -20ºC until use.
𝐶𝑟𝑜𝑠𝑠𝑙𝑖𝑛𝑘𝑖𝑛𝑔 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 (𝑌4 ) =
𝑇𝑜𝑡𝑎𝑙 𝑦𝑖𝑒𝑙𝑑 (𝑌5 ) =

𝑚3
𝑚0

𝑚3
∙ 100
𝑚2

∙ 100 or 𝑌5 = 𝑌3 ∙ 𝑌4 ÷ 100

(4)
(5)

4.1.2 Particle size analysis
2 mg GelMA MPs were suspended in 300 µl PBS and analysed under a Leica DFC310-FX
microscope. These were imaged and the diameter of the particles was manually measured with
ImageJ software. Afterwards, a histogram was plotted with all the data of the diameters to obtain a
distribution of the population. 3 samples were analysed, and 10 images of different regions were
taken per sample.

4.1.3 Microsphere degradation
GelMA microspheres were subjected to a degradation study. 5 mg of MPs were suspended in a
solution of 2 U/ml type I collagenase (≥ 125 U/mg lyophilised powder, Sigma-Aldrich, USA) in
PBS. They were left on an orbital shaker and timepoints were taken at day 1, 2, 4, 6, 10, 15, 20 and
28. The samples were centrifuged for 1 minute at 1000 rpm and washed twice with DI water to
remove the salts of the PBS. Afterwards, they were freeze dried and the dry weight was recorded.
The degradation profile was calculated with the following equation:
𝑅𝑒𝑚𝑎𝑖𝑛𝑖𝑛𝑔 𝑔𝑒𝑙, 𝑑𝑎𝑦 𝑥 (%) =

𝑤𝑥
∙ 100
𝑤0

(6)

The experiment was done in triplicate, and the degradation medium was changed every two days to
prevent the collagenase from losing activity.

4.2 Bioink characterisation
The bioink for printing consisted of three different materials: alginate (medium viscosity, SigmaAldrich, UK), GelMA (synthesized) and gelatin (300 bloom, type A from porcine skin, SigmaAldrich, USA).

4.2.1 GelMA synthesis
10% (w/v) gelatin (175 bloom, type A from porcine skin, Sigma-Aldrich, USA), dissolved in PBS
and autoclaved, was used for methacrylation. The sterile solution was heated in sterile conditions at
50ºC while stirring at a medium speed (600-800 rpm). Afterwards, methacrylic anhydride (Sigma-
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Aldrich, USA) was added drop by drop, at a concentration of 0.06% (v/v) (0.6 ml methacrylic
anhydride per gram gelatin). The reaction was left for 4 hours, after which the unreacted methacrylic
anhydride was removed by centrifugation (5 minutes, 3000 rpm). The pH of the solution was
adjusted to 7.0 with 5M sodium hydroxide (NaOH). Finally, the solution was dialysed for 4 days at
37-40ºC and freeze dried. The samples were stored at -20ºC until use.

4.2.1.1 NMR
1

H-NMR was used to assess the purity and methacrylation degree of GelMA. GelMA and gelatin

were dissolved in deuterium oxide (D2O) at a concentration of 10 mg/ml each. The solutions were
transferred to NMR tubes and analysed on the UltrashieldTM 400 Plus machine (Bruker, USA). The
data was analysed with the Bruker TopSpin 4.0.5 software. Table 4 summarises the settings for the
measurements.
Table 4. Solvents and settings used for the NMR measurements.

Settings

Test

Type of test

1

Solvent

D2O

Number of scans

64

Sample temperature (K)

300

H-water suppression zgpr

4.2.2 Bioink preparation
2% alginate was dissolved in PBS at 37°C overnight. Afterwards, GelMA was added to a final
concentration of 7.5%. The mixture was vigorously vortexed for 1-2 minutes and warmed up at
37°C until complete dissolution and blending of both materials. Finally, gelatin powder was added
and the same steps of vortexing and warming up were taken until a uniform blend of the 3 materials
was obtained. All the steps were performed sterilely (in a laminar flow cabinet, using sterile
tweezers and PBS, and UV-irradiating the materials before dissolving them).
Prior to printing, the ink was mixed with LAP photoinitiator (lithium phenyl(2,4,6trimethylbenzoyl)phosphinate, > 98%, Tokyo Chemical Industry, Japan) to a final concentration of
0.06% w/v. The ink was vortexed to obtain a uniform mixture. Microspheres (if needed) were added
to the gel and distributed throughout the ink with a positive displacement pipette. The resulting
mixture was then transferred to 3 ml syringes with the same pipette (maximum of 2.5 ml for
printing). The syringes were then left at 37ºC for 15 minutes to remove air bubbles generated due
to the mixing process, and they were then taken outside the incubator to get the room temperature
before printing. During the procedure, the samples were covered with aluminium foil to avoid
contact with light and pre-mature crosslinking.
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4.2.3 Preliminary printing characterisation
The printing was done with an in-house built co-axial printer (shown on the Introduction section,
part “1.3.3.1 Custom-made printer”). The initial characterisation was performed using a single
cartridge (setting the core:shell ratio at 1:0). The ink formulations containing gelatin were extruded
at room temperature, whereas the ink without gelatin was extruded at 15°C.

4.2.3.1 Filament test
The printing nozzle was placed far from the printing platform (x, y, z = 50, 50, 70) and the material
was extruded. The process of extrusion was recorded on a phone camera and the length of the
extruded ink was measured. The experiment was done in triplicate. Figure 12 shows an example of
the filament test.

Figure 12. Example of filament test. If the ink is too rainy, it will deposit droplets instead of extruding a line,
which makes it unsuitable for extrusion printing.

4.2.3.3 Filament fusion test
Lattices of a single layer, with an increasing distance between filaments, were printed. 0.23 ml/min
flow and 140 mm/min speed were used. The structure of the printed scaffolds is shown in Figure
13, together with the G-code. The resulting scaffolds and spacing between the filaments were
measured with ImageJ and compared to theoretical values.
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Figure 13. Scheme of the printed scaffolds and their dimensions. The scaffold on the left (A) shows the design,
the one on the right (B) shows the outcome if the ink had a perfect shape fidelity (1 mm diameter filaments).
Figure C displays the G-code used for the filament fusion test.

4.2.3.4 Layer stacking test
Pre-coded lattices were printed, with dimensions of 10 x 10 mm, and 5 strands with spacing of 2.5
mm between them (both in x and y direction). Each layer was 0.6 mm thick (Z), with a number of
layers increasing in pairs from 2 to 10 (thus, the height of the scaffolds ranged from 1.2 to 6 mm).

4.2.4 Rheology
The bioink was subjected to rheological studies in the AR-G2 Rheometer (TA Instruments), fitted
with at 40 mm cone plate (2° angle). The tests were performed in triplicate and the results were
recorded with the TA Rheology Advantage Instrument Control software. A solvent trap was used
in every test to prevent evaporation.
All the tests had a conditioning time for the bioinks, 5 minutes pre-shear (to remove the rheological
history of the inks) and 5 minutes equilibrium time (to stabilise the ink after the pre-shear). The
frequency and strain were 1 Hz and 1% respectively in every test unless specified, the shear rate
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was 1 s-1 unless specified, and the temperature was 15ºC for the 0% gelatin bioink and 22ºC for the
rest of the bioink, unless specified.
First, a temperature sweep was performed from 10ºC to 40ºC, at 1.5ºC/min. The aim was to examine
the behaviour of different bioinks at different temperatures (if they behaved more than a liquid or
more than a gel). Theoretically, an ink needs to behave like a gel to be suitable for bioprinting.
Second, a viscosity test was undertaken, in order to determine the behaviour of the bioink at different
shear rates (0.01-1000 s-1). Different shear rates are used to simulate the conditions where the ink is
at rest and where it goes through the printing nozzle, and this test was used to determine the viscosity
of the ink at both processes.
Apart from that, frequency and strain sweeps were performed. The frequency sweep had a frequency
range from 0.1 to 20 Hz, and the strain sweep, a strain range from 0.01% to 1000%. A step-strain
test was also done, where the recovery of the ink after different cycles of strain was assessed. This
consisted of a time sweep at 1% strain for 3 minutes, then 30 seconds at 100% strain (cycle 1). This
cycle was repeated four times. After the 100% strain step, the ink should recover its properties back
to what it was at the beginning.
Finally, an in-situ crosslinking rheology was performed. This was performed using with a different
geometry (20 mm parallel plate) which allowed the attachment of a light source for UV curing.
Temperature could not be controlled in this case, therefore, for both inks (0% and 3.5% gelatin)
were tested at room temperature. The crosslinking of the hydrogels in the printing process was done
using a light source (Omnicure® LX505) at 405 nm wavelength. However, this lamp does not have
the attachment for the rheometer, so the experiments were performed using another UV lamp,
Omnicure® Series 1500 (Lumen Dynamics, Canada). It was fitted with a 365 nm UV wavelength
filter (a commonly used wavelength, but cytotoxic). The lamp was set at 2 mW/cm2 intensity.
The specifications of the different tests are summarised in Table 5.
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Table 5. Conditions used for each rheological test. The temperature was set at 15°C for the ink without gelatin (0%), and at 22°C for the ink with gelatin.

Test

Pre-shear (s-1)

Equilibrium
(min)

T (°C)

Strain (%)

Frequency
(Hz)

Shear rate (s1
)

Time
(min)

UV (365 nm)

Temperature
sweep

5 min

5 min

10 – 40
(1.5°C/min)

1

1

-

-

-

Viscosity

5 min

5 min

15 / 22

1

1

0.01 - 1000

-

-

Frequency

5 min

5 min

15 / 22

1

0.1 - 20

-

-

-

Strain

5 min

5 min

15 / 22

0.01 - 1000

1

-

-

-

1

-

21

-

10

2 mW/cm2,
for 1 min at
min 2

1 for 3 min
Step-strain

5 min

5 min

15 / 22

100 for 30s
Repeat cycle (x5)

in situ UV
crosslinking
rheology

5 min

5 min

-

1
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1

-

4.2.5 Characterisation of casted hydrogel discs
Hydrogel discs were casted by pipetting 100 µl of ink mixture in PBS into an 8 mm Ø (diameter) x
1 mm thick mould, or 200 µl of ink mixture into an 8 mm Ø x 3 mm thick mould. These were
subjected to a double crosslinking process, which involves UV crosslinking for 1 minute, and then
ionic crosslinking using 2% (w/v) CaCl2 for 10 minutes. The UV crosslinking was performed with
a visible light lamp (Omnicure® LX505) at 405 nm wavelength and 2 mW/cm2 intensity. Before any
experiment, the intensity of the UV lamp was measured with the CON-TROL-CURE® Silver line
UV Radiometer. The distance of the light guide was adjusted to match 2 mW/cm 2 on the reading of
the light meter. For the following tests, only samples for mechanical testing were prepared in 3 mm
thick moulds, for the rest of the tests 1 mm thick samples were used.

4.2.5.1 Free polymer content and swelling ratio
Gels were casted in triplicate in water in the 1 mm thick moulds, and the initial weight of samples
was recorded (w0). They were freeze dried overnight and weighed (w1). They were later incubated
in PBS overnight at 37°C, washed twice with DI water and weighed again (w 2). Finally, they were
freeze dried overnight again and the final weight was recorded (w 3). The sol-gel fractions and
swelling ratio were calculated following the equations below:
𝑆𝑜𝑙 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 (%) =

𝑤1 − 𝑤3
∙ 100
𝑤1

𝐺𝑒𝑙 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 (%) = 100 − 𝑆𝑜𝑙 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛
𝑆𝑤𝑒𝑙𝑙𝑖𝑛𝑔 𝑟𝑎𝑡𝑖𝑜 (%) =

𝑤2
∙ 100
𝑤1

(7)
(8)
(9)

4.2.5.2 Mechanical test
Hydrogel samples were prepared using the above method in 3 mm thick moulds. The discs were
subjected to a compression test on the EZ-L Shimdazu mechanical tester, fitted with a 10 N load
cell. Stress (y axis) vs strain (x axis) was measured, allowing the gels to compress until they were
0.5 mm thick. Results were collected from the Shimdazu TrapeziumX software. The compression
modulus was calculated as the slope in the linear region of the stress-strain curve (10-15% strain).

4.2.5.3 Degradability of gels
Samples were prepared using the above method in 1 mm thick moulds. The discs were freeze dried
and weighed (w0). Afterwards, they were degraded in a solution of 2 U/ml type I collagenase (≥ 125
U/mg lyophilised powder, Sigma-Aldrich, USA) in PBS, at 37°C. Each day, the gels were collected,
washed twice with DI water and freeze dried. The next day, the weight was recorded (w 1) and
degradation medium was added to the gels. The process of collecting the gels, freeze drying and
recording the weight (wx) was done every day until the gels degraded completely. The degradation
profile was calculated with the equation (6).
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4.2.6 Microsphere distribution in ink
The dry GelMA microspheres (MPs) were first rehydrated overnight by adding 15 µl PBS per 5 mg
MPs. Rehydrated GelMA microspheres were mixed with the bioink to 10 mg MPs/ml ink and
transferred to a syringe for printing. 3 µl (1 mm of core ink, by setting the core:shell ratio at 1:0 so
that only the core ink was extruded) were extruded in a flat bottom 96-well plate, in three regions
of the syringe: beginning, middle and end. After the extrusion, the samples were imaged with the
Axiovert 40 CFL microscope. The images were then analysed with ImageJ to count the number of
microspheres per observation area. All were done in triplicate.

4.3 Release study
The release of the growth factor interleukin-2 (IL-2, BioLegend) from the GelMA microspheres
was studied. First, a 0.45 mg/ml IL-2 solution was added to the microspheres in a non-saturating
volume, by gently pipetting the IL-2 solution on top of the dry microspheres. This was left overnight
at 4°C to be absorbed. The following day, the release started in 0.1% BSA and 2 U/ml collagenase
I in PBS release medium. Samples were left on a shaking plate. At each timepoint the medium was
collected, frozen at -20ºC and replaced with new medium. 3 different conditions were tested.
On the one hand, there were free microspheres. The MPs loaded with IL-2 were directly suspended
in the release medium (in 1.5 ml Eppendorf tubes). The medium, where the IL-2 was released from
the microspheres, was collected at the timepoints (day 1, 2, 5, 10, 12, 14, 21) by centrifugation, to
settle the MPs at the bottom of the tube and avoid their collection. On the other hand, there were
casted microspheres. The MPs loaded with IL-2 were added to the 3.5% bioink, were casted in 8
mm Ø x 1 mm thick moulds and crosslinked as in section 4.2.5. Hydrogel discs were located in
release medium in 1.5 ml Eppendorf tubes. The medium was collected at the timepoints (day 1, 2,
4, 6, 8, 12, 14 21) by centrifugation to settle the hydrogels and MPs at the bottom of the tube and
avoid their collection.
Finally, the third condition was printed microspheres. The MPs loaded with IL-2 were added to the
3.5% bioink and co-axially printed. This was done having the 3.5% ink with the MPs at the shell
and a slightly different ink at the core (7.5% GelMA / 3.5% gelatin dissolved in 50 mM CaCl2 intead
of in PBS. In this way, when the alginate of the shell made contact with the core ink, it would start
crosslinking). The core:shell ratio was 0.25:0.75. 10 mm x 10 mm x 2.4 mm (x, y, z) scaffolds of 4
layers were printed, with 7 strands on each layer. The printed constructs were incubated in small
petri dishes with release medium, and the medium was collected at different timepoints (day 1, 2,
4, 6, 8, 10, 12, 14) with a pipette, avoiding the gels.
The amount of IL-2 in each sample was determined with an Enzyme-Linked ImmunoSorbent Assay
(ELISA).

4.3.1 ELISA
An ELISA kit (human IL-2 ELISA MAXTM deluxe set, Biolegend®) was used for the analysis. The
analyses were performed according to the instructions of the manufacturer. First, 96-well flat-
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bottom plates were coated with 100 µl/well capture antibody (diluted 200x in coating buffer), for
16 h at room temperature. The plates were then washed 3 times with 200 µl wash buffer (0.5%
Tween® in PBS) to remove the antibodies that did not bind to the plates. The plates were blocked
for 2 h at room temperature with 200 µl/well assay diluent (1x), to remove any free surface in the
plate where any proteins could bind unspecifically. The washing steps were repeated.
Then, 100 µl of standard solutions (with IL-2 concentrations of 1000, 500, 250, 125, 62.5, 31.5,
15.625 and 0 pg/ml in assay diluent 1x), and samples (diluted in 1x assay buffer) were added in
duplicate to the plate. The plates were incubated for 2 h at room temperature. The washing steps
were repeated to remove any unspecific proteins. Afterwards, 100 µl/well of detection antibody
(diluted 200x in 1x assay diluent) were added and plates were incubated for 1 h. The plates were
washed again, and 100 µl/well avidin-HRP in (diluted 1000x in 1x assay diluent) were added. Plates
were incubated for 30 minutes in the dark, at room temperature. The plates were washed thoroughly
5 times in wash buffer (30 s – 1 min each time). 100 µl/well of substrate solution were added and
the plates were incubated for 30 minutes in the dark at room temperature.
Finally, 100 µl/well stop solution (2N H2SO4) were added. The plate was immediately read in a
FLUOstar Omega plate reader (BMG Labech). The optical density was measured at 450 nm with
wavelength correction at 570 nm. The 570 nm reading was subtracted from the 450 nm reading to
obtain the correct absorbances. The concentration of each sample was determined by comparing
against a standard curve that was established using the series IL-2 standard solutions.
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Chapter 5
5. Results
5.1 GelMA microspheres
5.1.1 Yield of the process
The yield of each step of the generation and crosslinking of the microspheres (preparation of
uncrosslinked microspheres, chemical crosslinking of microspheres, and preparation of crosslinked
microspheres, respectively) was calculated following the equations (1) – (5). Table 6 summarizes
the results.
Table 6. Yield of the process of microsphere generation and crosslinking.

Part of the process

Yield (%)

Y1 (preparation of uncrosslinked microspheres)

90.2

Y2 (chemical crosslinking of microspheres)

94.8

Y3 (preparation of crosslinked microspheres)

85.5

Y4 (crosslinking efficiency)

95.8

Y5 (total yield)

81.9

The values in bold refer to the two most important values of the process. Y 4 suggests the adequacy
and efficiency of the crosslinking process, and Y 5 is the total yield of GelMA production, from
adding it to the oil on the first step to obtaining the crosslinked spheres. Both values were high,
suggesting that the entire process was highly efficient, especially the crosslinking step.

5.1.2 Particle size analysis
The microspheres were generated, crosslinked and dried as stated in the methods. Afterwards, a
small amount was rehydrated in water and analysed for the particle size distribution. Figure 14
shows the results.
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Figure 14. Microscopic images and particle size analysis of hydrated GelMA microspheres. A shows the
images of the microspheres at different magnifications (scale bars: 100 µm), B shows the particle size analysis
histogram, and C shows information about the diameters of the microspheres.

The particle size analysis showed a symmetric uniform distribution with almost the same average
and median. 3316 microspheres were studied. They ranged from 10 to 40 µm in diameter, with the
maximum peak at the 24 – 26 µm range. The average particle diameter was 25.2 µm, with a small
standard deviation (4.9 µm).

5.1.3 Degradation of microspheres
The microspheres were subjected to a degradation study for 28 days, using 2 U/ml type I
collagenase. Figure 15 illustrates the results.
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Figure 15. Degradation profile of GelMA microspheres. n = 3, error bars.

The degradation rate for the spheres was low, with less than 50% degraded by day 28. This low
degradation profile might be due to the strong chemical crosslinking of the microspheres (with the
ammonium persulfate and TEMED).

5.2 Bioink characterisation
As mentioned before in section 2 (preliminary work), previous students had characterised the bioink,
consisting of 7.5% GelMA and 2% alginate. The GelMA used for the bioink had different
characteristics compared to the one used for the microspheres. The GelMA for the bioink had a
lower bloom (175 vs 300 of the microspheres), which is more adequate for cell attachment and
growth. It was previously proven that GelMA prepared using a higher bloom gelatin (e.g. 300) led
to phase separation in blends of two or more polymers (for example, in the case of alginate-GelMA)
(118).
However, the previously used ink formulation (7.5% GelMA and 2% alginate) was printable at
15ºC. In this project, we aimed to make the ink printable at room temperature, as the custom-made
printer had temperature control in the bioink cartridges, but not in the nozzle and printing platform.
The previously established bioink did not have the optimal viscosity for extrusion printing at room
temperature, therefore, the formulation was optimised in this study by adding gelatin. At the
beginning, different gelatin concentrations were used, ranging from 2% to 5% (w/v). Various
experiments were performed to identify the most optimal gelatin concentration. Afterwards, the
bioink was characterised using the previous ink without gelatin as a control.

5.2.1 1H-NMR
Nuclear magnetic resonance spectroscopy was used to determine the degree of methacrylation of
the synthesised GelMA. Both GelMA and gelatin were analysed, and the results were analysed and
compared among them to obtain the methacrylation (or functionalisation) degree of GelMA. The
results are shown in Figure 16.
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gelMA

gelatin

Figure 16. NMR spectra of GelMA and gelatin. The region in green corresponds to the phenylalanine (7.2-7.5
ppm) and the region in grey, to the lysine (2.95-3.2 ppm).

First, both spectra were normalised with the phenylalanine region (green). Afterwards, the lysine
region (grey) was used to determine the degree of functionalisation (DoF) or methacrylation. This
was done with the following equation:
𝐷𝑜𝐹 (%) = 1 −

𝐴𝑙𝑦𝑠 𝑖𝑛 𝑔𝑒𝑙𝑀𝐴
∙ 100
𝐴𝑙𝑦𝑠 𝑖𝑛 𝑔𝑒𝑙𝑎𝑡𝑖𝑛

(10)

The degree of methacrylation of the synthesised GelMA was 68.1%, which is a medium-high
methacrylation degree.

5.2.2 Optimisation of the bioink for improved printability at room temperature
The effect of gelatin concentration on the printability of bioink at room temperature was investigated
using three types of tests. These were filament test, filament fusion test and layer stacking test. The
bioinks consisted of 7.5% GelMA, 2% alginate and a varying concentration of gelatin: 0%, 2%,
2.5%, 3%, 3.5%, 4% and 5%. Table 7 provides the designation of each ink with its respective ink
composition.
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Table 7. Summary of bioink composition of each ink tested.

Designation

Ink composition

0%

Alginate (2%) / GelMA (7.5%)

2%

Alginate (2%) / GelMA (7.5%) /gelatin (2%)

2.5%

Alginate (2%) / GelMA (7.5%) /gelatin (2.5%)

3%

Alginate (2%) / GelMA (7.5%) /gelatin (3%)

3.5%

Alginate (2%) / GelMA (7.5%) /gelatin (3.5%)

4%

Alginate (2%) / GelMA (7.5%) /gelatin (4%)

5%

Alginate (2%) / GelMA (7.5%) /gelatin (5%)

5.2.2.1 Filament test
In this test, the printing nozzle was positioned 5.5-6 cm above the printing platform. The ink (only
in the core) was extruded for 5 seconds. This determined the extrudability of each ink formulation.
If the ink was too rainy and generated droplets instead of an extruded line, it was discarded for the
rest of tests. Figure 17 shows the results.

Figure 17. Photos of the filament test performed with bioinks containing different gelatin percentages. The ink
without gelatin was also used for comparison. The ink was dyed red for better visibility. n = 3.

This test determined that, without adding gelatin, the ink was liquid and fell in droplets from the
extruding nozzle. Thus, the formula was not extrudable at room temperature. The rest of the
formulations passed the filament test and were subjected to the following experiments.
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5.2.2.2 Filament fusion test
This test was performed to determine the shape fidelity of the extruded filaments. The distance
between filaments increased after each strand. At lower separations, the filaments would be merged,
and separated at higher distances. The number of merged filaments was used as an indicator for the
shape fidelity. Figure 18 shows the results.

Figure 18. Printed scaffolds with different ink formulations, from 2% to 5% gelatin. The scaffolds had an
increasing distance between layers, ranging from 1 to 2.5 mm. n = 3.

The visual examination of the samples determined that the 2% gelatin samples had a poor shape
fidelity. Besides, 4% and 5% ink formulations were over-gelated, extruding thicker and irregular
filaments. These parameters (filament diameter and distance between filaments) were measured
with ImageJ and compared to the theoretical values. The results are in Table 8.
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Table 8. Measurements of the filament diameter and spacing of the printed scaffolds. The theoretical values
are shown on the first row for comparison. The values are displayed with their standard deviation. n = 3.

Diameter

d1

d2

d3

d4

d5

d6

Theoretical

1

0

0.25

0.5

0.75

1

2

2%

1.13 ± 0.25

-

-

0.66 ±
0.05

0.72 ±
0.13

1.05 ±
0.1

1.34 ±
0.15

2.5%

1.08 ± 0.1

-

-

0.41 ±
0.05

0.74 ±
0.16

0.88 ±
0.07

1.3 ±
0.16

3%

1.07 ± 0.09

-

0.38 ±
0.04

0.57 ±
0.06

0.71 ±
0.08

0.98 ±
0.11

1.41 ±
0.08

3.5%

1.07 ± 0.08

-

-

0.53 ±
0.05

0.69 ±
0.04

0.93 ±
0.13

1.45 ±
0.13

4%

1.12 ± 0.11

-

-

0.29 ±
0.05

0.55 ±
0.09

0.72 ±
0.06

1.11 ±
0.06

5%

1.13 ± 0.1

-

-

0.31 ±
0.09

0.56 ±
0.1

0.8 ±
0.08

1.15 ±
0.21

The theoretical distances between filaments are schematically explained on Figure 19. The
theoretical length of the filaments is shown on the left, which matches with the printing coordinates.
The theoretical distance between filaments is shown on the right, where a filament thickness of 1
mm is considered.

Figure 19. Theoretical length of filaments (left) and their theoretical distance (right) on the filament fusion test.
The distance between filaments increased at every strand printed (printing direction from left to right). The ink
would have the theoretical distances between filaments in case the shape fidelity was perfect. Even with an ink
with perfect shape fidelity, the first two filaments would be fused (as d1 is 0 mm).

Looking into the filament diameter, those printed using the inks 2.5%, 3% and 3.5% appeared to be
the closest to the theoretical value. However, there is no significant difference in the filament
diameter across all testing groups. In the smallest distances (0.25, 0.5 and 0.75 mm spacing), those
printed with the 2.5%, 3% and 3.5% formulations were closest to the theoretical values. Therefore,
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it was concluded that these three inks were the ones with the better shape fidelity. Furthermore,
observing the image of the 2% result (Figure 18), it was decided to not continue doing experiments
on that ink.

5.2.2.3 Layer stacking test
This test was performed to complete the preliminary printing characterisation. 2.5% - 5% inks were
tested. All the inks were printed at room temperature, with the same printing parameters: 0.23
ml/min flow and 140 mm/min speed. Lattices of 10 layers were intended to print, however, some
bioinks did not achieve the 10 layers (2.5%, 4% and 5% gelatin inks achieved only 8 layers), because
the strands merged or were brittle and the structure broke. The results are displayed in Figure 20.

Figure 20. Layer stacking test. The printable scaffold with the highest number of layers was chosen as best
result for each condition. Scale bar: 1 mm. n = 3.

The best results were obtained with 3% and 3.5% inks, as well-defined 10-layered structures could
be printed. The scaffolds printed using 2.5% ink formulation were too rainy on the 10th layer, with
the filaments merging. On the other hand, 4% and 5% gelatin scaffolds were over-gelled (as can
already be seen on their 8th layer), and the 10th layer was rough and brittle, and so they were
considered bad results. Figure 21 shows the 10-layered structures printed using the 2.5%, 4% and
5% gelatin inks respectively.

Figure 21. Images of the 10-layer results for 2.5%, 4% and 5% ink conditions. n = 3, scale bar: 1 mm.
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Considering all the results obtained in the preliminary printing characterisation, 3% and 3.5% were
selected to continue the studies.

5.2.3 Rheology
The different bioink formulations with 3% and 3.5% gelatin, as well as the ink without gelatin (0%),
were subjected to rheological studies to determine its behaviour. Rheology measures the dynamic
properties of fluids. The inks were subjected to rotation or oscillation, and their response was
collected and analysed.

5.2.3.1 Temperature sweep
First, a temperature sweep was performed on the chosen ink formulations: 3% and 3.5% (and 0%).
In this oscillation test, the frequency and strain remained constant (1 Hz and 1% respectively) and
the temperature ranged from 10ºC to 40ºC, at a rate of 1.5ºC/min. Results are shown in Figure 22.

Figure 22. Results of the temperature sweep in the 3 conditions tested. G’, storage modulus; G’’, loss modulus.
n = 3, error bars. The 0% gelatin ink (2% alginate/7.5% GelMA/0% gelatin) was gel-like (G’ > G’’) and it
became a liquid-like (G’’ > G’) before reaching room temperature (22ºC). The 3% and 3.5% gelatin inks (2%
alginate/7.5% GelMA/3% gelatin and 2% alginate/7.5% GelMA/3.5% gelatin respectively) were gel-like (G’
> G’’) and were close to become liquid-like from 30ºC to 40ºC, as G’ and G’’ had similar values.
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The storage modulus (G’) refers to the gel-like characteristics of a fluid, whereas the loss modulus
(G’’) refers to the liquid-like characteristics. When the storage modulus is higher than the loss
modulus (G’ > G’’), the ink is elastically dominated and shows solid-like properties (meaning that
it is gelled). On the contrary, when the loss modulus is higher than the storage modulus (G’’ > G’),
the ink is viscously dominated (meaning that it is liquid). For printing purposes, it is required for
the inks to be elastically dominated.
Figure 23 shows that all the inks were elastically dominated with low temperatures (10-15ºC) and
started decreasing in the storage modulus with the increase in temperature. The temperature where
the two moduli crossed in the ink without gelatin is around 21ºC. Thus, the ink was viscously
dominated (G’’ > G’) at the printing temperature (22ºC), therefore it was liquid and not suitable for
extrusion printing. A close-up observation of these graphs is shown below for a better analysis of
the ink behaviour at room temperature (15ºC – 25ºC).

Figure 23. Close-up observation of Figure 22 in the temperature range, from 15ºC to 25ºC. n = 3, error bars.
The ink without gelatin (2% alginate/7.5% GelMA/0% gelatin) changed from gel-like (G’ > G’’) to liquid-like
(G’’ > G’) at 21ºC. The inks with gelatin inks (2% alginate/7.5% GelMA/3% gelatin and 2% alginate/7.5%
GelMA/3.5% gelatin) had a similar behaviour among them, where G’ > G’’ was kept, although the difference
between G’ and G’’ became smaller as the temperature increased. This means that the bioinks with gelatin
retained gel-like properties from 15ºC to 25ºC.

52

The addition of gelatin (3% or 3.5%) increased the storage modulus of the 2% alginate 7.5% GelMA
ink, making it elastically dominated at 22ºC. The two options (3% and 3.5%) were suitable for
extrusion, as the storage modulus was higher than the loss modulus at this temperature. The graph
below (Figure 24) compares the storage moduli (G’) of all the inks.

Figure 24. Storage moduli (G’) of the different ink formulations (0%, 3%, 3.5%) at different temperature
ranges: 10ºC – 40ºC (left), 15ºC – 25ºC (right). n = 3, error bars. The 0% ink (2% alginate/7.5% GelMA) had
a different behaviour compared to the other two inks (3%, 3.5% gelatin), with a lower storage modulus,
especially at temperatures above 20ºC.

This comparison shows that the storage modulus was significantly higher in the inks with gelatin
(3% and 3.5%). Therefore, the two bioinks with gelatin were suitable for printing at room
temperature. The following rheology tests were performed at 22ºC for the bioinks with gelatin (3%
and 3.5% gelatin inks) and at 15ºC for the control bioink without gelatin (0% gelatin ink), unless
otherwise specified. The control bioink is 2% alginate 7.5% GelMA, used and characterised
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previously for printing at 15ºC, hence the comparison of the new bioinks with 3% and 3.5% gelatin
at 22ºC with the one without gelatin at 15ºC.

5.2.3.2 Viscosity
In the rotation test, the viscosity of the ink was measured in a range of shear rate (0.01 – 1000 s-1).
The rest of the parameters remained stable: 1 Hz frequency, 1% strain, 22ºC (3%, 3.5% ink) or 15ºC
(0% ink) temperature. Different forces and shear rates are applied in extrusion printing, changing
the ink viscosity and consequently its behaviour. Therefore, making sure that the ink had a certain
viscosity at a given shear rate was important. Figure 25 shows the results.

Figure 25. Graphical representation of ink viscosity at different shear rates (log scale). The two chosen inks,
3% and 3.5%, were compared to the 0% ink both at room temperature (22ºC) and at its optimal printing
temperature (15ºC). Equations show power trendlines for each data set. n = 3, error bars.

The graph shows a significant drop in viscosity with the increase in temperature from 15 to 22ºC
for the 0% ink (a 240-fold drop at 0.1 s-1 shear rate). On the other hand, the addition of gelatin
significantly increases the ink viscosity at 22ºC, comparing 3% and 3.5% to 0% (82-fold increase
for 3% and 130-fold increase for 3.5% when compared to 0% 22ºC ink at 0.1 s -1 shear rate). When
comparing the inks with gelatin to the 0% ink, 3.5% is the most similar one (as there is a 1.7-fold
drop from 0% 15ºC to 3.5% 22ºC, whereas from 0% 15ºC to 3% 22ºC there is a 2.95-fold drop).
Table 9 shows the average viscosity of each bioink at different shear rates.
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Table 9. Results of the viscosity (Pa·s) vs shear rate (s-1) rheology. All the conditions tested were compared.

Viscosity (Pa·s)

Shear rate
(s-1)

0% ink at 15ºC

0% ink at 22ºC

3% ink at 22ºC

3.5% ink at 22ºC

0.1

1880.33 ± 240.31

7.79 ± 0.91

638.60 ± 36.17

1018.70 ± 36.51

1

292.73 ± 10.18

2.15 ± 0.34

117.53 ± 7.11

168.40 ± 1.77

10

49.26 ± 10.18

0.73 ± 0.08

14.42 ± 0.63

18.72 ± 1.13

100

4.97 ± 0.14

0.46 ± 0.05

2.98 ± 0.42

2.61 ± 0.32

1000

0.65 ± 0.03

0.24 ± 0.02

0.80 ± 0.03

0.61 ± 0.02

The correlation between viscosity and shear rate determined their power law equations. These were
then used to calculate the shear rate each ink suffered in the printing process. Finally, that shear rate
was correlated to the viscosity (in the graph). This determined if the ink had an acceptable viscosity
at the printing process. Two equations were used to resolve it.
𝜂 = 𝐾 ∙ 𝛾 𝑛−1

(11)

η = viscosity
K = consistency factor
γ = shear rate
n = flow behaviour index
𝛾=

4𝑄 3𝑛 + 1
8𝑉 3𝑛 + 1
∙
=
∙
3
𝜋𝑅
4𝑛
𝐷
4𝑛

(12)

Q = volumetric flow rate of printing
R = printhead/nozzle radius
V = speed of printing
D = printhead/nozzle diameter
Equation 11 is used to describe a power-law fluid behaviour, where K and n are part of the power
trendlines (and the viscosity and the shear rate are y and x respectively). Furthermore, Equation 12
shows the Rabinowitsch–Mooney equation, which allows to estimate the shear rate during the
extrusion of the bioink through the nozzle (119). The printing speed, flow and nozzle diameter were
known values, and the flow behaviour index (n) was the exponent in the power-law fluid equation.
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Table 10. Rheological parameters obtained by fitting the viscosity data with the power law model (Equation
11) and the Rabinowitsch-Mooney equation (Equation 12). The final goal was to determine the shear rate of
the ink in the nozzle at the time of printing (γ), and the viscosity at that point (η nozzle). For calculating the
viscosity before and after printing (ηrest), a shear rate of 0.1 s-1 was assumed.

Ink

0%
15ºC

0%
22ºC

3%
22ºC

3.5%
22ºC

Power law
fitting

y = 288.34x-0.87

y = 2.3488x-0.36

y = 99.82x-0.74

y = 141.81x-0.82

K

288.34

2.35

99.82

141.81

n-1

n

-0.87

0.13

-0.36

γ (s-1)

ηnozzle (Pa∙s)

(Core)
125.44

(Core) 4.29
± 0.12

(Shell)
250.88

(Shell) 2.34
± 0.08

(C) 53.23

(C) 0.56 ±
0.07

(S) 106.46

(S) 0.44 ±
0.05

(C) 92.19

(C) 3.57 ±
0.43

0.64

-0.74

1880.33 ±
240.31

7.79 ± 0.91

0.20

-0.82

ηrest (Pa∙s)

(S) 184.38

(S) 2.15 ±
0.15

(C) 101.29

(C) 3.16 ±
0.28

(S) 202.58

(S) 1.78 ±
0.14

0.18

638.60 ±
36.17

1018.70 ±
36.51

A bioink suitable for extrusion printing has two desirable features. First, it presents shear thinning
while going through the printing nozzle. Second, a suitable bioink presents a fast recovery in
viscosity after extrusion. When the shear stress is removed, the viscosity increases, and the ink
behaves as a solid again, preserving the shape fidelity of the printed constructs.
K and n-1 were obtained by fitting the viscosity data with the power law model. The printing speed
(V) was constant in all the cases, 140 mm/min, which is 2.3 mm/s. Finally, the diameter of the
nozzle (D) was 400 µm in the core and 200 µm in the shell (0.4 and 0.2 mm). The shear rate in the
nozzle can be calculated using Equation 12, based on which one can estimate the viscosity of ink
during the process of printing (ηnozzle). The viscosity while going through the core of the printing
nozzle for the ink with 0% gelatin was 4.29 ± 0.12 Pa·s at 15ºC and 0.56 ± 0.07 Pa.s at 22ºC. The
bioinks with gelatin had a viscosity of 3.57 ± 0.43 Pa·s and 3.16 ± 0.28 Pa·s at 22ºC (for the 3% and
3.5% inks respectively). The results for the viscosity of the inks in the shell of the printing nozzle
were similar: 2.34 ± 0.08 Pa·s and 0.44 ± 0.05 Pa·s for the ink with 0% gelatin at 15ºC and 22ºC
respectively, and 2.15 ± 0.15 Pa·s and 1.78 ± 0.14 Pa·s for the 3% gelatin and 3.5% gelatin inks
respectively. The 0% ink at 22ºC was less viscous (0.56 Pa∙s), therefore, this confirmed that it
became liquid while extruding through the nozzle. The bioink must behave like a liquid when going
through the nozzle for it to be extrudable. When comparing the inks at 22ºC, the addition of gelatin
slightly increased the viscosity, meaning that more force has to be applied for extruding the inks
with 3% and 3.5% gelatin through the nozzle.
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Moreover, the ink must behave like a solid once it is out of the nozzle, to retain its shape. The
viscosity, among other factors, determines that. The shear rate “at rest”, after printing, where no
forces are applied, is considered 0.1 s-1. The viscosities for that shear rate were calculated from the
Equation 11 (ηrest). Considering that the 0% ink at 15ºC was a fluid while going through the core of
the nozzle (4.29 ± 0.12 Pa∙s), 0% ink could not retain its shape at 22ºC with 7.79 ± 0.91 Pa∙s at rest.
This was confirmed in earlier tests (filament test, filament fusion test), where the 0% bioink did not
retain its shape after being extruded at 22ºC. The other two inks (with 3% and 3.5% gelatin) had a
higher viscosity at rest (638.60 ± 36.17 Pa∙s and 1018.70 ± 36.51 Pa·s respectively for 3% and
3.5%). The 0% gelatin ink presented a viscosity of 1880.33 ± 240.31 at 15ºC. All the bioinks
presented a significant increase in viscosity between ηnozzle and ηrest, except the 0% gelatin ink at
22ºC. The differences among ηcore and ηrest were 1876.04 ± 240.53 Pa∙s for the 0% gelatin 15ºC ink,
7.23 ± 0.98 Pa∙s for the 0% gelatin 22ºC ink, 635.03 ± 36.60 Pa∙s for the 3% gelatin ink and 1015.54
± 36.79 Pa∙s for the 3.5% gelatin ink. Among these, 3.5% was chosen to continue with the rest of
experiments, as its difference in viscosity between at rest and going through the nozzle at 22ºC was
higher.

5.2.3.3 Effect of microsphere loading 2% alginate/7.5% GelMA/3.5% gelatin ink
Once the ink was chosen, microspheres were added to it to determine if they altered the ink
composition and printability. More viscosity measurements were performed on the 3.5% ink to
examine the effect of microspheres loading on the viscosity of bioinks (5 and 10 mg/ml
microspheres). Figure 26 shows the effect of the microsphere addition on the 3.5% gelatin bioink.
The ink without microspheres, with 5 mg/ml microspheres and with 10 mg/ml microspheres were
compared.
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Figure 26. Graphical representation of ink viscosity at different shear rates (log scale). The chosen ink, 3.5%,
was analysed without and with the inclusion of 5 mg/ml and 10 mg/ml GelMA microspheres. The experiment
was held at room temperature (22ºC). Equations show power trendlines for each data set. n = 3, error bars.

The Equations 11 and 12 were used to calculate the shear rate in the nozzle and its viscosity, as well
as the viscosity after the extrusion finished. Table 11 shows the results.
Table 11. Values extracted from the trendlines and equations 11 and 12. The final goal was to determine the
shear rate of the ink in the nozzle at the time of printing (γ), and the viscosity at that point (η).

Ink

3.5% gelatin

3.5% gelatin
+ 5 mg/ml
MP

3.5% gelatin
+ 10 mg/ml
MPs

Trendline

y = 141.81x-0.82

y = 167.44x-0.86

y = 168.89x-0.89

K

n-1

141.81

-0.82

167.44

-0.86

168.89

-0.89

n

γ (s-1)

ηnozzle
(Pa∙s)

(Core)
101.29

(Core)
3.16 ±0.28

(Shell)
202.58

(Shell)
1.78 ± 0.14

(C)
120.16

(C) 2.69 ±
0.35

(S)
240.32

(S) 1.48 ±
0.33

(C)
145.06

(C) 1.97 ±
0.25

(S)
290.13

(S) 1.06 ±
0.15

0.18

0.14

0.11

ηrest
(Pa∙s)

1018.7 ±
36.51

1115.67
± 109.61

1135 ±
205.66

Typically, the smaller the n value, the more shear thinning the ink has. In this case, the bioink with
10 mg/ml MPs had the lowest n value (desirable for having less pressure applied for the ink to go
through the nozzle) and the highest viscosity at rest (desirable for a better shape fidelity after
printing). In this case, there was a slight difference in the viscosity at the nozzle between the 3 inks,
but they all were low in general, suggesting liquid like properties in the nozzle for the ink with and
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without microspheres. Moreover, increasing the microsphere loading resulted in an increase in the
viscosity of the ink at rest, facilitating the shape retention of the prints. 10 mg/ml microspheres were
chosen as the MP concentration for the ink, as it showed slightly better printing properties. However,
the following rheological and hydrogel characterisation tests were performed in the 3.5% ink
without microspheres in order to save material.

5.2.3.4 Other rheological measurements
Other oscillation tests were performed to determine the stability and optimal ink conditions:
frequency, strain, and step-strain tests. In all of them, storage (G’) and loss (G’’) moduli of the 3.5%
ink were measured at 22ºC and were compared to the control sample (0% gelatin) at 15ºC. In all the
cases, all other parameters were kept constant (1 Hz frequency, 1% strain), except from the one that
varied (see section 4.2.4 Rheology and Table 5 for more details).
Figure 27 gathers the graphs of these tests, where the G’ of 3.5% ink was compared with the 0% ink
measured at 15ºC.

Figure 27. Results of the rheology tests, comparing the 2% alginate/7.5% GelMA/3.5% gelatin 22ºC bioink to
the 2% alginate/7.5% GelMA 15ºC bioink. Frequency sweep at 0.1-20 Hz range (A), strain sweep at 0.1-1000%
range (B) and step-strain test with 100% strain for the stress period and 1% strain for the recovery period (C).
The storage modulus (G’) is shown. Logarithmic scale was used in the x and y axes. n = 3, error bars.
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In the frequency sweep, the behaviour of the ink was studied from 0.1 to 20 Hz. In the strain sweep,
the ink behaviour was studied in the range of 0.1-1000% strain. These two tests were performed to
ensure that the ink was stable at the frequency and strain at printing, 1 Hz and 1% respectively. Both
ink types increased their storage modulus when the frequency increased, however, there is a
significant drop in G' for the 0% sample measured at 15ºC, which might be due to the collapse of
polymer network. Unlike the 0% sample measured at 15ºC, the G' of 3.5% ink, when measured at
22ºC, showed a linear trend in all the frequency region tested.
Regarding the strain sweep (Figure 27B), the G’ of both bioinks was stable below certain percentage
of strain (around 100% strain for the 0% gelatin ink at 15ºC, around 70-80% strain for the 3.5%
gelatin ink at 22ºC). Above that strain percentage, the polymer network of both inks might have
collapsed, resulting in a drop in storage modulus. The strain sweep was employed to calculate the
yield point of the samples (Figure 28). The yield point occurs when a material deforms, due to a
force. In this context, the material behaves as a solid (gel) in the syringe, and a force needs to be
applied for it to behave as a liquid and get extruded through the syringe. Therefore, the strain at the
yield point would be the one needed to apply at the syringe to start printing. This point was
calculated where the storage modulus (G’) dropped. Figure 28 explains it schematically.

Figure 28. Yield points of the two ink types, at the cutting point of the line on the x axis. The yield strains were
60% and 90% for the 3.5% and 0% inks, respectively.

The yield point of the 3.5% bioink at 22ºC was an average of 61.7 ± 2.9%, and the yield point of
the 0% bioink at 15ºC was an average of 93.3 ± 12.6%. According to these results, more force (or
strain) would be required to squeeze the 0% ink at 15ºC. Therefore, the 3.5% ink would be more
easily extruded.
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Apart from that, the step-strain sweep was also analysed (Figure 27 C). The ability of the ink to
recover after a stress was tested (for example, after the extrusion of the ink). This was a time sweep
where the strain increased from 1% to 100% for 30 seconds. Afterwards, the samples were given 3
minutes to recover at 1% strain, before subjecting them to another stress period. The stress-recovery
steps were repeated 5 times. When the ink was under stress (simulating the printing condition in the
nozzle), the storage modulus decreased. When the stress came back to 1%, the ink was expected to
recover to the initial storage modulus. The aim was to analyse the recovery time, and to see if the
ink recovered to the initial storage modulus after the stress. In both ink types, a fast recovery was
observed, obtaining the same storage modulus from before the stress in a short period of time
(maximum 30 seconds for the 0% ink and 80 seconds for the 3.5% ink). Even if the trend of the
storage modulus was slightly upwards, the ink recovered properly after every step. This
phenomenon (G’ slightly increasing over time) could not happen because of the evaporation of the
ink, as a solvent trap was used to prevent it. Some molecular reorganisations could be responsible
for it, where the polymer network would become stronger over time.

5.2.3.5 In-situ crosslinking rheology with UV or near-UV light
Finally, a last rheological test, a time sweep was performed with UV light, to monitor crosslinking
kinetics of both inks. The UV lamp used was at 365 nm (the most efficient for the LAP
photoinitiator), even if the hydrogels were casted with a 405 nm lamp. As it was mentioned in the
methods section (4.2.4 Rheology), a special UV box had to be attached to the rheometer, and the
only lamp available was the 365 nm one. The aim was to see the effect of the UV on the crosslinking
and comparing both inks (the 2% alginate/7.5% GelMA and the 2% alginate/7.5% GelMA/3.5%
gelatin). Results are in Figure 29.
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A

B

Figure 29. In-situ crosslinking trend of the 0% and 3.5% inks under UV light (365 nm wavelength). The full
results (A) and a close-up on the UV on/off region (B) are shown. n = 3, error bars. The time sweep started
with the UV light off. After 2 minutes, the UV light was turned on for 1 minute, and then off again. The 0%
ink (2% alginate/7.5% GelMA) and the 3.5% ink (2% alginate/7.5% GelMA/3.5% gelatin) had an abrupt
increase in G’ after the UV light turned on (due to photocrosslinking), and the G’ slightly increased even after
the UV light turned off.
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Figure 29 shows the increase in storage modulus of both bioinks, which occured when the UV light
was turned on. After the UV light was turned off, the storage modulus of both bioinks became stable.
Table 12 shows the storage modulus of the different conditions, at the beginning of the test and after
5 minutes (300 s).
Table 12. Summary of the results of the UV crosslinking rheology. The storage moduli and standard deviations
are shown for the two bioinks, before and after crosslinking. The difference between them is also shown, to
describe the increase in G’ during the crosslinking.

Storage modulus (G’) (Pa)
Condition

Before crosslinking (0 s)

After crosslinking (300 s)

Difference

0% ink 365 nm light

26.30 ± 2.26

4162.00 ± 68.00

4135.40 ± 70.26

3.5% ink 365 nm
light

89.39 ± 8.38

5630.33 ± 383.76

5540.94 ± 392.14

The biggest difference was at the starting point of the samples (before the light was applied), where
the 3.5% samples had a higher storage modulus than the 0% ones (89.39 ± 8.38 Pa·s for the 3.5%
ink and 26.30 ± 2.26 Pa·s for the 0% ink). The reason behind that was the lack of temperature control
at the rheology plate fitted for UV-light. All samples were tested at room temperature (22ºC), where
the 0% ink had a liquid behaviour, presenting a lower storage modulus. After crosslinking, both inks
increased in more than 4000 Pa·s their storage modulus. The increase of the 0% and 3.5% inks were
4135.40 ± 70.26 Pa·s and 5540.94 ± 392.14 Pa·s respectively. The higher storage modulus of the
3.5% ink was expected, as the samples contained more solid content (3.5% more gelatin than the
0% ink). This resulted in a more compact polymer network which was transated into a higher G’
before and after crosslinking.
After the rheology tests were concluded, the crosslinked hydrogels were characterised to determine
their swelling and mechanical properties as well as their degradation.

5.2.4 Characterisation of hydrogel discs
The swelling, mechanical and degradation properties of crosslinked hydrogels were determined.
3.5% bioink hydrogels were compared to 0% bioink hydrogels as a control. The hydrogel discs were
obtained by pouring the ink mixtures with LAP in 8 mm diameter moulds and crosslinking them
with 1 minute of UV light at 405 nm and 10 minutes of a 2% CaCl2 solution, as specified in the
methods (section 4.2.5). All the discs were 1 mm in height except in the mechanical test, where the
height was 3 mm.

5.2.4.1 Free polymer content and swelling
The free polymer content and swelling fraction of 0% and 3.5% hydrogels were shown in Figure
30.
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Figure 30. Results of the free polymer content (A) and swelling ratios (B) calculated on the 0% and 3.5%
hydrogel discs. Crosslinking conditions: 1 minute under 405 nm light at 2 mW/cm2 intensity and afterwards
10 minutes in a 2% CaCl2 solution. n = 3, error bars. Significative differences are shown (p > 0.05: n.s., p 0.010.05: *, p 0.005-0.01 **, p 0.001-0.005: ***, p < 0.001 ****).

The free polymer content refers to the soluble fraction of the hydrogel, this is, the part that dissolves
after being overnight in PBS. The polymerised fraction is the opposite of the soluble (dissolved)
fraction (the remaining part of the hydrogel). Moreover, the swelling ratio of the gels describes how
much water they absorb. In this case, the 3.5% hydrogels had a higher free polymer content and
slightly lower but non-significative swelling. Gelatin is soluble at 37ºC, therefore, the 3.5% gelatin
could have dissolved overnight at 37ºC, resulting in 29% ± 1.6% free polymer content (vs the 15%
± 3.7% of the 0% gelatin ink). The swelling ratios of the 0% ink and 3.5% ink were 13.20 ± 0.82%
and 12.95 ± 0.58% respectively.

5.2.4.2 Mechanical test
A compression test was performed on 3 mm thick hydrogel discs. The compression modulus was
calculated as the slope in the stress-strain curve at 10%-15% strain range. Four types of hydrogels
were compared: 0% or 3.5% ink and directly after casting them or after leaving them overnight in
PBS at 37ºC. The discs were left overnight at 37ºC to remove the unreactive polymers and the
gelatin. In this way, the mechanical strength could be compared between the gels with and without
the unreactive hydrogel and gelatin dissolved. Figure 31 shows the results.
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Figure 31. Compression modulus (kPa) in different gel conditions, showing the stiffness of each gel type. n =
3, error bars. Significative differences are shown (p > 0.05: n.s., p 0.01-0.05: *, p 0.005-0.01 **, p 0.001-0.005:
***, p < 0.001 ****).

These results showed some differences between conditions. There were no significant differences
between the two ink types on the gels tested directly after UV crosslinking, meaning they had a
similar stiffness. Besides, a decrease in the compression modulus was observed on the hydrogels
that had been overnight in PBS at 37ºC (compared to the ones tested on the same day). These lower
values correlated with the fraction dissolved overnight (free polymer content), therefore, the gels
became more porous, mechanically weaker. However, this difference was bigger in the samples
prepared using the 3.5% ink than the 0% ink, which was expected as the free polymer content was
higher in the samples crosslinked using the 3.5% ink (referring to the gelatin fraction that dissolved
overnight). The analysis was more focused on the results obtained after the removal of free
polymers, as the condition is more consistent with the targeted application on in vitro cell culture.
Observing the two gel types, the gels without gelatin were significantly stronger than the ones with
3.5% gelatin (45.01 ± 2.62 kPa of 0% vs 28.42 ± 1.46 kPa of 3.5%). In conclusion, both ink types
provided similar mechanical properties before the removal of free polymers. Then, both gel types
decreased their compression modulus compared to the “same day” studies, but the lack of
crosslinking of the gelatin made the 3.5% gels significantly weaker than the 0% ones.

5.2.4.3 Degrdability of gels
The same degradation test done with the microspheres (5.1.3) was performed with the hydrogels
prepared using 0% or 3.5% ink. The gels were subjected to a degradation study, using 2 U/ml type
I collagenase. Figure 32 shows the results.
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Figure 32. Degradation study of hydrogels. Measured with the dry weight of the discs. n = 6, error bars.

The hydrogel discs degraded fast, being completely degraded by day 5. 3.5% hydrogels degraded
faster, especially in the first two days. This, together with the above mentioned mechanical testing,
reflects the effect of the elution of unreactive polymers (and gelatin in the 3.5% gelatin condition),
which results in a more porous structure that speeds up the degradation process when compared to
the samples prepared using 0% gelatin ink.

5.2.5 Microsphere distribution in ink
It had to be ensured that the microspheres uniformly distributed in the ink before printing, and that
they did not settle at the bottom of the syringe while printing. To assess the distribution of the
GelMA microspheres in the ink, the microspheres, previously rehydrated with PBS, were mixed
with the 3.5% ink and deposited in syringes for printing. 30 minutes later (time taken into account
as the co-axial extrusion printing lasted no longer than 30 minutes), the ink was extruded in different
regions of the syringe (bottom, first extruded; middle and top, last extruded). These regions were
analysed under an optical microscope, and the count of microspheres was used to determine if their
distribution was uniform throughout the syringe. This experiment was done only in the 3.5% ink.
Results are displayed in Figure 33.
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Figure 33. Microsphere distribution in the syringe, showing three different regions and the count of
microparticles. n = 3, error bars. Significative differences are shown (p > 0.05: n.s., p 0.01-0.05: *, p 0.0050.01 **, p 0.001-0.005: ***, p < 0.001 ****).

The count showed that the microsphere distribution was uniform throught the printing syringe, with
no significant variation on the MP number in the different regions of the syringe. This proved that
a uniform distribution of the microspheres in the ink, a critical factor to ensure the printed structure
is reliable and replicable, was achieved.

5.3 Release study
A release study was performed from the GelMA microspheres to the medium. First, the IL-2 growth
factor was adsorbed into the dry microspheres, and then the release started. 3 different conditions
were analysed, including IL-2 loaded microspheres, casted hydrogels containing IL-2 loaded
microspheres, co-axially printed hydrogels containing IL-2 loaded microspheres.
In all the cases, an added timepoint was taken at day 0, immediately after adding the release medium.
This was measured to know what amount of the IL-2 was not adsorbed to the microspheres (and
released immediately), and this quantity was subtracted from the total IL-2 added, in order to
quantify the total IL-2 adsorbed to the spheres. Figure 34 shows the results.
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Figure 34. Accumulated release profile of the IL-2 in the three different conditions (free, casted and printed).
n = 3, error bars.

The release profile was very similar in the three cases, with an initial burst release and reaching a
plateau phase in the first 3-5 days. Initially it was expected that the casted and printed gels would
have a more sustained release over time when compared to the free microspheres. However, in the
three cases the profile was similar. One of the reasons why this could have happened was related to
the fast degradability of the hydrogels, which after 2-4 days of release were completely degraded
(section 5.2.4.3). Therefore, after day 4, the three conditions were the same (free microspheres).
Besides, another factor that could have influenced on that release profile was the low degradability
of the microspheres, and the strong interaction between the spheres and the IL-2. In this case, until
the spheres degraded, the IL-2 would be attached to them. As a result of that, the maximum release
obtained was 12% of the total inside the spheres.
On the first two days of the release, it is noticeable that the free microspheres were the ones releasing
IL-2 slower, and that the spheres embedded into the gel (be it casted or printed) had a faster initial
release. The free microspheres released 6.5% of the total 10.5% IL-2 released on the first day,
compared to the 8% of the total 10% on casted gels and 9.5% of the total 11.5% on printed gels.
Therefore, 62% of the total released IL-2 was released on the first day from the free microspheres,
80% from the casted gels and 82.6% from the printed gels. This might be due to the gels degrading
and releasing some microspheres to the release medium. These released microspheres from the gels
might have been collected with the release medium in day 1, resulting in a higher quantification of
IL-2. Nevertheless, this was a preliminary study, which could not be repeated due to time
constraints.
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Chapter 6
6. Discussion
In this project the 2% alginate, 7.5% GelMA and 3.5% gelatin ink was identified and assessed
against the ink previously developed, consisting of 2% alginate and 7.5% GelMA, with a focus on
improving the printability at room temperature. GelMA microspheres were added to the ink
formulation. These were also characterised and their effect on the bioink was assessed. Finally, the
release of the growth factor from the microspheres was also analysed. The discussion is focused in
three main points:
-

Bioink. Comparison between the two main inks (gelatin vs no gelatin). Analysis of filament
tests, rheology and hydrogel characteristics.

-

Microspheres. Preparation, characterisation of GelMA microspheres and their distribution in
the identified ink formulation.

-

Release. Characterisation and comparison of IL-2 release from the GelMA microspheres, and
casted and printed hydrogels where IL-2 preloaded microspheres were encapsulated.

6.1 Bioink
The bioink used was composed of 68% DoF 175 bloom GelMA (7.5%), medium viscosity alginate
(2%) and gelatin (300 bloom). GelMA and alginate concentrations had previously been optimised,
but this bioink was liquid at room temperature (22ºC), therefore, not printable. This project intended
to develop a bioink printable at room temperature, as the custom-made bioprinter used did not have
temperature control on the printing nozzle and base (as explained in section 1.3.3.1). The idea with
this project was to add gelatin to the previously developed ink to make it printable at room
temperature.
The first step of the bioink optimisation was to determine the gelatin concentration for printing at
room temperature. The filament test (Figure 17) showed that without gelatin, the ink was too rainy
and fell in droplets. Afterwards, the filament fusion test (Figure 18) and layer stacking tests (Figures
19-20) identified 2.5%, 3% and 3.5% as the best options. Lower gelatin concentrations provided
bad shape fidelity, with filaments spreading and merging after being deposited by the printer. Higher
gelatin concentrations generated rough constructs, where layer stacking was also compromised.
Some of these tests were previously performed by other groups (120). The distance between
filaments (Table 8) was a quantitative indicator of the shape fidelity in each ink formulation. In this
case, the distances between filaments printed using the 2.5% - 3.5% gelatin inks were the closer to
the theoretical distances. For this reason, these three were chosen for rheological characterisation.
Different rheological tests were performed: temperature sweep, viscosity test, strain sweep,
frequency sweep, step-strain and in situ UV-crosslinking rheology. Temperature sweep was first
done with the three chosen inks and the one without gelatin (Figure 21-23). When the storage
modulus (G’) is higher than the loss modulus (G’’), the ink is elastically dominated, this is, its gel-
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like properties are more dominant than its liquid-like properties. On the contrary, when G’’ > G’,
the ink is viscously dominated and its liquid-like properties prevail (121). For extrusion printing,
the ink was required to be elastically dominated (G’ > G’’). The ink without gelatin proved that it
was liquid at room temperature. All the inks with gelatin were gel-like at room temperature (22ºC),
however, 2.5% ink was almost on the verge of becoming liquid. Thus, it was discarded for the
following tests.
The next rheological test was the viscosity test (Figure 24). This was important for the assessment
of the printability. The viscosity of the ink plays a fundamental role for extrusion printing.
Generally, hydrogels behave as non-Newtonian materials, with shear thinning characteristics (121).
With shear thinning, the viscosity decreases when the shear stress increases. Before and after
printing, the shear stress can be considered inexistent (0.1 s-1). In these occasions, the ink is
elastically dominated (gel). However, for printing, the ink suffers a stress (shear stress) when it is
pushed through the nozzle. As mentioned before, hydrogels suffer from shear thinning, reducing
their viscosity until they become extrudable. In the viscosity test performed at room temperature,
all the inks exhibited shear thinning effects. The inks with gelatin were clearly more viscous than
the one without it. In addition, these were also compared to the ink without gelatin measured at
15ºC, as it was the previous printing condition. It was determined that the viscosity was similar
between 2% alginate/7.5% GelMA at 15ºC and 2% alginate/7.5% GelMA/3.5% gelatin. The power
law model and Rabinowitsch–Mooney equation (Equations 11 and 12 respectively) were employed
to calculate the shear rate exerted on the ink at the moment of printing, by taking into account the
nozzle dimensions and the ink consistency (122). All the calculations are displayed in Table 9. The
inks with 3% and 3.5% gelatin were determined as similar to the 0% ink measured at 15ºC, which
was previously defined as printable. Therefore, both 3% and 3.5% inks were also printable at room
temperature, and the gelatin concentration was chosen to be 3.5% as it showed a slightly higher
viscosity at rest. Previous works also show that other types of hydrogels also present shear thinning,
for instance, hyaluronic acid (123). Other viscosity rheologies of printable inks provided similar
results (124,125).
Other rheological tests included frequency sweeps, strain sweeps and step-strain sweeps (Figure
26). On the frequency and strain sweeps, the ink should ideally be constant in the region of the
frequency and strain for printing (which were 1 Hz and 1% strain). All the inks tested here showed
a similar trend, with a rising G’ with increasing frequency. Taking the 0.3 - 4 Hz interval into
account, the 0% bioink increased its G' from 490.5 ± 5.7 Pa·s to 752.2 ± 24.6 Pa·s (a difference of
261.7 ± 30.3 Pa·s), and the 3.5% increased it from 324.5 ± 5.3 Pa·s to 464.5 ± 14.3 Pa·s (a difference
of 140 ± 19.6 Pa·s). A similar trend was reported in hyaluronic acid (123). The 0% ink had a drop
in storage modulus at high frequency (it went from 1007.87 ± 20.25 Pa at 6.3 Hz to 304.33 ± 69.53
Pa at 20 Hz), due to the collapse of the hydrogel ink. The strain sweep of all the inks demonstrate a
similar trend, the G' values of these inks remain constant with the range of strain being tested. The
yield point of each ink determined, being 61.7% ± 2.9 and 93.3% ± 12.6 strain for the 3.5% ink
(22ºC) and the 0% ink (15ºC) respectively. Apart from those tests, a step-strain test was performed.
The purpose of the test was to assess if the recovery of the ink was complete after a stress period,
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and how long would that recovery take. Both ink types showed the ability to recover after the stress,
but the G’ was constantly increasing. This could be due to molecular reorganisation of the bioink.
The increase in G’ was 278 ± 17 Pa for the 0% ink and 546 ± 102.5 Pa for the 3.5% ink during the
entire test, and an average of 60.2 ± 12 Pa and 117.2 ± 22 Pa during each step for 0% and 3.5% inks
respectively (so the 0% ink increased less than the 3.5% ink). Importantly, the inks demonstrated a
rapid recovery rate after the stress period, reaching the previous storage moduli within 8 seconds.
Hence, both inks showed the ability to recover after printing to retain shape fidelity, and they were
able to withstand at least 5 cycles of stress-relaxation.
The last rheological test was the in-situ crosslinking (Figure 28). The 0% and 3.5% bioinks had a
similar strong crosslinking trend. This might have occurred due to the 7.5% GelMA of both inks
being UV-crosslinked. The molar extinction coefficient of the photoinitiator, LAP is 225 M-1cm-1
at 365 nm (as shown in Figure 10). LAP absorbed energy with UV light, generating strong networks.
The hydrogel properties were also tested in the form of gel discs. Free polymer content, swelling
ratio and Young’s modulus of the hydrogels prepared using the 0% ink or 3.5% ink were calculated
(Figure 29 and 30). The free polymer content was higher in the 3.5% gels (15.1% ± 3.7 free polymer
content for 0% hydrogels and 28.8% ± 1.6 for 3.5% gels). However, the differnce in swelling was
non significant (13.2 ± 0.8 ratio for 0% hydrogels and 13.0 ± 0.6 for 3.5% hydrogels).
Besides, the mechanical test was employed to test the stiffness of the gels (compression modulus).
There were no significant differences in the Young’s moduli between the hydrogel systems when
tested immediately after UV crosslinking (58.9 kPa ± 2.8 and 53.3 kPa ± 1.0 for the hydrogels
prepared using the 0% ink and 3.5% ink respectively). However, there was a marked difference on
the hydrogels that had been overnight in PBS at 37ºC (the 0% gels had 45.0 kPa ± 2.6 of Young’s
modulus and 3.5% gels had 28.4 kPa ± 1.5). Gels were porous after the free polymer content had
dissolved overnight, making them mechanically weaker. These results are consistent with the free
polymer content study, and suggested that the hydrogels prepared using the 3.5% ink results in a
less densely packed polymer network. Given that the difference in the free polymer content between
the two hydrogels was 13.7%, much higher than the gelatin concentration in the 3.5% ink, the
presence of gelatin may have some steric effect limiting the efficiency of the UV crosslinking and
resulting in a more porous structure. The Young’s modulus depends on many different factors: the
type of material, the degree of methacrylation of the GelMA, the source of GelMA, the alginate
viscosity and the alginate molecular weight, etc (103,126).
Finally, the hydrogel degradation studies showed that the discs degraded fast, being completely
degraded by day 5. The first two days 3.5% hydrogels degraded faster, probably due to its more
porous structure. Previous authors described 70% DoF GelMA hydrogel degradations with
collagenase of 70% in 28 days (127). Other authors assessed 10%/1% GelMA/alginate degradation,
obtaining a 6% degradation in 100 hours (4 days) (128). In that case, however, alginate lyase was
used instead of collagenase. Anyway, getting the gels completely degraded in 5 days was not
desirable, as they were expected to last in the implanted site for a minimum of a month. The
experiment was repeated twice with the same outcome. The reason why such fast degradations were
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obtained is unknown. Further validation experiments and optimisation of the ink systems may be
required in the future.

6.2 Microspheres
GelMA microspheres were generated by a water-in-oil emulsion method, with post-crosslinking
using APS and TEMED. Their diameter was analysed and plotted in a histogram (Figure 14). The
spheres were 12-40 µm in diameter, with the average in 25 µm. These results were compared to
GelMA microspheres from other authors (114). Their results showed much smaller microspheres.
For 15% DoF GelMA, 60% of the spheres were below 5 µm in diameter and 40% between 5 and
15 µm. For 50% DoF GelMA, 65% of the spheres were below 5 µm in diameter and 35% between
5 and 15 µm. For 90% DoF GelMA, 80% of the spheres were below 5 µm in diameter and 20%
between 5 and 15 µm. This showed a pattern where the higher the degree of functionalisation, the
smaller the spheres. The GelMA on this islet project was 82% DoF, however, the spheres were on
average 5 times bigger. This might be due to the method for MP generation (1500 rpm for
homogenisation vs 5000 rpm used in this project, application of N2) and crosslinking
(glutaraldehyde) used, or the GelMA concentration used (10% vs the 15% used in this project). In
our case, glutaraldehyde was discarded due to its cytotoxicity even in the smallest concentrations
(129).
The efficiency of the process of generation of microspheres was remarkable. The total yield was
82%, meaning that only 18% of the total GelMA used was lost during the whole process of
homogenisation to washing, drying and crosslinking. The crosslinking efficiency was determined
to be 96%, therefore, only 4% were uncrosslinked. The post-loading mode of growth factor to the
microspheres was also a key factor for minimising the loss of IL-2. By using the post-loading
technique, only the required amount of IL-2 was added to the appropriate amount of microspheres
for each experiment, which contributed positively to the efficiency and cost reduction of the process.
The degradability of the spheres (Figure 15) was low compared to other GelMA spheres reported in
the literature that degraded completely after 2 days (15% DoF) or 5 days (50% and 90% DoF) in 2
mg/ml collagenase solution (114). In the current system, around 50% of our GelMA spheres were
remaining after 30 days, despite the fact that a lower concentration of collagenase (2 U/ml,
corresponding to 20 μg/ml) was used. This concentration was employed because it was reported that
the degradation activity in the human body would be equivalent to 2 U/ml collagenase (130). The
slow degradation profile might reflect a highly crosslinked structure of the GelMA microspheres,
which may have resulted in a retarded released profile of IL-2 (131). Further experiments are
required to test the effect of IL-2 release on the on the biological functions of Tregs.
Another important factor about the microspheres was to prove that their addition did not alter the
ink characteristics significantly regarding printability. For this reason, rheology was employed to
compare the ink viscosity with or without microspheres (Figure 25). The results were very similar
with 0, 5 or 10 mg/ml MPs, proving that such loadings of microspheres did not alter the ink
behaviour. Finally, the microsphere distribution in the ink was an important factor. If the spheres
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sedimented at the bottom of the syringe before printing, the ink would become heterogeneous, and
the growth factor concentration would be non-uniform. The prints would no longer be reproducible.
In order to prove the homogeneous distribution, the microspheres were counted from different
regions of the syringe; top, middle, bottom (Figure 32). The count was similar in the three regions,
with no significant differences, indicating that the microspheres at 5 or 10 mg/ml can be uniformly
distributed in the ink.

6.3 Release
The release profile from the GelMA microspheres was studied in three different conditions: MPs
suspended in the release medium (free), MPs encapsulated in hydrogel discs (casted) and MPs
encapsulated and co-axially printed in the shell of the structure (printed). The release was very
similar in the three cases: initial burst release and plateau phase in the first 3-5 days. Initially it was
expected that the casted and printed gels would have a more sustained release over time when
compared to the free microspheres. However, the fast degradability of the hydrogels, which after 24 days of release were completely degraded, seemed to be the reason why there was no difference.
The three conditions showed a low total release (10-12% of the loaded IL-2 was only released). This
could have happened due to the low degradability of the microspheres, and the strong interaction
between the spheres and the IL-2. Other authors reported 70% of IL-2 release by day 21 from
dextran/PLGA-PLA microspheres (132). Anyway, the presence of growth factors has been shown
to be positive for recruiting cells (133), so having the IL-2 trapped in the GelMA microspheres may
have a positive effect in keeping the Tregs next to the islets and microspheres. To test this, future
experiments are required.
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Chapter 7
7. Future work and directions
First, some experiments should be repeated. Both hydrogel discs and printed scaffolds, included
those prepared using the gelatin-free ink, degraded within days (4-5 days). The gel degradation,
mechanical test and sol-gel experiments should be repeated using other GelMA, alginate and gelatin
batches (in case the ones used were contaminated), or even new LAP could be used.
Once the previous problem is solved, the release experiments should be repeated to observe any
possible differences between free and entrapped MPs. In vitro experiments will be critical and
essential to examine the effects of IL-2 release on the biological behaviour of Tregs. This
information will be utilised to further improve the release profile of IL-2.
After obtaining stable hydrogels, the scaffolds could be tested with cells. The viability and functions
of Tregs should be assessed in vitro, with and without microspheres, to assess if the IL-2 released
from the MPs have positive effects on their viability and function. Where feasible, future
experiments will involve co-axial printing of 3D structures where islets are located in the cores and
Tregs in the shells. The islet viability and functions would then be assessed. Finally, the work done
by Narangerel, a master student focused on the core and the vascularisation of the structure, could
be combined with this one. In this way, the core would consist of the ink developed by her, islets,
EPCs and VEGF (growth factors for endothelial cells) in PLGA microspheres. The shell would
consist of the ink developed in this work, Tregs and IL-2 in GelMA microspheres.
To finalise, the 3D printed constructs with the different core and shell, islets, endothelial cells and
Tregs would be subjected to animal studies. They would be implanted subcutaneously in mice and
the evolution of the mice and constructs would be monitored.
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Chapter 8
8. Conclusions
To sum up, the protocol to generate GelMA microspheres was established and optimised. Strongly
crosslinked microparticles were achieved, with a high yield and crosslinking efficiency. Their size
ranged from 12 to 40 µm (average of 25 µm), suitable to be loaded with IL-2 and incorporated in
the bioink. Furthermore, the bioink for the shell structure was optimised and characterised. Gelatin
was added to the previously characterised ink containing 2% alginate and 7.5% GelMA. The gelatin
concentration was narrowed down to 3.5%, and the characterisation determined similar properties
compared to the ink without gelatin. The microspheres were also incorporated to the ink and 1 cm
x 1 cm scaffolds were printed with high shape fidelity. Unfortunately, the scaffolds degraded in a
short period of time, which is a problem that will have to be solved in the future. Finally, the release
of IL-2 entrapped in the GelMA microspheres was monitored, showing an initial burst release but a
plateau phase after the second day (with a 10% of total release).
In conclusion, a bioink consisting of alginate, GelMA and gelatin was developed, printable by coaxial extrusion printing at room temperature. GelMA micropsheres, generated by water-in-oil
emulsion, were also incorporated to the bioink. The spheres with IL-2 entrapped provided a release
which would recruit Tregs. The final goal of these experiments would be to print islets in the core,
with Tregs in the ink we developed (and the microspheres) in the shell. Tregs could be determinant
on the success in implanting these constructs without immune response, and in providing a solution
for type 1 diabetes.
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Abstract
Bioprinting has arisen in the past years as a promising technology in tissue engineering. 3D printers are
capable of manufacturing complex shapes mimicking tissues with high fidelity. However, 3D printing is
not yet capable of solving one of the biggest problems in tissue engineering: the lack of vascularisation.
Without blood vessels and capillaries, thick constructs become necrotic in their inner part, making their
long-term culture inviable. 3D lithography is currently the bioprinting method with the highest accuracy
available, printing layers of 20 µm. Therefore, digital light processing (DLP) printing (a light-based 3D
lithography method) can be used to print a biocompatible material with perfusable channels that mimic
vascularisation. Nevertheless, there are not many available biomaterials printable with DLP.
In this project, a new bioink formulation was developed for DLP printing, which supported cell viability,
growth and differentiation into bone, endothelial cell attachment and monolayer formation for the creation
of blood vessels, and with adequate mechanical properties. Two photocrosslinkable hydrogels were tested
for the 3D printing and generating vascularised bone constructs: fish gelatin-methacrylate (f-GelMA) and
fish gelatin-norbornene (f-gelNB). Besides, two different photoinitiators were used to induce the
crosslinking: ruthenium and sodium persulfate (ru/SPS), a new promising visible-light initiator, and lithium
phenyl-2,4,6-trimethylbenzoylphosphinate (LAP), a UV-light photoinitiator. All the hydrogels were first
characterised regarding their crosslinking efficiency, mechanical properties, cell viability, proliferation and
printability. Afterwards, the best ink formulation was chosen and printed with mesenchymal stem cells
(MSCs) to check if osteogenesis and chondrogenesis were possible. Finally, the attachment of endothelial
colony forming cells (ECFCs) to the surface of hydrogels and their capacity of forming monolayers was
tested. Overall, f-GelMA 10% ru/SPS hydrogels were selected as the best condition for bioprinting and
developing bone and cartilage, but ECFCs could not attach to their surface.
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Laymen’s summary
3D printing applied to biology, also known as bioprinting, has arisen in the past years as a promising
technology in tissue engineering. Tissue engineering is the science that studies the combination of cells,
materials and biological factors to replace tissues. 3D printers are capable of manufacturing complex shapes
mimicking tissues with high fidelity, which is important for the correct function of these tissue models.
However, 3D printing is not yet capable of solving one of the biggest problems in tissue engineering: the
lack of vascularisation (generation of blood vessels and capillaries). Without it, thick constructs cannot
obtain oxygen and nutrients in their inner part, and cells in this part die. 3D printers are able to print channels
that mimic these blood vessels, but an extremely high resolution is required for this purpose, as some blood
vessels are only a few µm thick. 3D lithography (or digital light processing (DLP)) is currently the
bioprinting method with the highest accuracy available. These printers use a liquid resin, which reacts with
light (either visible or UV light). When light hits a specific area of the resin, a thin layer of it reacts
becoming solid, and complex 3D objects, designed digitally, are printed layer by layer with high resolution.
Therefore, this technology can be used to print a biocompatible material (a material compatible with cells
and not harmful to living tissues) with channels that mimic vascularisation. Nevertheless, there are not
many available biomaterials that can be printed with the DLP printer.
In this project, a new bioink (biocompatible printable resin) formulation was developed for DLP printing,
which supported cell living, growth and development of bone. Endothelial cells also needed to attach and
form a monolayer. Endothelial cells are found on the walls of blood vessels, so if they are added to the
inside of the printed channels, they need to cover the whole surface of the channel (what means generating
a monolayer) to develop blood vessels. Two hydrogels were tested to check if they were adequate for 3D
printing and generating bone constructs with blood vessels: fish gelatin-methacrylate (f-GelMA) and fish
gelatin-norbornene (f-gelNB). Both are modified from fish skin gelatin and react and solidify in presence
of light. Besides, these hydrogels need a molecule, called photoinitiator, which reacts and solidifies the
hydrogels in presence of a given type of light (visible or UV). Two different photoinitiators were used to
induce the gelation: ruthenium and sodium persulfate (ru/SPS), a new promising visible-light initiator, and
lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP), a UV-light photoinitiator. All gels were first
characterised regarding their hydrogel properties, cell compatibility and capacity for DLP printing.
Afterwards, the best bioink formulation was chosen and printed with mesenchymal stem cells (MSCs) to
check if cartilage and bone could be developed. MSCs are pluripotent cells, which means that they can
develop into many different cell types, including osteocytes (bone cells) or chondrocytes (cartilage cells).
Finally, the attachment of endothelial colony forming cells (ECFCs, which are a type of endothelial cells)
to the surface of hydrogels and their capacity of forming monolayers was tested. Overall, f-GelMA 10%
ru/SPS hydrogels were selected as the best condition for bioprinting, but ECFCs could not attach to their
surface.
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1. Introduction
3D bioprinting has arisen in the past recent years as a promising method in various fields, especially in tissue
engineering, because of its ability to generate biocompatible systems (1). It consists of the addition of biomaterials
in a layer-by-layer fashion, achieving 3D constructs of various sizes, geometries and complexities (2). Using a
combination of polymers (that act as scaffolds), living cells and growth factors, these constructs are able to mimic
natural tissues in vitro (2). 3D bioprinting is currently being applied for various purposes: high throughput
screening for drug testing or disease models, organ-on-a-chip models, personalised medicine, transplanting and
tissue engineering (2,3). The last one has the biggest repercussion, as it is thought that the creation of artificial
organs for transplanting could be possible in the future (4). The use of bioprinting has several advantages over the
classical tissue engineering approaches. Until recently, tissues used to be studied in vitro in 2D monolayers, where
the 3D environment of the natural tissue (cell-cell or cell-ECM interactions), crucial for its correct functioning,
was poorly recreated (5,6). Besides, achieving complex shapes and structures with conventional 2D or 3D
culturing is difficult, whereas they are easily manufactured with a 3D printer. Therefore, 3D bioprinting allows a
better spatial relation of molecules than conventional methods do (1), and customised complex shapes can be
generated.
3D bioprinting is one type of the additive manufacturing (AM) technology, used for printing biological or
bioactive models (7). AM works as a computer-aided design and fabrication (CAD) technique. First, the desired
construct is designed and the bioprinter’s software slices it in thin layers. Afterwards, the biomaterials are
deposited in the XYZ directions, using the digitally sliced layers as a reference. Finally, the bioprinted construct
is cultured in vitro for the maturation of the tissue (1,6). There are different 3D bioprinting technologies, such as
extrusion, inkjet, laser-induced or stereolithography. The choice of the technique depends on the aim of the
printing and the type of tissue (2). Moreover, the materials used for bioprinting, also known as bioinks, must be
suitable for the aim and the type of printing. They usually consist of scaffolds made of ceramic, polymeric,
metallic, hydrogel or composite materials, and they provide cells with mechanical strength, as well as a niche
where cells can attach, migrate and proliferate (7). These scaffolds are also generally porous, as it has been
previously proven that they support better cell viabilities than purely solid ones (8). The bioinks need to be
biocompatible for both cells and the host, printable, and structurally and mechanically stable in order to guarantee
a long-term cell viability (9). Nevertheless, 3D bioprinting still has some drawbacks, being the lack of
vascularisation in the bioprinted tissues and the lack of available bioinks the two most relevant ones. Blood vessels
participate in the gas and nutrient exchange in tissues, a crucial function for the viability of tissues, but they cannot
be bioprinted due to printing speed and resolution issues (1). On the other hand, the use of an optimal material
that has an adequate biocompatibility, printability and mechanical strength remains a challenge (1,7). Extensive
research is being performed to find a solution to these major problems in the field of biofabrication, testing
methods for vascularization in tissues and new bioink formulations.
The vascular system, formed by blood vessels (macrovessels) that branch into small capillaries (microvessels),
supplies tissues with oxygen and nutrients (10,11). The diameters of the vessels range from 2,5 cm in the aorta to
20 µm in the thinnest capillaries (12), and the maximum distance between two capillaries is 200 µm, which
correlates with the maximum diffusion of oxygen in the body (13,14). The inner part of the blood vessels is coated
with the endothelium, a monolayer of endothelial cells that acts as a barrier for controlling nutrient and molecule
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exchange between the tissues and blood (11,12). Without vascularisation, nutrients and oxygen are unable to reach
the centre of the tissues, which become necrotic (1,15). Hence, there are currently two possible approaches to
achieve vascularised engineered tissues. The first one relies on the neoangiogenesis of the tissue, which occurs
when the bioprinted construct develops de novo vasculature. Angiogenic factors and endothelial cells (ECs) are
included in the bioink to obtain this type of vascularisation, the growth factors recruit the cells, encouraging
capillary formation, and the ECs self-assemble creating vessels (12,16,17). However, the process is generally slow
(18) and the complete vascularisation of the construct cannot be achieved, as blood vessels are generated randomly
and they are not always interconnected (12). For this reason, this method is not recommendable for thick constructs
(17). The second approach for achieving vascularised tissues relies on artificially generating tubular
microchannels that resemble the vascular system, and attaching ECs to their inner walls (12,16,18). This often
results in a need to manufacture complex shapes, which is possible using the 3D bioprinting technology (12).
Some attempts bioprinting blood vessels have been made before, showing a serious limitation in the printing
resolution, as only big vessels (with a minimum diameter of 5 mm) have been successfully printed (1,19).
Therefore, both techniques could be combined, employing the bioprinting for generating macrovesselss, and the
neoangiogenesis for microvessels (16). Even in this case, a 3D printing technique with the highest resolution
possible should be used.
In summary, the most adequate bioprinting technology for the generation of tubular structures that resemble blood
vessels is the one with the highest resolution. Table 1 summarises some features of each 3D printing technology,
including their maximum resolution.
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Table 0.

Table 1. Summary of features, advantages and disadvantages of the main four 3D bioprinting methods: inkjet printing,
extrusion-based printing, laser-assisted printing and 3D lithography. Sources: Donderwinkel et al., Li et al. (2,7).

Characteristics

Inkjet printing

Extrusion
printing

Laser-assisted
printing

3D lithography

Cell viability

~ 90%

40-80%

> 95%

> 90%

Cell density

< 106 cells/ml

High, no limit

< 108 cells/ml

High, no limit

Ink viscosity

3,5-12 mPa/s

Up to 6·107 kPa/s

1-300 mPa/s

High, no limit

Cost

Low

Medium

High

Low

Printing speed

High

Low

Medium

High

Resolution

20-100 µm

200 µm

> 20 µm

20-200 µm

Biomaterials

Low viscosity
liquids, cells,
growth factors,
biomolecules

Wide range of
biocompatible
materials,
hydrogels,
ceramics, cells,
etc

Ceramics,
hydrogels, cells, etc

Light-sensitive
photocurable polymers

Advantages

Availability,
concentration
gradients of
materials possible

Many materials
available,
homogeneous cell
distribution

High precision,
resolution

Highest resolution,
increasing number of
resins available

Disadvantages

Poor vertical
structure, only
liquid materials,
thermal stress to
cells

Low resolution
and viability,
poor stiffness

High cost and
manufacturing time

Lack of biocompatible
resins, use restricted to
photopolymerisable
materials

The table shows that all the methods have their limitations, but focusing on the resolution, inkjet printing, laserassisted printing and 3D lithography are the most precise technologies. For bioprinting constructs with cells, the
technology must also have a high printing speed, high viability and allow printing of high cell densities. The only
technology which provides all these features is the 3D lithography.
3D lithography uses the principle of photopolymerization to turn liquid resins into solid (1). It can be laser-based
(stereolithography or SLA) or light-based (digital light processing or DLP), being the latter the most
biocompatible. Figure 1 shows the scheme of a DLP printer. DLP printers work with a digital micromirror device
(DMD) projection system, where light is digitally directed to the micromirrors. These mirrors create a light pattern
that is projected in the prepolymer (6,20,21). Thin layers are then polymerised in a layer-by-layer fashion, only
where light is projected. Each layer attaches to the building plate, then, this plate automatically moves in the Z
direction, and the next layer is projected and photopolymerized (6,22). The process continues until the 3D
construct is printed. As in other 3D printing techniques, the CAD design is sliced in layers and each layer is
projected on the bioink, matching each CAD layer with each printed layer (8). Finally, the light patterned by the
DLP printer can either be visible or UV light (22).
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Figure 0

Figure 1. DLP printer’s scheme (23), edited. The light comes from below, reaching the DMD where the light pattern is
projected towards the bioresin. The bioresin or photopolymer is only crosslinked at the surface of the building plate, only
where the light is projected. A motor pulls the building plate a few µm up, to receive another light pattern and obtain a second
layer above the first one. The top layers of the constructs are printed last.

An entire layer is printed with a single projection, which results in a fast and reproducible printing process
(3,6,20,21). Besides, it is a versatile method, able to print different materials with different mechanical properties,
porosities or cells (6). Furthermore, an external force is not applied (as it occurs in extrusion-based printing, where
the bioink is pushed through a nozzle), providing the DLP technology with a high cell viability of around 90%
(9,21). Finally, DLP is well known for its high resolution, being possible to print 25-50 µm layers (3,7,8,21,22).
The high accuracy of this bioprinting method allows to better mimic the complex microenvironment and structure
of tissues (22). Therefore, given the high resolution and fast printing of the DLP, it should be possible to print a
biomaterial with channels mimicking a vascular network, and then seed endothelial cells inside the channels to
obtain vascularised tissues. Unfortunately, there are currently not many photopolymerisable materials that allow
cell viability, because most photoinitiators (molecules used to induce the photopolymerisation) employed in DLP
are soluble in organic solvents, which are cytotoxic (6,8,22). Therefore, a cytocompatible photopolymerisable
bioink needs to be developed for its use in the DLP bioprinting.
Hydrogels are the most widely used bioinks in 3D bioprinting. They are porous hydrophilic polymers that
resemble the extracellular matrix of tissues, with high biocompatibility and cytocompatibility (20). They can
absorb up to 90-99% of their dry weight in water and their physical and chemical properties are tunable (24–26).
They can also be 3D bioprinted to obtain complex shapes and morphologies (1,7,27). Natural polymers (collagen,
laminin, gelatin, alginate, hyaluronic acid or fibrin), synthetic ones (polyethylene glycol (PEG) or polyvinyl
alcohol (PVA)) or a combination of both can be used to generate hydrogels (24,25,28). Furthermore, some types
of hydrogels are photopolymerisable, what is necessary for employing the hydrogel in the DLP printer. They
polymerise in presence of light (visible or UV), generating covalent crosslinks that are more stable and stronger
than other types of gelations such as thermal ones. Besides, their gelation is controllable, occurs in a short time,
and there is no use of extreme temperatures or pH ranges that harm cells (21,29).
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Gelatin is a commonly used polymer for hydrogel generation. It is derived from the hydrolysis of collagen and it
presents a lower immunogenicity than its precursor (5,30). It is obtained inexpensively from various sources,
included pork, calf or fish skin (4). Gelatin contains RGD (arginine-glycine-aspartate) sequences, which support
cell attachment and growth (5,30–32). Currently, porcine or mammalian-derived gelatin is generally used,
although it is thermally instable and it becomes gel at room temperature (33,34). Porcine gelatin is soluble in
water above 40ºC (35). This is especially problematic for bioprinting, where a precise control of the gel viscosity
is necessary (15). For example, the bioresin needs to be liquid for the DLP printing, which is not possible if the
gelatin is solid at room temperature (and even if it was possible to keep the gel at 40ºC for the printing process,
the viability of the encapsulated cells would decrease). As a solution, cold-water fish gelatin, liquid at room
temperature (20-25ºC) can be used instead of the porcine one (32,33). Apart from being thermally more stable, it
is more economic (32) and it has been proven to have similar physical and chemical properties to those of porcine
GelMA, as well as a similar biocompatibility (33). Gelatin hydrogels are formed by thermorreversible
crosslinking, as they are soluble in water (at >20-25ºC the fish gelatin) and they form gels when temperature drops
(30,34,35). Unfortunately, these gels are mechanically weak and unstable, so they are not suitable for long-term
cell culture (5,24). Hence, gelatin needs to be chemically modified to make it more stable and photopolymerisable.
Gelatin methacrylate, GelMA, is a modified gelatin widely employed for biomedical purposes. It is a
photocrosslinkable hydrogel at room temperature (27,36), biocompatible, with tunable chemical and mechanical
properties and applicable for long-term cell culture (17,33). It has been previously used in bioprinting, included
3D lithography or stereolithography (20,32), and it also shows properties for attaching endothelial cells, what is
desired for creating vasculature (10). This polymer is obtained by adding methacrylate groups (methacrylic
anhydride) to the amines of gelatin (35–37), in a process shown in Figure 2. The hydrogel is obtained from a
mixture of the precursor (GelMA in this case), the photoinitiator and cells or biomolecules if they need to be
encapsulated. When light of a given wavelength is directed to the mixture, the photoinitiator absorbs photons and
excites or decomposes, initiating the polymerysation (24,31,37). The crosslinking of GelMA, shown in Figure
5A, occurs in a radical-mediated chain-growth reaction, which is fast and leads to the generation of heterogeneous
crosslinks (24). However, the radical-mediated reactions present some limitations. First, they are oxygen inhibited,
as oxygen reacts with the radicals, quenching them (31). As a consequence, a higher concentration of
photoinitiators is required for the reaction, and even in this case, the crosslinking is incomplete (31). Second, due
to the oxygen inhibition, the generated crosslinks are insufficient, conditioning the shape fidelity of the designs.
This is especially undesirable in bioprinting, as the technology relies on the generation of precise and complex
shapes (31). Third, the release of radicals that occurs in the process can affect cells, deriving in cell damage or
death (5,30).
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Figure 2. Scheme of the functionalisation of gelatin to GelMA (32). Methacrylate groups are added to the amine groups of
gelatin. These methacrylic groups will react with other GelMA polymers to generate hydrogels.

As a solution to the problems that radical-mediated crosslinking presents, some hydrogels photocrosslink in
orthogonal photoclick reactions, also called step-growth thiol-ene reactions (5,24,30). Gelatin norbornene, gelNB,
is one of the hydrogels that photopolymerises in an orthogonal photoclick reaction (5,24,30). Modified from
gelatin, it presents similar physical and chemical features to GelMA, with a higher cytocompatibility and similar
ability to immobilise cells and proteins (5,24). This gel is obtained adding carbic anhydride molecules to gelatin
(30), as is shown in Figure 3. The polymerisation of gelNB relies on a similar mechanism to that of GelMA, where
light excites the photoinitiator and this reacts with the hydrogel, initiating the reaction. But in this case, a
crosslinker with thiol groups is also needed to link different gelNB molecules (for example, polyethylene glycoltetrathiol (PEG-4SH)), and the chemical reactions that occur are different. The photoinitiators react with
sulfhydryl groups of the crosslinker, generating radicals that react the norbornene groups (24). In the resulting
hydrogel, the gelNB molecules are linked together via the crosslinker (24). A scheme of the crosslinking of gelNB
is shown in Figure 5B. This crosslinking method presents some advantages over the chain-growth
photopolymerisation of GelMA. First, the generated chains are more organised and homogeneous (38). Second,
the reaction is not oxygen inhibited (24,30,39), preserving the shape of the designs, hence, it is a are more suitable
polymer for bioprinting. Third, the lack of oxygen inhibition allows the use of lower photoinitiator concentrations,
reducing the toxicity (39). This results in a better cytocompatibility (5,24). Finally, the crosslinking of gelNB is
extremely fast (30).

Figure 3. Scheme of the functionalisation of gelatin to gelNB (30). Norbornene groups are added to the amine groups of gelatin.
These norbornene groups will react with other thiols used as crosslinkers to generate hydrogels.

Therefore, both GelMA and gelNB can form stable and cytocompatible hydrogels when they are crosslinked in
presence of light and a photoinitiator. As mentioned above, the photoinitiators are molecules that, when they
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receive light in a specific wavelength, they start the photopolymerisation (26,40). These also need to be
biocompatible, cytocompatible and water soluble (26). Currently there are many photoinitiators that have been
used with GelMA or gelNB, however, researchers are still searching for the optimal one to achieve stable gels
without being toxic or harmful. The most commonly used ones work in the UV light range (250-400 nm
wavelengths) (21). For example, Irgacure 2959 is the most widely used photoinitiator, as it is water soluble and
there are no adverse effects in cell viability at the concentrations employed for gel crosslinking (40). Another
commonly used photoinitiator, lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP), also works under UV
light exposure. It is more water-soluble and less cytotoxic than Irgacure 2959, and less initiator concentration is
needed (40). However, the use of UV light (320-365 nm) for the crosslinking carries some limitations. UV
irradiation can generate reactive oxygen species (ROS) that lead to DNA damage and possible cell toxicity
(21,25,31). This damage is enhanced in long exposure times, which occurs in bioprinting. Besides, it has been
shown that UV light has a low penetration depth, that may cause a poorer crosslinking in large constructs (31).
For these reasons, the use of visible light is preferred for the bioprintng with encapsulated cells. LAP can be also
used in near-UV visible light (405 nm) (40), but being close to UV wavelengths, it has also been reported as
harmful to cells at long exposure times (21).
Using visible light-sensitive photoinitiators is safer (21,25) and it has also been demonstrated that visible light
penetrates more than UV light does, facilitating the crosslinking efficiency on thick constructs (25). Nevertheless,
most of the commercially available visible light photoinitiators have poor water solubility and toxicity (31,41).
One of the most commonly used initiators is Eosin Y (500-600 nm), but it often requires coinitiators which are
toxic (21,25,40). Apart from that, there is a relatively new visible-light photoinitiator that has not been extensively
used yet: the tris(2,2ʹ-bipyridyl)dichlororuthenium(II) hexahydrate (ruthenium or Ru) (31,42). It absorbs light at
a peak of 452 mn, it is highly soluble in water and it requires of sodium persulfate (SPS) as a co-initiator (42).
Furthermore, it is cytocompatible and it is not oxygen inhibited (31), so even with GelMA, the shape of the
bioprinted constructs remain accurate. Figure 4 shows the molecular structure of both ruthenium and SPS. When
ruthenium is in presence of light, it donates an electron to SPS, breaking both molecules and initiating the
crosslinking reaction (42). This photoinitiation system can be used with both GelMA and gelNB.

Figure 4. Structure of the photoinitiator (ruthenium) and its co-initiator (sodium persulfate) (22).

Once that the hydrogel and photoinitiators are selected, the photopolymerisation occurs mixing the hydrogel
(either GelMA or gelNB), the photoinitiators (Ru/SPS), the crosslinker in the case of gelNB and the cells. This
mixture is exposed to visible light and the gel crosslinks (as can be seen in Figure 5).
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Figure 5. Photocrosslinking of GelMA (A) and gelNB (B) with visible light and the ruthenium/SPS photoinitiation system.
Source: Yoon et al. (32), modified (5,22).

Unfortunately, the Ru/SPS system is only able to crosslink the hydrogel precursor for a maximum of 30 minutes,
what results in a problem for DLP bioprinting, where only 2-3 mm thick constructs can be generated in this period
of time. Nevertheless, there are no restrictions on the X and Y directions (as long as the designs fit in the building
plate of the printer), so hydrogel models with channels that resemble vasculature can be bioprinted.
The aim of this project was to develop a bioresin able to differentiate towards bone and cartilage, and capable of
creating channels that mimic vasculature where endothelial cells could attach and form monolayers.
For this purpose, first different hydrogel formulations were characterised to select the best gel composition
regarding crosslinking efficiency, stiffness, cell viability and proliferation. Afterwards, printing parameters of the
selected gels were optimised, to obtain constructs with as small as possible perfusable channels. Later, on the one
hand constructs with cells were printed to assess the differentiation towards bone and cartilage, and on the other
hand endothelial cells were seeded on the surface of gels, to check their attachment and monolayer formation.
After all these experiments, the best gel and printing conditions were selected. Hydrogels varied on the gel
concentration, the gel type (fish-GelMA and fish-gelNB) and the photoinitiator (ru/SPS and LAP). The more
recently introduced gelNB and ru/SPS were compared to the more extended GelMA and LAP, to make a
comparison and check if any improvements were achieved.
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2. Methods
2.1 Hydrogel preparation
Hydrogels were made dissolving the hydrogel precursor in PBS and adding the photoinitiator. Freeze dried cold
fish GelMA (f-GelMA) or cold fish gelNB (f-gelNB), both of 80% degree of functionalisation (DoF), were
dissolved in PBS until obtaining a stock of 30% (w/v) concentration. These were warmed on the roller plate in
the incubator to facilitate the dissolution. The two photoinitiators used, ru/SPS and LAP, were also dissolved,
making the following stocks:
-

Ruthenium (ru), tris(2,2ʹ-bipyridyl)dichlororuthenium(II) hexahydrate (224758, Sigma-Aldrich, USA):
20 mM stock

-

Sodium persulfate (SPS), (S6172, Sigma- Aldrich, USA): 200 mM stock

-

Lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP), (900889, Sigma-Aldrich, USA): 2% (w/v)
stock

For f-gelNB gels, a crosslinker was also needed, polyethylene glycol 4 arms, also known as PEG4SH or P4A
(JKA7002, Sigma-Aldrich, USA). A 50 mM stock was made. Once all the reactives were dissolved in PBS, they
were mixed to obtain different gel conditions, shown in Table 2. Twelve conditions were tested in order to select
the best one for the final goal, printing the hydrogels with the DLP.
Table 2. Reactives used for each condition. In the beginning, 12 conditions were tested using f-GelMA or f-gelNB, ru/SPS or
LAP and different gel concentrations. The resting volume until reaching the final volume was filled with PBS. The mould used
for casting the gels also differed in some conditions. n = 3.

Final concentration in mixture
Condition

f-GelMA
(% w/v)

f-gelNB
(% w/v)

Ru
(mM)

SPS
(mM)

LAP
(% w/v)

P4A
(mM)

Mould

Ru/SPS

5

-

2

20

-

-

Silicon

LAP

5

-

-

-

0,05

-

Teflon

Ru/SPS

10

-

2

20

-

-

Silicon

LAP

10

-

-

-

0,05

-

Teflon

Ru/SPS

15

-

2

20

-

-

Silicon

LAP

15

-

-

-

0,05

-

Teflon

Ru/SPS

-

5

2

20

-

3,58

Silicon

LAP

-

5

-

-

0,2

3,58

Silicon

Ru/SPS

-

10

2

20

-

7,16

Silicon

LAP

-

10

-

-

0,2

7,16

Silicon

Ru/SPS

-

15

2

20

-

10,74

Silicon

LAP

-

15

-

-

0,2

10,74

Silicon

f-GelMA

5%

10%

15%

f-gelNB

5%

10%

15%
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Silicon moulds were used in almost all cases. However, f-GelMA suffers from oxygen inhibition with LAP, so
Teflon moulds were used for these conditions to generate the hydrogels in an anoxic condition. All mixtures
containing f-GelMA or f-gelNB were handled with gel pipettes.
Before mixing the reactives, all of them were kept in dark, covered with aluminium foil. Once mixed, they were
added in the silicon mould or Teflon mould and exposed to visible light (ru/SPS gels) or UV light (LAP gels) to
photocrosslink the hydrogels. Visible light was irradiated with a 20 W LED lamp (JMW20P-S, Jobmate,
Australia) for 7,5 minutes, and UV light was irradiated in a UV oven, a UVP CL-1000L UV linker (UVP
Cambridge, UK; 365 nm, 7 mW/cm²) for 5 minutes. Ø8 mm x 1 mm discs were obtained. 3 gels per condition
were made.

2.2 Characterisation of hydrogels
Hydrogels were characterised to select the best conditions. Their crosslinking efficiency and mechanical
properties were tested.

2.2.1 Crosslinking efficiency
The crosslinking efficiency of hydrogels was assessed calculating the sol fraction, gel content and swelling ratio.
For this purpose, hydrogels underwent a set of freeze drying and swelling steps:
→

-

Make gels

-

Freeze drying overnight →

-

Swelling overnight

-

Freeze drying overnight →

m0
mdry,1

→

mswollen
mdry,2

Hydrogels were weighed inside eppendorfs and the weight of the empty eppendorfs was subtracted to obtain the
hydrogel mass. When hydrogels were made, they were weighed (m0) and freeze dried overnight. For this purpose,
the eppendorfs were left open and wrapped with parafilm. A needle was used to make holes in the parafilm and
let the liquid come out when freeze drying. The samples were frozen at -80ºC before placing them in the freeze
dryer (Alpha 1-2 LD plus Freeze dryer, Salmenkipp, the Netherlands). The next day, the samples were removed
from the freeze dryer and weighed (m dry,1). 0,5 ml PBS was added to each sample and they were left overnight in
the incubator at 37ºC to rehydrate. The following day, the gels were placed in other (previously weighed)
eppendorfs and weighed (mswollen), and they were freeze dried again, as explained above. The day after, they were
weighed (mdry,2).
The first dry weight involves both the crosslinked and the uncrosslinked part of the hydrogel. Then, gels were in
PBS, where the uncrosslinked part of the gels dissolved, so the second dry weight is only of the crosslinked part.
In this way it is possible to calculate how much of the total gel did not crosslink, which is known as the sol fraction.
The higher it is, the poorer the crosslinking is, so ideally, low values are desired. The sol fraction of the hydrogels
was calculated with the following equation (31):
𝑆𝑜𝑙 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 (%) =

𝑚𝑑𝑟𝑦,1 − 𝑚𝑑𝑟𝑦,2
𝑚𝑑𝑟𝑦,1

∙ 100

(1)
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Apart from that, it is possible to calculate the amount of water that that the hydrogel absorbs and bounds to its
molecules, which is known as the swelling ratio. Hydrogels generally have a high swelling capacity, but too high
values are also not desirable, because they are related to a poorer crosslinking efficiency. Moreover, when
microchannels are printed, as in the final goal of this project, high swelling ratios may lead to a constriction of the
channels (18,36). The swelling ratio was calculated following the equation shown below (31):
𝑆𝑤𝑒𝑙𝑙𝑖𝑛𝑔 𝑟𝑎𝑡𝑖𝑜 (𝑞) =

𝑚𝑠𝑤𝑜𝑙𝑙𝑒𝑛
𝑚𝑑𝑟𝑦,2

(2)

Finally, the gel content, which refers to the macromer concentration in each hydrogel, was calculated as shown in
the next equation:
𝐺𝑒𝑙 𝑐𝑜𝑛𝑡𝑒𝑛𝑡 (%) =

𝑚𝑑𝑟𝑦,1
𝑚0

∙ 100

(3)

2.2.2 Mechanical testing
The twelve hydrogel conditions were also subjected to a compression testing with a Dynamic Mechanical
Analyzer (Q800 DMA, TA Instruments, USA). Their elastic modulus was calculated by plotting their stress-strain
curves. The diameter of hydrogels was measured with a digital calliper, and the software (TA Instrument Explorer)
calculated their height. A strain ramp from -20% to -30% was applied, with an initial strain of -1%, and data was
collected every 0.2 seconds. Once the stress-strain curves were plotted, the Young’s modulus was calculated as
the slope of the curve.

2.3 Cell culture
2.3.1 Mesenchymal stem cells
Equine mesenchymal stem cells (eqMSCs) were used for cell encapsulation experiments. All the materials
(medium, cells, flasks, falcon tubes, …) were handled sterilely inside the laminar flow cabinet.
Cryopreserved vials stored in liquid nitrogen were obtained and defrosted until little ice was left in the vial. Then,
all the liquid was transferred to a 50 ml falcon tube with 10 ml expansion medium. The MSCs expansion medium,
described below, was previously prepared and prewarmed at 37ºC before its use. The 50 ml falcon was centrifuged
(Centrifuge 5810R, Eppendorf, Germany) for 5 minutes at 1500 rpm in order to remove the medium used to
cryopreserve the cells, which is toxic when it is warm and in long term. The supernatant was removed, cells were
resuspended in 20 ml expansion medium and counted. To do so, 20 µl of the mixture were transferred to a sterile
Eppendorf, 20 µl of trypan blue (TC10 trypan blue dye, 145-0013, Bio-Rad, USA) were added and 10 µl to the
mixture were placed in a cell counting slide. This slide was placed in the cell counter (TC10 Automated Cell
Counter, 145-0001, Bio-Rad, USA), which gave the cell concentration per ml. Once the cell quantity in the falcon
tube (concentration * volume) was calculated, the falcon tube was centrifuged again, 1500 rpm, 5 minutes. In the
meanwhile, the number of T175 flasks needed to contain 0,5*10 6 cells in each one was calculated, and 20 ml
expansion medium were added to each flask. The supernatant of the centrifuged tube was removed, 2 ml of
expansion medium per flask were added to the tube, and the pellet was resuspended. 22 µl of basic fibroblast
growth factor (bFGF) per ml flask were added to the falcon tube, and its content was split into all the T175 flasks,
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adding 2 ml to each. The flasks were stored in the incubator at 37ºC and 5% CO 2 for them to grow and expand in
optimal conditions.
MSCs expansion medium:
-

Dubeco’s Modified Eagle Medium (DMEM) (1X) + GlutaMAX, + 4,5 g/l d-glucose, + pyruvate
(31966021, Thermo Fisher Scientific, USA):

500 ml (- 50 ml)

+

Fetal bovine serum (FBS):

10%

+

Penicillin/streptomycin (P/S):

1%

+

Basic fibroblast growth factor (bFGF):

fresh, 1 µl/ml

(50 ml)
(5 ml)

Medium was replaced every 3-4 days, by suctioning the medium and adding 20 ml medium + (2 ml medium + 22
µl bFGF) to each flask.
When the flasks were confluent, they were split into more flasks. Trypsin (25200, Thermo Fisher Scientific, USA)
was used to detach the cells from the bottom of the flasks. First, medium was suctioned, and flasks were washed
with 5 ml sterile PBS0. The PBS was also suctioned, and 2,5 ml trypsin/flask was added to each flask, spread at
the bottom and incubated at 37ºC for 2 minutes. The trypsin was then inactivated by adding 5 ml expansion
medium, cell clumps were broken by pipetting the liquid on the flask walls and the liquid was moved to a 50 ml
falcon tube. The tube was centrifuged (1500 rpm, 5 minutes), cells were counted and split in 0,5 million cells per
flask, as explained above.

2.3.2 Endothelial colony forming cells
Some experiments were also performed with endothelial colony forming ells (ECFCs). Both fluorescently labelled
(GFP-ECFCs) and non-labelled cells were used. Cells were thawed, seeded and expanded as explained above,
with the only difference that endothelial cell culture medium was used this time:
Endothelial cell expansion medium:
-

Endothelial cell Growth Medium (EGM-2), (CC-3156, Lonza, USA): 500 ml (-50 ml)
+

Fetal bovine serum (FBS):

10%

+

Penicillin/streptomycin (P/S):

+

EGM-2 singlequots ((CC-3156, Lonza, USA):

1%

(50 ml)
(5 ml)

▪

Hydrocortisone (CC-4112A)

0,2 ml

▪

hFGF-β (CC-4113A)

2 ml

▪

VEGF (CC-4114A)

0,5 ml

▪

R3-IGF-1 (CC-4115A)

0,5 ml

▪

Ascorbic acid (CC-4116A)

0,5 ml

▪

hEGF (CC-4317A)

0,5 ml

▪

GA-1000 (CC-4381A)

0,5 ml

▪

Heparin (CC-4396A)

0,5 ml

Once medium was made, it was aliquoted in 50 ml falcon tubes, and the tubes were frozen at -20ºC until use.
Cells were seeded in T75 flasks at 0,5*106 cells/flask, and medium was replaced every 2-3 days.
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2.4 Cell encapsulation in hydrogels
Passage 6 equine MSCs were encapsulated in f-GelMA and f-gelNB hydrogels to test the cell viability and
proliferation. Hydrogels were prepared as explained in the 2.1 section, with two differences: MSCs were also
added to the hydrogel mixture, and all the reactives were handled sterilely.
The final cell concentration was 106 cells/ml hydrogel, so a stock of 80*106 cells/ml was prepared first, by
trypsinising, centrifuging and counting the cells as explained above. F-GelMA and f-gelNB were sterile, so they
were added to previously weighed 50 ml falcon tubes in the flow cabinet, and tubes were weighed closed to keep
sterility inside. The rest of reactives (ru, SPS, LAP, P4A) were not sterile, so they were weighed and dissolved
non-sterilely and then sterile filtered in the flow cabinet with 0,22 µm filters. Stocks at the same concentration as
in 2.1 section were made, with the final concentrations mentioned in Table 3. All the materials (spatula, tweezers,
silicon and Teflon moulds, …) were either autoclaved or sterilized in ethanol. Crosslinking was performed inside
the flow cabinet with the visible light lamp or a UV light lamp at 365 nm wavelength (6 mW/cm 2). 6 gels were
made per condition, 3 for the day 1 analysis and 3 for the day 7 analysis.
Table 3. Hydrogel conditions and material concentrations used for embedding MSCs. n = 3.

Final concentration in mixture
f-GelMA
(% w/v)

f-gelNB
(% w/v)

Ru
(mM)

SPS
(mM)

LAP
(%
w/v)

P4A
(mM)

MSCs
(cells
/ml)

Mould

Ru/SPS

10

-

2

20

-

-

10*106

Silicon

LAP

10

-

-

-

0,05

-

10*106

Teflon

Ru/SPS

15

-

2

20

-

-

10*106

Silicon

LAP

15

-

-

-

0,05

-

10*106

Teflon

Ru/SPS

-

5

2

20

-

3,58

10*106

Silicon

LAP

-

5

-

-

0,2

3,58

10*106

Silicon

Ru/SPS

-

10

2

20

-

7,16

10*106

Silicon

LAP

-

10

-

-

0,2

7,16

10*106

Silicon

f-gelNB

f-GelMA

Condition

10%

15%

5%

10%

Once the hydrogels were made, they were moved to a 48 well plate and cultured in 0,5 ml MSCs expansion
medium/well for a week, in the incubator at 37ºC. Medium was refreshed every 2-3 days.

2.5 Cell viability
Cell viability of hydrogels was tested performing a live-dead assay, at day 1 and 7 of hydrogel culture with
embedded MSCs. First, hydrogels were cut in half with a sterile scalpel blade (the test was performed in half gel
only). Afterwards, they followed a set of washing and staining steps:
-

5 minutes

PBS0-Ca-Mg (x2)

-

15 minutes

calcein AM/ethidium homodimer-1 in PBS0-Ca-Mg (*)

-

5 minutes

PBS0-Ca-Mg (x2)
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(*) the calcein AM and ethidium homodimer-1 are part of the live-dead kit (LIVE/DEAD™ Viability/Cytotoxicity
Kit for mammalian cells, L3224, Thermo Fisher Scientific, USA). 0,25 µl calcein AM and 0,5 µl ethidium
homodimer-1 per ml PBS were used and kept in dark. The gels were incubated (for 15 minutes) in the incubator
at 37ºC.
When the live-dead test was finished, the hydrogels (3 samples per day and condition) were observed at the
fluorescence microscope (BX51, Olympus, Japan), showing living cells in green (where the calcein AM binds,
with a 488/530 nm excitation/emission filter) and dead cells in red (where the ethidium homodimer-1 binds, with
a 530/580 nm excitation/emission filter). Live and dead pictures of 5 sections per sample were taken, at 10x or
20x magnification of the microscope. The living and dead cells were counted with the ImageJ software. The cell
count from all sections of the same hydrogel was summed, and the viability ratio was obtained:
𝐶𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 =

𝑙𝑖𝑣𝑖𝑛𝑔 𝑐𝑒𝑙𝑙𝑠
𝑑𝑒𝑎𝑑 𝑐𝑒𝑙𝑙𝑠

∙ 100

(4)

After taking pictures of the live-dead assay, samples were freeze dried overnight (as explained in section 2.2.1).

2.6 DNA quantification
DNA of MSCs embedded in hydrogels was quantified by a PicoGreen assay. First, freeze dried samples were
digested with papain. 1,57 mg/ml cysteine-HCL (DL-cysteine hydrochloride, C9768, Sigma-Aldrich, USA) and
250 µg/ml papain (Papain from papaya latex, P3125, Sigma-Aldrich, USA) were added to the 2X papain digestion
buffer. 200 µl of the mixture were added to each sample (which were inside the Eppendorfs used for the freeze
drying), and they were incubated overnight at 60C. The following day the samples were vortexed and incubated
at 60ºC for one more hour.
Afterwards, the PicoGreen assay was performed (once the samples were at room temperature). First, a standard
curve was made with a λDNA stock (QuantiT™ PicoGreen™ dsDNA assay kit, P11496, Thermo Fisher
Scientific, USA). This stock was 100 µg/ml, and before making the standard curve, it was diluted 50 times in 1X
TE buffer, obtaining a 2 µg/ml stock (A). The rest of the stocks for the standard curve, shown in Table 4, were
made mixing a part of A in 1X TE buffer:
Table 4. Volumes of A (λDNA) and TE buffer added to each point of the working curve, with their final DNA concentrations.
The final volume of each sample was 220 µl.

Standard curve

λDNA (A) V (µl)

1x TE buffer V (µl)

[λDNA] (ng/ml)

A

(already made)

(already made)

2000

B

176

44

1600

C

132

88

1200

D

88

132

800

E

44

176

400

F

22

198

200

G

11

209

100

H

0

220

0
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Then, the samples from the papain digestion were diluted in 1X TE buffer so that they fit in the working curve,
so if a high DNA amount is expected, a higher dilution should be applied. In the case of the hydrogels, they were
diluted 5 times. 100 µl of both the standard curve and the samples, in duplo, were added to a flat bottom 96-well
plate. Finally, the PicoGreen reagent was diluted 200 times in 1X TE buffer and kept in dark until use. 100 µl
were added to each well with a multi-channel pipette, incubated for 5 minutes in dark and measured. The
measurements were made in the Fluoroskan spectrofluorimeter (Fluoroskan Ascent FL, 5210450, Thermo Fisher
Scientific, USA), with an excitation/emission filter at 485/520 nm. The emission intensity of each well was saved
and transferred to an Excel file. The standard curve was made with the values of A-H samples, obtaining a linear
regression equation. This was used to calculate the DNA concentration of the rest of the samples (ng/ml), where
the 1:5 dilution was considered. The DNA amount was also calculated, using the 200 µl of the papain digestion
as volume.

2.7 DLP printing of hydrogels
Hydrogels were printed at the digital light processing (DLP) printer. First, the desired constructs were designed
in TinkerCAD (Autodesk, USA), modified (re-scaled in some cases) with Print Studio software (Autodesk, USA)
and processed with the Perfactory software (EnvisionTEC, Germany), where the print jobs were built and sent to
the Perfactory® 3 Mini (EnvisionTec, Gladbeck, Germany). The printer used a 60 mm lens, which allowed a
resolution of 50 µm, and every time before using was calibrated to set the desired light intensity. The intensity
varied until the optimal was found, and the irradiation time per layer was 10 seconds.
Hydrogels were 3D printed adding 2 ml of the precursor mixture to the centre of the baseplate, with care on not
leaving bubbles. The baseplate used was a special one for hydrogels, empty and highly hydrophobic. In this way,
the precursor liquid added did not spread through the plate and stayed where it was added. When hydrogels were
printed, for a maximum of 30 minutes, they were removed from the building plate using a scalpel blade and
washed in PBS for 15 minutes before analysing or using them. Both the building plate and the baseplate were
washed first with PBS and later with ethanol. The baseplate was handled and washed smoothly.
The settings used for printing hydrogels had an error where the bottom layers of the design were not printed. In
order to determine how thick was the unprinted part, a 4 x 4 x 4 mm 3 cube was printed using the same settings
and the photocurable resin PIC100. The z axis of the cube was measured to determine the thickness of this
unprinted part, and a layer this thick was added to the bottom of the hydrogel designs.

2.8 Characterisation of hydrogels
The hydrogel precursors were added to a glass slide, which was located at the printer. Different light energies
were irradiated to print Ø4 mm discs, and discs with different thicknesses were obtained. Pictures of the resulting
gels were taken, and their thicknesses, also known as the cure depth (Cd), were measured with ImageJ and plotted
versus the irradiation energy to obtain the working curve. The slope of these curves is the light penetration depth
(Dp), and the point where the working curves cut the x axis is the minimum irradiation energy required to crosslink
the hydrogel (Ec). The working curve was plotted following the equation (5):
𝐶𝑑 = 𝐷𝑝 ∙ ln

𝐸
𝐸𝑐

(5)
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A photoabsorber, Ponceau 4R (food colorant E124), a red dye, was also added to decrease the light penetration
depth. 0, 1 or 2% dye was added to each condition, Table 5 shows all the conditions that were tested.
Table 5. Summary of the hydrogel conditions tested for 3D printing.

Final concentration in mixture
Condition

Ru/SPS

Dye (%
v/v))

f-GelMA (%
w/v)

f-gelNB
(% w/v)

Ru
(mM)

SPS
(mM)

LAP (%
w/v)

P4A
(mM)

0

10

-

2

20

-

-

1

10

-

2

20

-

-

2

10

-

2

20

-

-

0

10

-

-

-

0,2

-

1

10

-

-

-

0,2

-

2

10

-

-

-

0,2

-

0

15

-

2

20

-

-

1

15

-

2

20

-

-

2

15

-

2

20

-

-

0

15

-

-

-

0,2

-

1

15

-

-

-

0,2

-

2

15

-

-

-

0,2

-

0

-

5

2

20

-

3,58

1

-

5

2

20

-

3,58

2

-

5

2

20

-

3,58

0

-

5

-

-

0,2

3,58

1

-

5

-

-

0,2

3,58

2

-

5

-

-

0,2

3,58

0

-

10

2

20

-

7,16

1

-

10

2

20

-

7,16

2

-

10

2

20

-

7,16

0

-

10

-

-

0,2

7,16

1

-

10

-

-

0,2

7,16

2

-

10

-

-

0,2

7,16

10%

f-GelMA

LAP

Ru/SPS
15%
LAP

Ru/SPS
5%

f-gelNB

LAP

Ru/SPS
10%
LAP

In previous experiments 0,05% LAP was used for f-GelMA, but this time the concentration was increased to 0,2%
to avoid oxygen inhibition. Ru/SPS hydrogels were printed at the Perfactory® 3 Mini, but the LAP hydrogels
were printed at the Ember printer (Autodesk, USA) at 405 nm wavelength. 2 samples per condition were printed.

24
Bioresin development for 3D lithography

Ane Urigoitia Asua

Master thesis

2.9 Positive and negative features, ECFC attachment discs
Some designs were printed at the Envisiontec printer to optimise the printing energy. Experiments were only
performed with the ru/SPS, 2% dye hydrogels, as LAP gels showed poor results. The following designs were
printed at 100, 80 and 65 mJ/cm2 energies:
-

Positive features (CAD design in Figure 6): 9,4 mm x 4 mm x 3,2 mm (x, y, z). In the z axis the printing
error (1,2 mm) was considered, so the real height of the design was 2 mm. The protuberances were 0,7
mm tall and 1 mm, 0,75 mm, 0,5 mm 0,3 mm, 0,2 mm, 0,1 mm and 0,05 mm wide respectively.

Figure 6. CAD design of positive features.

-

Negative features (CAD design in Figure 7): 8,7 mm x 4 mm x 3,2 mm (x, y, z). In the z axis the printing
error (1,2 mm) was considered, so the real height of the design was 2 mm. The channels had their first
0,5 mm (y) of 1 mm diameter to facilitate the perfusion, and the rest 3,5 mm varied: 1 mm, 0,75 mm, 0,5
mm 0,3 mm, 0,2 mm and 0,1 mm respectively.

Figure 7. CAD design of negative features.

-

Endothelial cell attachment discs (CAD design in Figure 8): Ø6 mm x 3,7 mm (z). In the z axis the
printing error (1,2 mm) was considered, so the real height of the design was 2,5 mm. The discs had an
inner empty disc of Ø4 mm x 1 mm (z), so that cells could be seeded without the cells falling from the
discs.

Figure 8. CAD design of ECFC attachment discs

The hydrogel conditions shown in Table 6 were tested.
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Table 6. Hydrogel conditions used for positive and negative features, and ECFC attachment discs.

Final concentration in mixture
Condition

f-GelMA
ru/SPS
f-gelNB
ru/SPS

Dye (%
v/v))

f-GelMA (%
w/v)

f-gelNB (%
w/v)

Ru
(mM)

SPS (mM)

P4A
(mM)

10%

2

10

-

2

20

-

15%

2

15

-

2

20

-

10%

2

-

10

2

20

7,16

After printing, pictures were taken. Positive and negative features were measured (the thickness of positive
features and the channel diameter of negative features) and compared to the theoretical size. In case of negative
features, horizontal and vertical diameters were compared, because generally there is some overcrosslinking in
the z axis, so the vertical diameter is smaller. The more similar both diameters were, the less overcrosslinking
there was, and the better result. Negative features were also perfused with a needle and a syringe containing red
dye.
Positive and negative features were kept in PBS at 5ºC, and ECFC attachment discs were kept in ethanol at 5ºC.

2.10 Printing of complex structures
Two designs were printed.
-

Branching channels (CAD design in Figure 9): f-GelMA 10% and 15% ru/SPS 2% dye hydrogels were
printed at 70 mJ/cm2 energy. The design was 10,5 mm x 8 mm x 3,2 mm (x, y, z). In the z axis the
printing error (1,2 mm) was considered, so the real height of the design was 2 mm. A Ø1 mm channel
branched into Ø0,8 mm channels, which branched in Ø0,6 mm channels.

Figure 9. CAD design of the branching channels structure

-

Spiral channel (CAD design in Figure 10): f-GelMA 8% + p-GelMA 2%, ru/SPS 2% dye hydrogels were
printed at 70 mJ/cm2 energy. The design was 7,5 mm x 2,4 mm x 3,2 mm (x, y, z). In the z axis the
printing error (1,2 mm) was considered, so the real height of the design was 2 mm. A Ø0,55 mm straight
channel crossed the structure, and a Ø0,55 mm spiral channel twisted around the straight channel.
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Figure 10. CAD design of the construct with the spiral channel

Pictures of both printed designs were taken, and they were perfused with the red dye.

2.11 DLP printing of cell-laden hydrogels
Ø6 mm x 3 mm designs (Ø6 mm x 1,8 mm with the error) of both 10% ru/SPS 2% red dye f-GelMA and f-gelNB
were printed with MSCs. For this purpose, reactives were prepared as in section 2.4 (f-GelMA and f-gelNB were
weighed in sterility and the rest -ru, SPS, P4A, dye- were sterile filtered) and equine MSCs passage 4 were cultured
and trypsinised as in section 2.3.1. The final concentration of cells was 20*10 6 MSCs/ml hydrogel, so a stock of
80*106 MSCs/ml was prepared. The final concentrations of each reactive are shown in Table 7.
Table 7. Hydrogel conditions used for printing with MSCs.

Final concentration in mixture
Condition

f-GelMA
(% w/v)

f-gelNB (%
w/v)

Ru (mM)

SPS (mM)

P4A (mM)

MSCs
(cells/ml)

f-GelMA 10% ru/SPS
2% dye

10

-

2

20

-

20*106

f-gelNB 10% ru/SPS
2% dye

-

10

2

20

7,16

20*106

As the printer was not in sterile conditioons, the baseplate was kept in ethanol for 20 minutes and the printer was
thoroughly washed with ethanol (the inner walls, the building pate, etc). Before starting the print, the ethanol was
removed from the baseplate and it was let dry. The hydrogel mixture was taken from the flow cabinet, added to
the printer and the print was started. When the print was finished, the discs were transferred to a sterile 6-well
plate and taken to the flow cabinet. Once there, they were washed in sterile PBS0 for 15 minutes, and then they
were transferred to a 48-well plate, where 1/3 of the hydrogels were cultured in chondrogenic medium, 1/3 in
hypertrophic medium and 1/3 in osteogenic medium for 28 days.
Chondrogenic differentiation medium:
-

Dubeco’s Modified Eagle Medium (DMEM) (1X) + GlutaMAX, + 4,5 g/l d-glucose, + pyruvate
(31966021, Thermo Fisher Scientific, USA):

48,5 ml

+

Fetal bovine serum (FBS):

10%

(5 ml)

+

Penicillin/streptomycin (P/S):

1%

(0,5 ml)

+

Ascorbic acid (ASAP):

1%

(0,5 ml)

+

Β-glycerophosphate (BGP):

1%

(0,5 ml)

+

Dexamethosane:

0,1 µM

(2 µl)
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Transforming growth factor β (TGFβ):

FRESH, 10 ng/ml (1 µl/ml)

Osteogenic differentiation medium:
-

Minimum essential medium α (α-MEM) (1X), without ribonucleosides or deoxyribonucleosides
(22561021, Thermo Fisher Scientific, USA):

43,5 ml

+

Penicillin/streptomycin (P/S):

1%

(0,5 ml)

+

Ascorbic acid (ASAP):

1%

(0,5 ml)

+

ITS premix:

1%

(0,5 ml)

+

Dexamethosane:

0,1 µM

(2 µl)

The hypertrophy was achieved by culturing the gels in chondrogenic medium for the first 14 days and then
switching to osteogenic medium. Medium was refreshed every 2-3 days. At day 28 of culture, hydrogels were
harvested, cut in 3 parts as shown in Figure 11, and one part was used for cartilage differentiation and DNA
quantification assays (DMMB and PicoGreen), another part for bone differentiation and DNA quantification
assays (ALP and PicoGreen), and the third part for histological analyses. 4 samples per condition were used.
chondrogenic
f-gelMA/
f-gelNB

chondrogenic
d14

chondrogenic
f-gelMA/
f-gelNB

d14

f-gelMA/
f-gelNB

1 2
3

osteogenic

1

2

3

2
3

harvest

1

2
3

harvest

1

2
3

d28

d14

histological
analysis

1

d28

osteogenic

osteogenic

harvest

d28

cartilage:
DMMB +
PicoGreen

1

2
3

bone: ALP +
PicoGreen

Figure 11. Schematic illustration of the culture of printed hydrogel discs and their treatment.

The histological analysis, DMMB and ALP are explained below, and the PicoGreen was performed as in section
2.6.

2.12 DMMB assay
The DMMB assay is the most commonly used technique to quantify glycosaminoglycans (GAGs), which are
abundant in the cartilage tissue. The dimethylmethylene blue (DMMB) reagent reacts with sulphates on the GAGs.
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Before the experiment, the hydrogels were freeze dried overnight and papain digested in PBS-EDTA overnight
as in section 2.6.
The next day, the DMMB assay was performed. First, a standard curve was made with chondroitin sulphate (CS).
A 0,5 mg/ml CS stock was diluted 50 times in PBS-EDTA buffer (A). The rest of the standard curve was obtained
diluting the previous point 2 times, as shown in Table 8.
Table 8. Concentrations of each point of the standard curves, and volumes to add to obtain them.

Standard curve

CS V (µl)

PBS-EDTA V (µl)

[CS] (µg/ml)

A

500

0

10

B

250 of A

250

5

C

250 of B

250

2,5

D

250 of C

250

1,25

E

250 of D

250

0,625

F

250 of E

250

0,3125

G

250 of F

250

0,15625

H

250 of G

250

0,078125

I

250 of H

250

0,0390625

J

0

250

0

Afterwards, the samples were diluted. As 1/4 hydrogel was used this time, a 1/3 dilution was made. Then, 100 µl
of the standard curve and samples were added in duplo to a flat bottom 96-well plate. Finally, 200 µl DMMB
staining solution were added to each well with a multi-channel pipette and the absorbance was measured by the
absorption microplate photometer (VersaMax ELISA, Molecular Devices, USA), at 525 and 595 nm. The results
were transferred to an Excel file.
To calculate the quantity of GAGs in each sample, the 525 nm absorbance was divided by the 595 nm absorbance
to extract the blank. Then, the standard curve was plotted with the polynomic formula (y = ax 2 + bx + c), and the
GAG concentration of the samples was obtained using this formula. The GAG quantity was the concentration
multiplied by the volume employed in the papain digestion (0,2 ml).
The chondrogenic differentiation was shown as GAGs/DNA, so the papain digested samples were also used for a
DNA quantification assay, performed according to the 2.6 section.

2.13 ALP test
Alkaline phosphate (ALP) is an early osteogenic marker, so it is used to determine osteogenesis. 250 µl
mammalian protein extraction reagent (MPER, 78503, Thermo Scientific Systems, USA) and frozen at -80ºC.
Afterwards, they were defrosted and grinded. The grinder was washed twice in PBS-Tween and twice in PBS
between samples. Once grinded, they were centrifuged for 5 minutes at 1500 rpm.
In the meanwhile, the ALP substrate solution and the standard curve were prepared. The first one was made adding
a pNPP tablet and a Tris buffer tablet to 20 ml MPER buffer. The second one was prepared by adding the ALP
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enzyme to the MPER buffer (A). The volumes used and the final ALP concentration on each tube is shown in
Table 9.
Table 9. Volumes and final concentrations of the standard curve.

Standard curve

ALP V (µl)

MPER V (µl)

[ALP] (U/ml)

A

0,5

249,5

2

B

125 of A

125

1

C

125 of B

125

0,5

D

125 of C

125

0,25

E

125 of D

125

0,125

F

125 of E

125

0,0625

G

125 of F

125

0,03125

H

0

250

0

Then, samples’ supernatant was collected, with care of not taking the pellet. The desired dilutions were made, in
this case, no dilution, and 100 µl of the standard curve and samples were added in duplo to a flat bottom 96-well
plate. Finally, 100 µl ALP substrate solution were added to each well with a multi-channel pipette and the
absorbance was measured by the absorption microplate photometer (VersaMax ELISA, Molecular Devices,
USA), at 405 and 655 nm, every minute for 30 minutes.
A standard curve of ALP activity/ml versus absorbance at 29 minutes was plotted to obtain a linear regression.
The equation of this regression was to the activity/ml of the samples to calculate their ALP activity. The activity
was calculated by multiplying the sample volume, 0,25 ml.
Moreover, the osteogenic differentiation was shown as GAGs/DNA, so the grinded and centrifuged samples were
also used for a DNA quantification assay, performed according to the 2.6 section.

2.14 Processing of samples for histological analysis
Part of the hydrogels were processed for histology. These were located inside cassettes (the gels prom the same
conditions in the same cassette) and left overnight in phosphate buffered 37% formaldehyde.
The following day, samples were dehydrated and prepared to embed in paraffin with the following steps:
1.

1h 70% ethanol

2.

1h 96% ethanol (x2)

3.

1h 100% ethanol (x2, the second was left overnight)

4.

1h xylene (x2)

5.

Minimum 2h liquid paraffin (in the oven at 60ºC), refresh once

Finally, samples were embedded in paraffin, cooled down in an embedding station (Leica EG1150 modular tissue
embedding center, Leica Biosystems, Germany) and stored for further analyses.
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2.15 ECFC attachment to hydrogel surface
The ability of endothelial colony forming cells (ECFCs) to hydrogel surfaces was tested. Different trials were
made:
1.

Printed hydrogel discs (in section 2.9), stored in ethanol to keep sterility, were rehydrated in sterile PBS0
twice overnight before performing the experiment.

2.

Hydrogels were casted in a 24-well plate, and many conditions were tested: f-GelMA 10% and 15%, fGelMA 9% and 14% with 1% p-GelMA (10% and 15% gel in total), f-GelMA 8% and 13% with 2% pGelMA (10% and 15% gel in total), p-GelMA 10% and 15%, f-GelMA 10% 0,5/5 mM/mM ru/SPS, fGelMA 10% with MSCs seeded on top, f-GelMA 10% + fibrinogen, f-GelMA 8% with 2% porcine
GelMA (10% gel in total) and non-fluorescent ECFCs. (*) The casted gels were washed overnight in
PBS before the experiment.

3.

Sterilely casted hydrogel discs in the silicon mould, washed thoroughly in sterile PBS to remove all
uncrosslinked residues: f-GelMA 10% and 15%, f-GelMA 8% and 13% with 2% p-GelMA (10% and
15% gel in total), p-GelMA 10% and 15%, f-GelMA 10% + fibrinogen. In one case condition medium
was used (**).

(*) Except from the case with 0,5/5 (mM/mM) ru/SPS, hydrogels had 2/20 mM/mM ru/SPS.
(**) Condition medium was used to check if cells did not attach to the gel surface because these released a toxic
compound. Thus, cells were not seeded on top of the hydrogel, but in a separate well where there was not a
hydrogel. When medium was changed, the medium that was in contact with the hydrogel was transferred to the
well with cells. If cells died, it would mean that hydrogels release a toxic compound which detached or killed the
cells.
The day of the experiment, ECFCs were trypsinised, counted (as in section 2.3) and added to the surface of the
hydrogels in a concentration of 6,6*10 5 cells/ml. The volume added corresponded to the one where 131,3 cells
per mm2 hydrogel were seeded.
After seeding the cells, they were left in the incubator for 30-45 minutes, so that the cells could attach to the
hydrogel, and after this period of time, 0,4 ml endothelial cell medium was added. Medium was changed every 23 days.
Fluorescent (green) pictures were taken every 2-3 days to check the evolution of the attachment. The samples on
the 24-well plate were observed at the inverted microscope, but the discs were observed at the upright fluorescence
microscope.

2.16 Statistical analysis
A two-way ANOVA, with a subsequent Bonferroni test, was performed to find significant statistical differences
between conditions. Different degrees of significance were taken into account: * for p < 0,05, ** for p < 0,01, ***
for p < 0,001 and **** for p < 0,0001.
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3. Results
3.1 Hydrogel characterisation
12 gel conditions were tested to select the best ones for further testing. First, the gels were characterised to
determine their crosslinking efficiency and stiffness. 6 gels per condition were made, 3 for the sol fraction,
swelling and gel content, and 3 for the compression testing.

3.1.1 Crosslinking efficiency and stiffness
The crosslinking efficiency was tested, by weighing the gels after a set of freeze drying and swelling steps. The
results are shown in Figure 12.

A

B

C

Figure 12. Crosslinking degree of different gel conditions, measured with different parameters: (A) sol fraction, (B) gel content
and (C) swelling ratio. Standard deviations (n=3) and significative differences are shown.

Besides, the stiffness of the gels was tested by a compression testing on the Dynamic Mechanical Analysis
machine. The results are shown in Figure 13.
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Figure 13. Stiffness of the 12 gel conditions, calculated from the compression test. Standard deviations (n=3) and significative
differences are shown.

Significant differences can be observed among gels. F-GelMA 5% gels were weak, the Ru/SPS ones dissolved
after being overnight in PBS, therefore, the sol fraction and swelling ratio could not be calculated. The LAP ones
did not dissolve, so the crosslinking efficiency could be calculated, being too weak. For the rest of conditions, the
f-gelNB 5% also have a poor crosslinking efficiency, as can be noted by the high sol fraction and low gel content
(Figure 12A and C). F-gelNB gels had a higher crosslinking degree than the f-GelMA ones, comparing the same
concentrations at the sol fraction and gel content. Comparing photoinitiators, there were no significant differences
in the sol fraction and gel content, but there were in the swelling ratio (Figure 12B). The majority of the gels
crosslinked with Ru/SPS absorbed more water than those crosslinked with LAP.
As for the stiffness (Figure 13), although f-GelMA 5% LAP gels could be used to obtain all the weights for the
crosslinking efficiency, they were too weak to perform the compression test. Apart from that, LAP gels were
clearly stiffer than Ru/SPS ones and the f-gelNB ones stiffer than those of the same concentration of f-GelMA.
At higher gel concentration, stiffer gels.
Taking into account these results, 5% f-GelMA and 15% f-gelNB were removed for further testing, the first one
because gels were too weak and they dissolved, and the last one because gels were too stiff.

3.1.2 Cell viability and proliferation
The conditions that were not discarded (f-GelMA 10-15% and f-gelNB 5-10%) were tested to check cell viability
and proliferation. MSCs were encapsulated, and a live/dead assay was performed for viability (Figure 14) and a
Picogreen assay and cell counting for proliferation (Figure 15).
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Figure 14. Cell viability over time, checked with a live/dead assay at day 1 and 7 after encapsulation. Minimum viability line
is shown in red (80% living cells). Standard deviations (n=3) and significative differences are shown.

A

B

Figure 15. Cell proliferation over time, measured with a DNA quantification assay, PicoGreen (A) and the cell count from the
live-dead images (B) at day 1 and 7. Standard deviations (n=3) and significative differences are shown.

Visually, f-gelNB gels were weaker than f-GelMA ones, and LAP gels similar or weaker than Ru/SPS gels, when
in the previous tests the contrary was concluded (in Figure 13). F-gelNB 5% LAP gels dissolved by day 7, so tests
could not be performed at that timepoint.
Regarding viability (Figure 14), most of the significant differences were at day 1, but by day 7 they were all at a
similar level, being the living:dead cell ratio higher than before. In general, all of them present a similar viability
ratio, higher than the minimum accepted one (80%), a week after cell encapsulation. The only exception was fgelNB 5% LAP, where there was no gel.
As for proliferation, the DNA concentration was significantly reduced from day 1 to 7 in all cases. At day 7,
differences could be observed among the f-GelMA group (Figure 15A), but not among the f-gelNB group.
Besides, when comparing 10% f-GelMA vs f-gelNB gels, the first ones had a higher DNA amount than the second
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ones, what correlates with higher living cell count. This decrease in DNA concentration was unusual, as it
generally either increases (17) or stays similar (29,31). Thus, the cell count of the living cells from the live:dead
assay at days 1 and 7 was plotted (Figure 15B). In this case, there were no significant differences, therefore, cell
number maintained over a week. Anyway, the cell proliferation experiment should have been repeated. No
conditions were discarded for the following experiments.

3.2 Bioprinting optimisation
Before printing complex structures and cells with the DLP stereolithography, the printing parameters were
optimized.

3.2.1 Printing error
The Envisiontec DLP printer has an error when printing with the settings used for hydrogels. A 4 mm cube was
printed with the hydrogels test and PIC100 (Figure 16) and the part that was not printed (error), was measured
(Table 10).

y

z

x

x

Figure 16. Cube printed with the DLP using PIC100 and the hydrogel settings from the software. Theoretically all sides had
the same length, 4 mm. Pictures were taken at the microscope with 2.5x magnification.
Table 10. Measurements taken from all the sides of the cube. Each side was measured twice, using ImageJ and making the
conversion to µm with the 2.5x scalebar. Standard deviation (sd) shown (n=2).

Axis

Average length (µm)

sd

x

4016,84

10,38

y

3998,60

26,95

Z

2848,76

25,83

The z side is smaller, as can be seen in both Figure 16 visually, and Table 10 checking the size of each. Both the
x and y sides had the theoretical size, 4000 µm approximately (4 mm). However, the z side was smaller, with
around 2,85 mm. The error was calculated:
4007,72 (𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑏𝑒𝑡𝑤𝑒𝑒𝑛 𝑥 𝑎𝑛𝑑 𝑦) − 2848,76 = 1158,96 𝜇𝑚 ≈ 1,16 𝑚𝑚
Therefore, every time hydrogels were printed a 1,2 mm extra layer that would not be printed was added at the
bottom part of the design.
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3.2.2 Working curves
Working curves were made for both f-GelMA and f-gelNB, Ru/SPS (Figure 17) and LAP (data not shown). The
Ru/SPS gels were made with the Envisiontec DLP and the LAP gels with the Atum DLP.
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Figure 17. Working curves of gels with Ru/SPS, f-GelMA 10% (A), f-GelMA 15% (B), f-gelNB 5% (C) and f-gelNB 10%
(D). The curves were calculated measuring the thickness of discs at different irradiated energies. Standard deviation is shown
in the graphs (n=2).

The same experiment was performed using LAP. However, the results were not good. Using the lowest energy
where gels could be crosslinked, the light penetration depth was too high (around 300 µm). As a result, it was
decided to continue with the experiments only with the Envisiontec and Ru/SPS gels.
For the Ru/SPS group (Figure 17A and B), the trendlines with their equations were calculated in each graph.
These equations are used to calculate the EC, the minimum energy needed to crosslink the gel (in Table 11), with
the following the equation 5 mentioned in the 2.8 section:
𝐶𝑑 = 𝐷𝑝 · ln

𝐸
𝐸𝐶

→

𝐸𝐶 = 𝑒 −𝑏/𝑠𝑙𝑜𝑝𝑒

(5)
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Table 11. Minimum energy needed to crosslink the gel, obtained from the working curves. ln E C was obtained by -b/slope.

b

slope

ln EC

EC (mJ/cm2)

no dye

-465,41

147,48

3,16

23,47

1% dye

-375,62

122,99

3,05

21,20

2% dye

-385,05

101,51

3,79

44,40

no dye

-562,25

206,28

2,73

15,27

1% dye

-416,82

134,87

3,09

21,99

2% dye

-826,8

198,40

4,17

64,54

no dye

-222,20

93,81

2,37

10,68

1% dye

-294,79

91,38

3,23

25,18

2% dye

-478,57

118,85

4,03

56,07

no dye

-145,93

71,00

2,06

7,81

1% dye

-319,34

96,51

3,31

27,35

2% dye

-339,04

95,78

3,54

34,46

Condition

F-GelMA

10%

15%

F-GelNB

5%

10%

Once the minimum energy was calculated, the best condition for printing was selected, as well as the minimum
printing intensity for each of them. The dye was used to increase the minimum energy, which is preferable. Thus,
for all conditions the 2% dye was selected. As for the energy, all of them were between 35 and 65 mW/cm 2. Most
of the following experiments and trials were performed with f-GelMA 10% 2% dye.

3.2.3 Positive and negative features
The resolution for printing hydrogels was tested, by printing positive and negative features, and perfusing the
negative features (Figure 18).
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Figure 18. F-GelMA 10% 2% dye prints. Front view of positive features (A), bars with the theoretical width of each feature
(µm). Back view of negative features (B), bars with the theoretical diameter of each channel (µm). Top view of negative
features (C), perfused with red dye. Condition: f-GelMA 10% 2% dye 65 mJ/cm2. Pictures were taken at the microscope with
1.5x magnification.

For f-GelMA, different conditions and intensities were tested, being 10% 2% dye 100 mJ/cm 2, 10% 2% dye 80
mJ/cm2, 10% 2% dye 65 mJ/cm2 and 15% 1,5% dye 100 mJ/cm2 the best ones. The printed constructs were
compared among them, by measuring the width of the positive and the diameter of the negative features on imageJ,
and the channels were perfused. For the negative features, the horizontal and vertical diameters were calculated
to detect the overcrosslinking (explained in section 2.9). By obtaining the ratio between the vertical and horizontal
diameters, the circularity of the channels was calculated. In the following tables (Table 12 and 13), the comparison
among these four conditions was made.
There were some difficulties printing 15% f-GelMA. The obtained constructs were brittle in the top layers,
resulting in broken positive features or channels most of the times. For this reason, it was chosen to reduce the
dye concentration from 2% to 1,5%.
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Table 12. Comparison among the width of the positive features printed with f-GelMA. The closer to the theoretical, the better.

F-GELMA – POSITIVE FEATURES
Measured thickness (µm)

Column
thickness
(µm)

10% 2% dye 100
mJ/cm2

10% 2% dye 80
mJ/cm2

10% 2% dye 65
mJ/cm2

15% 1,5% dye 100
mJ/cm2

1000

1318,96552

982,758621

1094,82759

1215,51724

750

1000

767,241379

844,827586

922,413793

500

714,285714

560,344828

593,406593

653,846154

300

500

494,505495

423,076923

445,054945

200

285,714286

230,769231

291,208791

274,725275

100

159,340659

-

153,846154

153,846154

50

-

-

-

-

Table 13. Comparison among the circularity of the negative features printed with f-GelMA. The closer to the 1, the better.

F-GELMA – NEGATIVE FEATURES
Circularity
Channel
size (µm)

10% 2% dye 100
mJ/cm2

10% 2% dye 80
mJ/cm2

10% 2% dye 65
mJ/cm2

15% 1,5% dye 100
mJ/cm2

1000

0,78854626

0,82524272

0,9009009

0,92741935

750

0,9005848

0,93333333

0,95930233

0,92307692

500

0,88888889

0,89473684

0,94915254

0,89830508

300

0,83333333

0,87179487

0,925

0,85294118

200

-

-

0,95652174

-

100

-

-

-

-

In both positive and negative features, the 10% 65 mJ/cm2 was the best option. The positive features were closer
to the theoretical size, and the negative features were the most circular ones. Besides, only the 65 mJ/cm 2 gel was
perfusable until the third channel (500 µm), being the other 10% gels until the second (750 µm) and the 15% one
only in the first (1 mm). The last one might have been because of the dye concentration used (1,5% instead of
2%), but as explained before, it was difficult to print full constructs at this gel concentration and 2% dye.
On the other hand, the same experiment was performed with f-gelNB. Trials with both 5% and 10% gel
concentration (2% dye) were made, but the obtained prints were poor, as it is shown in Figure 19.
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Figure 19. F-gelNB 10% 2% dye prints. Back view of positive features (A) and back view of negative features (B). Condition:
f-gelNB 10% 2% dye 65 mJ/cm2. Pictures were taken at the microscope with 1.5x magnification.

The figure shows the best results obtained with gelNB. Generally, the prints were broken, as part stayed
crosslinked on the baseplate (where the resin was located) instead of remaining on the building plate. Hence, most
of the printing experiments were performed with GelMA.

3.3 Osteogenesis and chondrogenesis of bioprinted hydrogels
Both f-GelMA and f-gelNB 10% were printed with 2% dye and at 70 mJ/cm2 energy with MSCs embedded. These
were cultured in chondrogenic, hypertrophic and osteogenic medium for 28 days. At day 28, gels were harvested
to perform DMMB, ALP and PicoGreen tests. Results for chondrogenesis and osteogenesis are shown in Figure
20.
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Figure 20. DMMB quantification (A) and ALP quantification (B) at day 28 of culture. DMMB was used to quantify GAGs
(cartilage formation) and ALP for bone formation. Values were normalised for DNA quantity. Standard deviations (n=4) and
significative differences are shown.

Although f-gelNB gels were also printed, they had the same problem as when positive and negative features were
printed. As a result, the gels were thinner than the f-GelMA ones, most of them dissolved over the 28 days, and
the ones that did not dissolve were extremely small and had undetectable GAG, ALP and DNA amounts.
Therefore, they were discarded. Regarding GelMA hydrogels, cartilage production was significantly higher in the
gels with chondrogenic medium (Figure 20A). For bone production, f-GelMA gels cultured in osteogenic medium
had significantly higher ALP values than those cultured in chondrogenic medium. Thus, MSCs printed in fGelMA gels could differentiate into cartilage and bone, whereas more testing should be done with f-gelNB to
reach to a conclusion.
The harvested gels were also processed for histology, but these assays still need to be performed.

3.4 Printing of complex structures
Complex channels were printed to ensure that a vascular model could be printed in hydrogels with DLP lithograpy.
Multiple channels that branched at different levels and spiral channels were printed.

3.4.1 Branching channels
The model shown below was printed (Figure 21) with f-GelMA 10% and 15%, 2% dye and 70 mJ/cm2 energy.
The constructs were perfused with red dye.
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Figure 21. Printed structure with branching channels, f-GelMA 10% 2% dye 70 mJ/cm2 energy. The bars (A) show the
theoretical diameter of the channels. The channels with 600 µm diameter were designed at different levels, being the external
ones slightly upper and the internal ones slightly lower than the rest. The channels were perfused (B). 3 gels per condition
were printed. Pictures were taken at the microscope with 1,2x magnification.

Perfusing 10% gels was easier than 15% gels. Moreover, it has been previously mentioned that printing 15% gels
carried some difficulties. Thus, it was determined that 10% gels had a better printing resolution. The 2 best gels
were fixed in formalin to further perform a microCT.

3.4.2 Spiral channel
Apart from the branched channels, a structure with a straight channel at the centre and a spiral channel surrounding
it was printed (Figure 22), with GelMA 10% (mixing 8% fish and 2% porcine), 2% dye and 70 mJ/cm 2. It was
perfused with red dye.
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Figure 22. Printed structure with spiral channel, f-GelMA 8% - p-GelMA 2%, 2% dye 70 mJ/cm2 energy. The theoretical
diameter of the channels is 550 µm. The gel after being printed (A) and after being perfused (B). 6 gels were printed. Pictures
taken at the microscope with 2.0x magnification.

In this case, only the first two-three twists could be perfused. A possible reason might be the fact of adding the
2% porcine GelMA, or the difficulty of the dye going from the lower part to the upper part of the twists. Anyway,
the printing energy should be optimized again. The 2 best gels were fixed in formalin to further perform a
microCT.

3.4 ECFC attachment to hydrogel surface
The attachment of the endothelial cells to the surface of gels was tested. To ensure that endothelial cells would
attach to the walls of channels, a preliminary test was performed printing discs with a wall surrounding them
(Figure 23). 4 conditions were printed, f-GelMA 10% 2% dye 100, 80 and 65 mJ/cm2, and f-GelMA 15% 1,5%
dye 100 mJ/cm2.

A

B

Figure 23. Pictures of the discs used to seed endothelial cells on top, top view (A) and 3/4 view (B). Images were taken at the
microscope with 1.5x magnification. 10% f-GelMA 2% dye, 65 mJ/cm2 is shown in the figure.

These gels were used to seed fluorescent endothelial cells on top, and their attachment and ability to generate a
monolayer and cover the surface of the gels was tested (Figure 24).
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Figure 24. Evolution of the endothelial cell attachment to the surface of gels. 10% f-GelMA 2% dye 65 mJ/cm2 is shown in
the figure, at day 0, 1, 3, 6 and 7 (A-E, respectively). Pictures were taken at the upright fluorescence microscope, 4x
magnification. 4 gels per condition were used.

Only pictures of the best condition are shown, because all had a similar trend. Cells seemed to grow on the first
two days, but they did not attach and form monolayers, and they died over time.
The same experiment was performed with the gels casted in a 24 well plate. Many different conditions were tested
(shown in the 2.15 section), obtaining slightly better results with the gels containing 1% or 2% porcine GelMA.
The results are shown in Figure 25 and 26.
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Figure 25. 9% f-GelMA + 1% p-GelMA gels. Pictures were taken at the inverted microscope at different magnifications, at
day 1, 3 and 6 after adding the cells. 2 gels were made per condition.
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Figure 26. 14% f-GelMA + 1% p-GelMA gels. Pictures were taken at the inverted microscope at different magnifications, at
day 1, 3 and 6 after adding the cells. 2 gels were made per condition.

In both cases (Figures 25 and 26), cells seemed to be forming monolayers at day 1. However, no proliferation was
observed at day 3, and most of the cells were not attached by day 6. Furthermore, the attached cells did not look
like normal endothelial cells when they form a monolayer, where cells have a more polygonal shape rather than
being stretched (an example is shown on Figure 27). The day 6 10% gel picture at 20x magnification is not the
shape or size endothelial cells have, probably some cells were converged because they were dying.

Figure 27. ECFCs attached to GelMA hydrogels, forming a monolayer (10). Picture taken at day 5 with 10x magnification.

None of the tested conditions worked, and it was speculated that it could have been due to the toxic molecules the
gels released when they were not washed properly.
To determine if the last point was a problem, 6 mm diameter gels were casted and washed thoroughly during days.
When they stopped releasing orange dye (due to the ruthenium), endothelial cells were attached on top. In one of
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the conditions (f-GelMA 15%) condition medium was used in cells seeded wells without hydrogels (explained in
the 2.15 section). In this way it could be proved if gels released a toxic compound that kills the cells. Results are
shown in Figure 28.
Day 4

Day 6

Day 8

Day 11

Figure 28. Fluorescent endothelial cells attached to the bottom of the 48-well plate. Images taken at the inverted fluorescence
microscope at 10x magnification. Medium in contact with gels without cells was added at day 4 and 7.

The pictures show that not only cells did not die, but they proliferated when they were seeded in plastic (coated
with collagen). The medium that had previously been in contact with gels did not cause any damage to cells in
attachment or proliferation. Therefore, toxicity of hydrogels was not the reason why cells did not attach and died.

4. Discussion
Photocrosslinkable hydrogels are highly used for tissue engineering applications, because their properties (sol
fraction, swelling, stiffness) are tunable and they allow high cell viability (36). Getalin methacrylate (GelMA) is
one of the most commonly used hydrogels (33). However, hydrogels functionalised with methacrylate polymerise
in a chain-growth reaction that may not be suitable for some cell types (30). For this reason, hydrogels that are
polymerised via thiol-ene photoclick reactions, such as gelatin norbornene (gelNB) are preferred (5,24,28,30), but
gelNB has not been well explored yet. Besides, UV light has been more widely used for the light-induced
crosslinking, but long UV exposure results in DNA damage (21). Hence, new strategies are being explored using
visible light, such as the ru/SPS system (22,31,42).
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Theoretically, gelNB hydrogels crosslinked with ru/SPS would be the most suitable for tissue engineering
applications, due to the previously mentioned advantages that both the gel precursor and the photoinitiators
present. Nevertheless, the use of this combination has not been reported yet, therefore, different hydrogel
combinations of GelMA, gelNB, ru/SPS and LAP were characterised and compared. Apart from that, cold fish
gelatin was used instead of the regularly used porcine gelatin, due to its lower gelling point (33), which facilitates
its applicability to DLP printing.
When the crosslinking efficiency and stiffness of gels was analysed, f-gelNB hydrogels had a higher gel content
than their f-GelMA equivalents, which means that their crosslinking efficiency was higher on f-gelNB gels.
Besides, swelling ratio of gels was analysed because it is related to mechanical properties of gels (36). This
parameter is inversely proportional to the gel content, as the gel content increases with the density of the networks
generated, and the swelling capacity of the gel is lower when these networks increase (43). In general, ru/SPS gels
swelled more than LAP gels. According, to Lim et al. (31), GelMA 10% Ru/SPS gels had a sol fraction of around
10% and a swelling ratio of 9-10, whereas in this case, the sol fraction was 28% and the swelling ratio 14.
However, it must be underlined that they used porcine GelMA, not fish GelMA, so the differences may lie in the
source of the gelatin. When compared to p-GelMA, f-GelMA gels showed a higher swelling ratio (32).
Apart from that, the Young’s modulus obtained by the compression test were also compared. This parameter is
related to the swelling ratio, increasing when the swelling decreases and vice-versa (44). F-gelNB and LAP
hydrogels were stiffer when compared to f-GelMA and Ru/SPS respectively. Besides, Yoon et al. and Wang et
al. (32,33) compared, among other factors, the stiffness of fish and porcine GelMA, showing that gelatin from
cold-water fish had a lower elastic modulus than the porcine one. It has been also shown that the degree of
methacrylation of the hydrogel affects the stiffness, increasing with the methacrylation (10,17,32,36,45). In our
case, highly methacrylated (80%) fish hydrogels were used, as Yoon et al. did (32), obtaining a result of around
5 kPa, 13 kPa and 47 kPa for 5%, 10% and 15% f-GelMA respectively. These are slightly higher than the LAP fGelMA results, 8 kPa and 35 kPa for 10% and 15% f-GelMA, probably because of the different photoinitiator
used by Yoon et al., Irgacure 2959. Too weak hydrogels degrade easily and do not provide cells with mechanical
support, and too stiff hydrogels do not allow cells to migrate into it and the ECM they release stays confined
around the cells instead of spreading all over the gel. For this reason, too weak (f-GelMA 5%) and too stiff
hydrogels (f-gelNB 15%) were discarded.
Hydrogels are known to support cell growth with high viability (36). This could be observed in the results, where
cell viability was over 80% by day 7 in all the conditions (except from 5% f-gelNB LAP gels, which degraded
over time). Many authors have encapsulated different cell types in different hydrogels before. For example, Nichol
et al. and Wang et al. encapsulated fibroblasts in different GelMA concentrations (21,33,36), Muñoz et al. and
Lim et al. used MSCs (30,31). Lim et al. compared the use of the visible light (ru/SPS) to the UV light (Irgacure
2959), determining that the visible light provided a higher cell viability (of around 85%, similar to the results of
f-GelMA ru/SPS day 7). Muñoz et al. compared MSCs viability encapsulated in GelMA and gelNB, where they
determined that gelNB gels showed higher cell viability than GelMA ones. However, the differences in both
visible and UV light-induced crosslinking, and f-GelMA and f-gelNB are not significant for these experiments,
therefore, these premises cannot be confirmed. Finally, Lin et al. (8) reported that 0,125% or higher LAP

48
Bioresin development for 3D lithography

Ane Urigoitia Asua

Master thesis

concentrations were toxic for cells. For f-GelMA gels, 0,05% LAP was used, but for f-gelNB gels, 0,2% LAP was
used. This might be the reason why in Figure 14 cell viability is poor in f-gelNB LAP gels at day 1.
On the other hand, cell concentration in gels decreased in more than two-fold in almost all cases, meaning that
cells did not proliferate and died over time. These results are supported by Celikkin et al. (27), who observed a
decrease in DNA content over time when MSCs were encapsulated in GelMA. However, they contrast with the
results obtained by other authors (9,21,31,32), where cells embedded in hydrogels proliferate over time. Despite
the use of other photoinitiators or cells, in all cases they grow two to three times when embedded in GelMA, even
when UV light is used. Lim et al. (31) proved that the use of ru/SPS photoinitiators improves cell proliferation
over Irgacure 2959. Besides, according to Yoon et al. (32), there are no significant differences in cell proliferation
among porcine and fish GelMA. Unfortunately, gelNB hydrogels are not comparable to previous literature. As
the results obtained show the opposite of what has been previously stated, microscopy pictures from the live-dead
assay were used to compare the cell count from day 1 to 7. Figure 15B shows that the number of cells remains
stable in all cases except from f-GelMA LAP gels, where there is not even a significant decrease. Therefore,
although literature already shows that ru/SPS gels outperform Irgacure or LAP gels, the proliferation test should
be repeated in order to obtain a reliable conclusion and decide if there are significant differences among f-GelMA
and f-gelNB.
Printability of hydrogels was tested by the generation of working curves in the DLP for all conditions (f-GelMA,
f-gelNB, ru/SPS and LAP). The use of the photoabsorber (Ponceau red) was intended to decrease the light
penetration depth of hydrogels, and thus, make the printing porcess more tunable and controllable. The working
curves provide an approximate information of the irradiation light energy required to obtain a high resolution on
the prints, contributed by the thickness of the layers printed, the thinner the better. Working curves were correct
and linear for ru/SPS gels, however, with LAP hydrogels, they were not linear, being the light penetration depth
too high for printing gels with small channels (the thinnest layers were 300 µm, whereas with ru/SPS 50-70 µm
layers could be obtained). In any case, it has been previously reported that long UV or near-UV light exposure,
decreases cell viability and is mutagenic (4,31). Moreover, in order to reduce oxygen inhibition with GelMA,
LAP concentration was increased to 0,2%, which has been previously mentioned to be toxic (8). Thus, even if
LAP hydrogels were printable, cells would have a poor viability. Apart from that, it has been proven that oxygen
inhibition deteriorates the final result of the print, what occurs using photoinitiators such as LAP or Irgacure 2959,
but not with ru/SPS (22). For this reason, all experiments were continued using only ru/SPS and visible light, with
2% photoabsorber.
When the hydrogels were printed, f-gelNB failed in all the printed designs. Part of the gels were on the building
platform where the prints should be, but other parts were on the baseplate where the resin is. It was hypothesized
that this occurred because f-gelNB reacts faster than f-GelMA, as it has no oxygen inhibition (30). Thus, it was
thought that the bioresin placed at the beginning of the print gelated before the print finished, staying, in part, on
the baseplate. Furthermore, when 15% f-GelMA prints were more brittle and the top layers (the ones that print in
the end) were not well crosslinked. Therefore, almost all the gels were printed with 10% f-GelMA. The printing
resolution was good, proven by the positive features, where 100 µm thick columns could be printed. However,
not all channels from the negative features were open and perfusable, and energy was decreased to obtain more
open channels. The best results were obtained with a 65 mJ/cm 2 irradiation energy, where 500 µm channels were
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perfusable. Besides, branched channels of 1 mm, 800 µm and 600 µm diameter were successfully printed and
perfused, demonstrating that a complex vascular model could be printed with the DLP. It has been previously
demonstrated (18) that comparing hydrogel channelled constructs over non-channelled ones, cell viability (90%
over 55% at day 7) and osteogenesis (40 times higher ALP activity in channelled ones at day 14) is significantly
higher in the first ones. Therefore, the viability of printing channels with DLP implies a great advance for longterm 3D culture and tissue engineering
Apart from that, MSCs were printed with the DLP in hydrogel discs, where chondrogenesis and osteogenesis were
checked at day 28. F-gelNB discs were not printed correctly and reliable results could not be obtained, so only
differences among f-GelMA gels were compared. It was observed that ALP activity was significantly higher on
gels cultured in osteogenic medium. However, ALP is an early osteogenic marker. Celikkin et al. (27) measured
osteogenesis over time in GelMA hydrogels, noticing that ALP activity had a peak at day 14 but decreased
afterwards. Thus, ALP measurement would be a more suitable approach for a day 14 timepoint, and a calcium
deposition assay could be performed at day 28 instead, as Celikkin et al. showed (27). Despite this issue, it was
proven that MSCs printed in hydrogels were able to undergo osteogenesis. Regarding chondrogenesis, there were
significant differences among the 3 culture mediums at day 28, being the chondrogenic medium the best one.
Nevertheless, these results were worse than the ones in the literature, where MSCs embedded in GelMA showed
a ratio of GAGs/DNA of 125 (46). The difference could be related to the use of f-GelMA instead of p-GelMA,
the photoinitiator or the printing process. Moreover, according to Li et al. (7), hydrogels with 30 kPa of stiffness
show better results at maintaining a cartilaginous phenotype in MSCs, thus, stiffness of hydrogels should be also
considered for this purpose. In any case, this experiment should be repeated to include a day 1 (and maybe a day
14) timepoint and include the f-gelNB gels.
Finally, the attachment of ECFCs and their ability to form monolayers on the f-GelMA surface was tested, with
poor results. Cells did not attach and died over time and it was due to neither the use of fish GelMA (because tests
were also performed in porcine GelMA and a fibrinogen coating, with similar results), nor the hydrogels releasing
a toxic compound that killed ECFCs (because cells attached to the bottom of the plate and did not die when
medium in contact with gels was added). Various authors worked on endothelial cell attachment to GelMA before.
Klotz et al. (10) seeded GFP-ECFCs on GelMA 5% hydrogels, forming a confluent monolayer by day 10 in gels
with 50% methacrylation degree. Cells detached from 30% methacrylated gels, and the experiment was not
performed in highly methacrylated gels (the gels used in our experiments were 80%). Nichol et al. (36) seeded
GFP-HUVECs on the surface of hydrogels with different GelMA concentrations, proving that cells adhered better
to more concentrated GelMA gels, and Gauvin et al. (20) seeded the same cells on a GelMA scaffold with
hexagonal pores, covering all the surface in 4 days. All these results were with porcine GelMA, which might differ
to the use of fish GelMA. However, Yoon et al. (32) showed no difference between cell attachment to fish or
porcine GelMA surface, and no difference between medium (55%) or high (90%) methacrylation degree (although
they were fibroblasts, not endothelial cells). Moreover, it has also been shown that HUVECs attach to the channels
inside p-GelMA (18,36). Bertassoni et al. (18) tested endothelial cell attachment to channels with different
diameters, demonstrating that in all of them cells eventually form confluent monolayers. All these references share
the use of Irgacure 2959 as a photoinitiator, so the use of ru/SPS might have a negative effect on the capacity of
ECFCs to attach to hydrogels. Hence, a control with an Irgacure 2959 hydrogel should have been used to compare
the effect of the photoinitiator on cell attachment.
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5. Future prospects
Some experiments should be repeated or performed in the future to obtain vascularised hydrogels where MSCs
could proliferate and derive into either bone or cartilage. First, the MSCs should be embedded again into both fGelMA and f-gelNB hydrogels and cultured for 7 days to repeat the proliferation analysis. If the results show
again that DNA concentration decreases in a week period, it means that cells do not survive in these gel
formulations.
Second, the problem of 3D printing with f-gelNB should be solved. To do so, first gelNB gels should be casted
with lower photoinitiator concentrations and see if there is little change in crosslinking efficiency and stiffness.
This needs to be tested because literature shows that gelNB gels can be generated with lower photoinitiator
concentrations (39). Once the formulation with the lowest acceptable photoinitiator concentrations is achieved,
the gels should be 3D printed and whether the problem is solved or not should be checked. Lower printing energies
could also be tested until obtaining the best printing parameters to achieve high resolution constructs.
Third, the chondrogenesis and osteogenesis assays should be repeated, this time with f-gelNB gels and new
timepoints at day 1 and 14 apart from the day 28. A late osteogenic marker, like calcium deposition, could also
be measured.
Finally, the endothelial cell attachment problem should be solved. More different conditions could be tested to
find the reason why it did not work, including f-gelNB hydrogels, and a control with Irgracure 2959, which most
of the attachment experiments are performed with in the literature.
Once all these problems are solved, the final experiment could be performed: printing both f-GelMA and f-gelNB
hydrogels with embedded MSCs and complex channels. ECFCs would be then seeded in the surface of the
channels and the constructs would be cultured to check the feasibility of the vascularisation and development of
bone.

6. Conclusions
In summary, this study showed that fish GelMA hydrogels could be employed to print complex channelled
structures with perfusable channels as small as 500 µm thick. Besides, these hydrogels could also be printed with
MSCs and differentiate into osteocytes and chondrocytes. In general, gels crosslinked with ru/SPS photoinitiators
showed better results than the ones with LAP. These were similar in crosslinking efficiency and mechanical
properties, but better in cell viability and proliferation. On the other hand, there were no differences among GelMA
and gelNB hydrogels, proving that gelNB gels can be used instead of GelMA ones due to the oxygen inhibition
that the latter show. Apart from that, the 3D printing of the hydrogels with the DLP printer was optimised, with
positive results for f-GelMA ru/SPS but poor results for f-gelNB ru/SPS. Finally, the attachment of endothelial
cells to the surface of the GelMA ru/SPS hydrogels was not achieved.
In conclusion, f-GelMA crosslinked with ruthenium and SPS is an adequate hydrogel to print complex channelled
and perfusable constructs with the DLP, and it is also capable of embedding MSCs that grow and differentiate.
However, the gelNB with ruthenium and SPS still needs to be optimised for printing, and endothelial cells cannot
attach to the surface of the hydrogels. Once these two problems are solved, f-GelMA and f-gelNB with ruthenium
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and SPS will be promising bioinks to print vascularised models with embedded MSCs and endothelial cells seeded
on the surface of the channels.
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